[
  {
    "question_number": "Q57",
    "question_text": "A patient presents with hyperphagia, personality changes, and memory loss. What is the likely diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Normal pressure hydrocephalus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests diagnosis of a dementia syndrome (FTD) based on classic behavioral and cognitive symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q48",
    "question_text": "In the case of Gerstmann syndrome, what is the associated language deficit?",
    "options": "{\"A\": \"Anomic aphasia\", \"B\": \"Wernicke\\u2019s aphasia\", \"C\": \"Transcortical motor aphasia\", \"D\": \"Conduction aphasia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about a specific cognitive deficit (language impairment) associated with Gerstmann syndrome, a cluster of symptoms often discussed in the context of focal cortical dysfunction and cognitive neurology/dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q32",
    "question_text": "To differentiate between frontotemporal dementia (FTD) and Alzheimer's disease (AD), which imaging modality is most useful?",
    "options": "{\"A\": \"PET scan\", \"B\": \"MRI\", \"C\": \"CT brain\", \"D\": \"CSF\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of diagnostic tools (neuroimaging) used specifically to differentiate between major dementia subtypes.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q80",
    "question_text": "For the same patient, what treatment would you recommend?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Lifestyle modification\", \"C\": \"Memantine\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of treatment options (pharmacological vs. non-pharmacological) for a dementia condition implied by the context (\"same patient\", likely from a preceding dementia scenario).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient presents with visual hallucinations and fluctuating levels of consciousness, with symptoms suggesting parkinsonism. What is the most likely diagnosis?",
    "options": "{\"A\": \"Lewy body disease\", \"B\": \"Idiopathic Parkinson's disease\", \"C\": \"Amyotrophic lateral sclerosis\", \"D\": \"Frontotemporal dementia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Dementia with Lewy Bodies based on its core clinical features.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q45",
    "question_text": "A 70-year-old male presented with a shuffling gait, freezing, and urinary incontinence. Upon examination, he has a stooped posture and unsteady gait. What is the diagnosis?",
    "options": "{\"A\": \"Normal Pressure Hydrocephalus\", \"B\": \"Vascular Dementia\", \"C\": \"Parkinson's Disease\", \"D\": \"Progressive Supranuclear Palsy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing Normal Pressure Hydrocephalus (NPH), a treatable cause of dementia and gait disturbance, based on its characteristic triad.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q25",
    "question_text": "What is the differentiating feature between Alzheimer disease and Lewy body dementia?",
    "options": "{\"A\": \"Sleep disturbance\", \"B\": \"Brain atrophy on MRI\", \"C\": \"Anterograde memory loss\", \"D\": \"Early shuffling gait\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of key clinical features that help distinguish between two common dementia syndromes (AD vs. DLB).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q71",
    "question_text": "In a scenario of Mild Cognitive Impairment (MCI), what is the recommended treatment?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"High dose Vitamin E\", \"C\": \"Cognitive training and lifestyle modification\", \"D\": \"Memantine\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about management strategies for Mild Cognitive Impairment (MCI), focusing on potential treatments.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q68",
    "question_text": "A patient with increasing forgetfulness had to change his bank ATM card because he misplaced it. This has affected his activities of daily living (ADLs), but he is doing well at work. This presentation is suggestive of:",
    "options": "{\"A\": \"Mild Cognitive Impairment (MCI)\", \"B\": \"Dementia\", \"C\": \"Normal age-related memory loss\", \"D\": \"Delirium\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to differentiate between Mild Cognitive Impairment (MCI) and Dementia based on the impact on activities of daily living (ADLs).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q61",
    "question_text": "Dementia with Lewy Bodies (DLB)",
    "options": "{\"A\": \"Characterized by early memory loss and language deficits\", \"B\": \"Typically presents with prominent visual hallucinations and fluctuating cognition\", \"C\": \"Is primarily caused by vascular pathology\", \"D\": \"Does not involve parkinsonism features\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: This MCQ likely refers to identifying DLB from a preceding case description or asks a question about it. It directly relates to a specific dementia diagnosis.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q55",
    "question_text": "A 70-year-old male presents with cognitive decline, ataxia, and a startle response. What is the likely diagnosis?",
    "options": "{\"A\": \"Alzheimer\\u2019s disease\", \"B\": \"Lewy body dementia\", \"C\": \"Normal pressure hydrocephalus\", \"D\": \"Creutzfeldt-Jakob disease\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the differential diagnosis of cognitive decline associated with motor features (ataxia, startle response), potentially pointing towards CJD or other rapidly progressive dementias/movement disorders.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q52",
    "question_text": "In the context of Dementia with Lewy Bodies (DLB), which medication is used for cognitive symptoms?",
    "options": "{\"A\": \"Quetiapine\", \"B\": \"Rivastigmine\", \"C\": \"Clonazepam\", \"D\": \"Pimavanserin\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the specific pharmacological treatment (Rivastigmine) for cognitive enhancement in Dementia with Lewy Bodies (DLB).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q31",
    "question_text": "Korsakoff dementia is characterized by impairment of which type of memory?",
    "options": "{\"A\": \"Episodic memory\", \"B\": \"Immediate memory\", \"C\": \"Working memory\", \"D\": \"Procedural memory\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the specific cognitive profile (predominant episodic memory impairment) characteristic of Korsakoff syndrome, often discussed alongside dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q58",
    "question_text": "A patient with cognitive decline also presents with urinary incontinence and a magnetic gait. What is the most likely diagnosis?",
    "options": "{\"A\": \"Parkinson's disease\", \"B\": \"Normal pressure hydrocephalus\", \"C\": \"Alzheimer's disease\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Normal Pressure Hydrocephalus (NPH) based on its classic triad including cognitive decline.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q64",
    "question_text": "This is a 70-year-old female with a history of short-term memory impairment, long-term memory not affected, and depression with withdrawal from people. CSF shows low amyloid and positive TUA. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal Dementia (FTD)\", \"B\": \"Alzheimer's Disease (AD)\", \"C\": \"Dementia with Lewy Bodies (DLB)\", \"D\": \"Corticobasal Degeneration (CBD)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose Alzheimer's Disease based on clinical presentation (amnestic cognitive profile) and supportive CSF biomarker findings.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q42",
    "question_text": "What is the most common memory type affected in Korsakoff's encephalopathy?",
    "options": "{\"A\": \"Episodic memory\", \"B\": \"Declarative memory\", \"C\": \"Working memory\", \"D\": \"Semantic memory\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the characteristic cognitive deficit (episodic memory impairment) in Korsakoff syndrome.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q83",
    "question_text": "A patient came with behavioral changes; what is the gene defect?",
    "options": "{\"A\": \"TDP-43\", \"B\": \"MAPT\", \"C\": \"C9orf72\", \"D\": \"FUS\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links behavioral changes (suggestive of bvFTD) to associated underlying pathology/proteinopathy (TDP-43), which is central to understanding FTD spectrum disorders.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q67",
    "question_text": "The second most common neurodegenerative dementia is:",
    "options": "{\"A\": \"Lewy Body Dementia (LBD)\", \"B\": \"Frontotemporal Dementia (FTD)\", \"C\": \"Alzheimer's Disease (AD)\", \"D\": \"Vascular Dementia\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the epidemiology and relative prevalence of different neurodegenerative dementia types. (Duplicate of Q70).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q59",
    "question_text": "A 60-year-old university professor started to forget things and frequently loses his bank cards, but it is not affecting his job. The patient is worried about his memory. What is the most likely diagnosis?",
    "options": "{\"A\": \"Mild cognitive impairment.\", \"B\": \"Alzheimer disease.\", \"C\": \"Frontotemporal dementia.\", \"D\": \"Normal age-related memory decline.\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Mild Cognitive Impairment (MCI) based on subjective and objective cognitive concerns without significant functional impairment in daily life.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q65",
    "question_text": "A 56-year-old female presents with behavioral changes and personality alterations. She starts talking to strangers and receives warnings from work due to inappropriate sexual jokes. She has poor personal hygiene and a Mini-Mental State Examination (MMSE) score of 28/30. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease (AD)\", \"C\": \"Lewy body dementia (LBD)\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose behavioral variant Frontotemporal Dementia (bvFTD) based on characteristic personality and behavioral changes with relatively preserved cognition initially.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q66",
    "question_text": "A 58-year-old female presents with changes in behavior, memory issues, and visual hallucinations. MRI shows frontal and parietal atrophy. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease (AD)\", \"C\": \"Dementia with Lewy bodies (DLB)\", \"D\": \"Corticobasal degeneration (CBD)\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the differential diagnosis of dementia presenting with a mix of behavioral, cognitive (memory), and psychotic (hallucinations) symptoms, considering DLB and atypical AD/FTD presentations.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q89",
    "question_text": "For the same patient, what treatment would you recommend?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Lifestyle modification\", \"C\": \"Donepezil\", \"D\": \"Memantine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of standard pharmacological treatment options for dementia (likely AD or DLB based on typical options provided).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q30",
    "question_text": "A 77-year-old man with a 3-year history of personality changes and cognitive impairment reports seeing small animals around him. His wife notes that there are days when he is extremely confused and agitated, and days when he is closer to his prior baseline. What is the most likely diagnosis?",
    "options": "{\"A\": \"Dementia with Lewy bodies (DLB)\", \"B\": \"Mild cognitive impairment (MCI)\", \"C\": \"Alzheimer\\u2019s disease\", \"D\": \"Schizophrenia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to diagnose Dementia with Lewy Bodies (DLB) based on its core features: cognitive decline, visual hallucinations, and fluctuations.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q37",
    "question_text": "Apathy is more commonly seen in which condition?",
    "options": "{\"A\": \"Alzheimer disease\", \"B\": \"Parkinson disease\", \"C\": \"Amyotrophic lateral sclerosis\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the relative prevalence of specific neuropsychiatric symptoms (apathy) across different neurodegenerative diseases, including common dementias.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q44",
    "question_text": "A 62-year-old male exhibits inappropriate behavior, impaired social functioning, and a tendency to eat sweets. He pays no attention to personal hygiene for the last year. A PET scan shows frontal and temporal hypometabolism. What is the most likely diagnosis?",
    "options": "{\"A\": \"Alzheimer's Disease (Frontal type)\", \"B\": \"Frontotemporal Dementia (FTD)\", \"C\": \"Creutzfeldt-Jakob Disease (CJD)\", \"D\": \"Vascular Dementia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose behavioral variant Frontotemporal Dementia (bvFTD) based on characteristic behavioral symptoms and supportive neuroimaging (PET).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q79",
    "question_text": "What is the best test to check cognitive impairment in a patient with MCI?",
    "options": "{\"A\": \"MOCA\", \"B\": \"MMSE\", \"C\": \"Serial Seven\", \"D\": \"Clock Drawing Test\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of appropriate cognitive screening tools (MoCA often preferred over MMSE) for detecting Mild Cognitive Impairment (MCI).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q47",
    "question_text": "Apathy is more commonly seen in which of the following conditions?",
    "options": "{\"A\": \"Frontotemporal dementia\", \"B\": \"Idiopathic Parkinson's disease\", \"C\": \"Traumatic brain injury\", \"D\": \"Wilson's disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the relative prevalence of apathy across different neurological conditions, including FTD where it is a prominent feature.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q81",
    "question_text": "Typical history of Lewy Body Dementia (LBD); PET showed posterior corpus callosum abnormality (the picture is not obvious); what is the diagnosis?",
    "options": "{\"A\": \"Lewy Body Dementia (clear from the history)\", \"B\": \"Alzheimer\\u2019s Disease\", \"C\": \"Frontotemporal Dementia\", \"D\": \"Vascular Dementia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Confirms the diagnosis of LBD based on a typical clinical history, despite possibly ambiguous or atypical imaging findings mentioned.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q84",
    "question_text": "A patient with a history of neuropsychiatric symptoms and dementia for more than 5 years had PrPSc. What is the diagnosis?",
    "options": "{\"A\": \"Variant CJD\", \"B\": \"Kuru\", \"C\": \"Familial insomnia\", \"D\": \"Familial CJD\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to differentiate subtypes of prion disease based on duration, clinical features (neuropsychiatric/dementia), and the presence of abnormal prion protein (PrPSc), suggesting familial CJD given the long duration.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q7",
    "question_text": "The nonfluent/agrammatic variant of primary progressive aphasia (nfvPPA) is primarily associated with atrophy in which brain region?",
    "options": "{\"A\": \"Left inferior frontal gyrus (Broca area)\", \"B\": \"Right temporal lobe\", \"C\": \"Medial temporal lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the specific neuroanatomical correlate (localization of atrophy) for a subtype of Primary Progressive Aphasia (nfvPPA), which falls under the FTD spectrum.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q53",
    "question_text": "In a patient with normal semantic and language function, what is the pathology associated with behavioral variant frontotemporal dementia (bvFTD)?",
    "options": "{\"A\": \"TDP-43\", \"B\": \"FTD type A TDP\", \"C\": \"FTD type B TDP\", \"D\": \"FTD type C TDP\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the common underlying neuropathology (TDP-43) associated with the clinical syndrome of bvFTD.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q38",
    "question_text": "A 67-year-old male is brought to the clinic because of cognitive decline and multiple neurological symptoms over the last 6 months. Initially, he stopped worrying about his job and started to exhibit unusual behaviors. He leaves the house without showering, then he became apathetic and anhedonic. For the last month, he has ataxia, frequent falls, and myoclonic jerks. An MRI was obtained and shown. What is the most likely diagnosis?",
    "options": "{\"A\": \"Frontotemporal Dementia (FTD)\", \"B\": \"Creutzfeldt-Jakob Disease (CJD)\", \"C\": \"Alzheimer's Disease (AD)\", \"D\": \"Lewy Body Dementia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose CJD based on a rapidly progressive course involving cognitive decline, behavioral changes, apathy, ataxia, and myoclonus.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient has normal pressure hydrocephalus (NPH) and abdominal tuberculosis. What is the most appropriate management?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Flumazine\", \"C\": \"Copper\", \"D\": \"None of the above\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Primarily focuses on NPH, a cause of dementia. Although the options seem unrelated to NPH or TB management (potentially a flawed question), the core condition mentioned related to cognitive decline is NPH.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q78",
    "question_text": "Pathology showed Lewy bodies. What is the diagnosis?",
    "options": "{\"A\": \"Lewy body dementia\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Alzheimer\\u2019s disease\", \"D\": \"Multiple system atrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Directly links the key neuropathological finding (Lewy bodies) to the corresponding dementia diagnosis (LBD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q63",
    "question_text": "A patient exhibits word-finding difficulties and behavioral changes. What is the most likely diagnosis?",
    "options": "{\"A\": \"Pick's disease\", \"B\": \"Alzheimer's disease\", \"C\": \"Frontotemporal dementia\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the diagnosis of FTD spectrum disorders based on a combination of language (word-finding) and behavioral symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q88",
    "question_text": "An elderly man has been acting out his dreams, kicking his wife, and experiencing vivid visual hallucinations. His delirium workup was negative. What is the most likely diagnosis?",
    "options": "{\"A\": \"Lewy body dementia\", \"B\": \"Alzheimer's disease\", \"C\": \"Corticobasal degeneration\", \"D\": \"Frontotemporal dementia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to diagnose DLB based on the combination of REM sleep behavior disorder (RBD) and visual hallucinations.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q35",
    "question_text": "A patient comes with progressive dementia over the last 6 months, exhibiting startle and sensory myoclonus. A DWI image shows a cortical ribbon sign. What is the likely diagnosis?",
    "options": "{\"A\": \"Prion disease\", \"B\": \"Alzheimer's disease\", \"C\": \"Frontotemporal dementia\", \"D\": \"Lewy body dementia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Prion disease (CJD) based on rapid progression, specific motor signs (startle myoclonus), and characteristic MRI findings (cortical ribboning on DWI).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q82",
    "question_text": "In an Alzheimer patient, what are the expected cerebrospinal fluid (CSF) results?",
    "options": "{\"A\": \"Low Amyloid \\u03b2, High Tau\", \"B\": \"High Amyloid \\u03b2, Low Tau\", \"C\": \"Normal Amyloid \\u03b2, Normal Tau\", \"D\": \"Low Amyloid \\u03b2, Low Tau\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic CSF biomarker profile (low A\u03b242, high total Tau, high phospho-Tau) found in Alzheimer's disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q86",
    "question_text": "What helps differentiate Alzheimer's disease from frontotemporal dementia?",
    "options": "{\"A\": \"Anterograde memory loss\", \"B\": \"Language difficulties\", \"C\": \"Behavioral changes\", \"D\": \"Visual hallucinations\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about key distinguishing clinical features between AD (typically prominent early anterograde memory loss) and FTD (typically prominent early behavioral or language changes).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q85",
    "question_text": "A patient presents with one year of progressive apathy and memory loss. What is the most likely diagnosis?",
    "options": "{\"A\": \"Alzheimer's disease\", \"B\": \"Frontotemporal dementia\", \"C\": \"Vascular dementia\", \"D\": \"Lewy body dementia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the differential diagnosis of dementia based on core symptoms of apathy and memory loss, requiring consideration of AD, FTD, and others.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q87",
    "question_text": "Cholinesterase inhibitors are most useful for which condition?",
    "options": "{\"A\": \"Apathy\", \"B\": \"Depression\", \"C\": \"Anxiety\", \"D\": \"Psychosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the symptomatic target (apathy) that can potentially improve with cholinesterase inhibitors in dementia. (Duplicate of Q26).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q91",
    "question_text": "Typical history of Lewy Body Dementia (LBD), PET showed posterior corpus callosum abnormality (the picture is not obvious); what is the diagnosis?",
    "options": "{\"A\": \"Lewy Body Dementia (clear from the history)\", \"B\": \"C9ORF/Ch9 (TDP-43)\", \"C\": \"Behavioral variant Frontotemporal Dementia (bvFTD)\", \"D\": \"Frontotemporal Dementia - Amyotrophic Lateral Sclerosis (FTD-ALS)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Confirms the diagnosis of LBD based on clinical history, contrasting it with other dementia-related entities. (Duplicate of Q81).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q73",
    "question_text": "In the same scenario of MCI, what is the conversion rate of cognitive impairment to dementia?",
    "options": "{\"A\": \"6%\", \"B\": \"10 - 20%\", \"C\": \"21 - 30%\", \"D\": \"31 - 90%\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of the typical annual conversion rate from MCI to dementia. (Similar to Q13, Q15).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q34",
    "question_text": "Which disorder most commonly presents with apathy?",
    "options": "{\"A\": \"Progressive supranuclear palsy (PSP)\", \"B\": \"Parkinson's disease\", \"C\": \"Frontotemporal dementia (FTD)\", \"D\": \"Alzheimer's disease (AD)\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the relative frequency of apathy across various neurodegenerative disorders, including FTD and AD. (Similar to Q37, Q47).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q54",
    "question_text": "In the Mini-Mental State Examination (MMSE), which component carries the highest weight?",
    "options": "{\"A\": \"Orientation\", \"B\": \"Registration\", \"C\": \"Attention and calculation\", \"D\": \"Recall\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Assesses knowledge about the structure and scoring of a standard cognitive screening tool (MMSE) used in dementia assessment. (Orientation and Recall are highest).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q64",
    "question_text": "The same imaging findings as previous but with agrammatic aphasia are present. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Prion disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific language deficit (non-fluent/agrammatic aphasia) to the likely dementia syndrome (FTD/PPA).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q91",
    "question_text": "A male patient was brought to the hospital by his wife for forgetfulness issues. He has difficulty with speech expression with his friends, which has made his social life difficult. On examination, he couldn\u2019t recall 3 items on the MMSE. He has impaired naming and repetition, with intact comprehension. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Semantic dementia\", \"B\": \"Primary progressive aphasia\", \"C\": \"Frontotemporal lobe dementia\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes cognitive and language decline (impaired naming/repetition with intact comprehension, plus memory issues) pointing towards a Primary Progressive Aphasia variant within the FTD spectrum.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q55",
    "question_text": "A patient exhibits changes in eating habits towards sweet foods. Imaging shows changes consistent with frontotemporal dementia (FTD). What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Prion disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific behavioral change (altered eating habits - preference for sweets) often seen in FTD to the diagnosis.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q113",
    "question_text": "A 77-year-old man came with his wife to the clinic with a 3-year history of personality changes and cognitive impairment. She reported that he keeps seeing small animals around him and he moves a lot while he is sleeping. There are days when he is extremely confused and agitated and days when he is closer to his prior baseline. What is the most likely diagnosis?",
    "options": "{\"A\": \"Lewy body dementia\", \"B\": \"Alzheimer\\u2019s disease\", \"C\": \"Schizophrenia\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the core clinical features of Dementia with Lewy Bodies (cognitive decline, visual hallucinations, fluctuations, probable REM sleep behavior disorder).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q64",
    "question_text": "The same imaging findings as previous but with agrammatic aphasia are present. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Prion disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific language deficit (non-fluent/agrammatic aphasia) to the likely dementia syndrome (FTD/PPA). (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q91",
    "question_text": "A male patient was brought to the hospital by his wife for forgetfulness issues. He has difficulty with speech expression with his friends, which has made his social life difficult. On examination, he couldn\u2019t recall 3 items on the MMSE. He has impaired naming and repetition, with intact comprehension. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Semantic dementia\", \"B\": \"Primary progressive aphasia\", \"C\": \"Frontotemporal lobe dementia\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes cognitive and language decline (impaired naming/repetition with intact comprehension) pointing towards a Primary Progressive Aphasia variant within the FTD spectrum. (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q44",
    "question_text": "In the context of primary progressive aphasia, which of the following is true regarding the semantic variant (PPA-S)?",
    "options": "{\"A\": \"It affects fluency and grammar\", \"B\": \"It is associated with impairments of object naming and word comprehension\", \"C\": \"It is due to right temporal atrophy\", \"D\": \"It is characterized by severe dysarthria\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the specific clinical features of a dementia subtype (Semantic Variant PPA). (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q55",
    "question_text": "A patient exhibits changes in eating habits towards sweet foods. Imaging shows changes consistent with frontotemporal dementia (FTD). What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Prion disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific behavioral change (altered eating habits) to the associated dementia syndrome (FTD). (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q43",
    "question_text": "A patient presents with apathy and cerebral atrophy, along with changes in eating habits. Imaging from a PET scan and brain MRI shows decreased metabolism in the frontal and temporal lobes, particularly in the left frontal lobe. What is the diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Lewy body dementia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Integrates behavioral symptoms (apathy, eating changes) and imaging findings (frontotemporal hypometabolism/atrophy) typical of FTD. (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q113",
    "question_text": "A 77-year-old man came with his wife to the clinic with a 3-year history of personality changes and cognitive impairment. She reported that he keeps seeing small animals around him and he moves a lot while he is sleeping. There are days when he is extremely confused and agitated and days when he is closer to his prior baseline. What is the most likely diagnosis?",
    "options": "{\"A\": \"Lewy body dementia\", \"B\": \"Alzheimer\\u2019s disease\", \"C\": \"Schizophrenia\", \"D\": \"Frontotemporal dementia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the core clinical features of Dementia with Lewy Bodies (cognitive decline, visual hallucinations, fluctuations, probable REM sleep behavior disorder). (Duplicate classification)",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q128",
    "question_text": "What is the pathology associated with ALS-FTD?",
    "options": "{\"A\": \"TDP-43\", \"B\": \"Tau protein\", \"C\": \"Ubiquitin\", \"D\": \"SOD1\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the underlying molecular pathology (TDP-43 proteinopathy) common to Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q64",
    "question_text": "In a patient with mild cognitive impairment who is still independent, what is the most appropriate management option?",
    "options": "{\"A\": \"Donepezil\", \"B\": \"Lifestyle modification\", \"C\": \"Memantine\", \"D\": \"Rivastigmine\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the management approach for Mild Cognitive Impairment (MCI), a stage often preceding dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q45",
    "question_text": "In a patient with Alzheimer\u2019s Dementia, what is the most common symptom observed?",
    "options": "{\"A\": \"Apathy\", \"B\": \"Delusion\", \"C\": \"Memory loss\", \"D\": \"Disorientation\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of common clinical features and neuropsychiatric symptoms (apathy being very common) in Alzheimer's Disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q85",
    "question_text": "In Alzheimer\u2019s dementia, which gene mutation is related to earlier onset?",
    "options": "{\"A\": \"APP\", \"B\": \"APOE\", \"C\": \"PSEN1\", \"D\": \"PSEN2\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific genes (APP, PSEN1, PSEN2) associated with early-onset familial Alzheimer's disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q66",
    "question_text": "Alzheimer\u2019s dementia is most commonly related to which gene mutation?",
    "options": "{\"A\": \"APP\", \"B\": \"APOE\", \"C\": \"PSEN1\", \"D\": \"PSEN2\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the most common genetic risk factor (APOE) associated with late-onset Alzheimer's disease, contrasting with early-onset genes like APP, PSEN1, and PSEN2.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q243",
    "question_text": "What is the second most common cause of dementia?",
    "options": "{\"A\": \"Vascular dementia\", \"B\": \"Dementia with Lewy bodies\", \"C\": \"Frontotemporal dementia (FTD)\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the epidemiology and relative prevalence of different subtypes of dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q292",
    "question_text": "What is the LBD PET finding associated with?",
    "options": "{\"A\": \"Occipital hypometabolism\", \"B\": \"Frontal hypometabolism\", \"C\": \"Temporal hypometabolism\", \"D\": \"Parietal hypometabolism\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about a characteristic neuroimaging finding (occipital hypometabolism on FDG-PET) associated with Dementia with Lewy Bodies (LBD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q281",
    "question_text": "A long scenario describes a male with behavior issues, myoclonus, and ataxia for 3 months, along with dementia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Creutzfeldt-Jakob disease (CJD)\", \"B\": \"Alzheimer's disease (AD)\", \"C\": \"Dementia with Lewy bodies (DLB)\", \"D\": \"Frontotemporal dementia\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a rapidly progressive dementia with associated features (myoclonus, ataxia) highly suggestive of Creutzfeldt-Jakob disease (CJD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q322",
    "question_text": "An Alzheimer\u2019s patient presents with depression symptoms (sadness, insomnia) and agitation. What medication would you give?",
    "options": "{\"A\": \"Cipralex\", \"B\": \"Trazodone\", \"C\": \"Quetiapine\", \"D\": \"Rivastigmine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the pharmacological management of behavioral and psychological symptoms of dementia (BPSD), specifically depression and agitation in an Alzheimer's patient.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q331",
    "question_text": "Which of the following suggests Alzheimer Disease (AD) rather than Lewy Body Dementia (LBD)?",
    "options": "{\"A\": \"Staring into space for long periods\", \"B\": \"Visual hallucinations\", \"C\": \"Parkinsonian motor features\", \"D\": \"Anterograde memory loss\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to differentiate between Alzheimer's Disease and Lewy Body Dementia based on characteristic clinical features (prominent early memory loss in AD vs. fluctuations/hallucinations/parkinsonism in LBD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q399",
    "question_text": "In the context of Alzheimer's Disease (AD), which medication is considered first-line for hallucinations and agitation?",
    "options": "{\"A\": \"Quetiapine\", \"B\": \"Clozapine\", \"C\": \"Trazodone\", \"D\": \"Rivastigmine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the management of behavioral and psychological symptoms of dementia (BPSD), specifically hallucinations/agitation in Alzheimer's disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q288",
    "question_text": "What clinical features help to distinguish Dementia with Lewy Bodies (DLB) from Alzheimer Disease (AD)?",
    "options": "{\"A\": \"Fluctuations in cognitive function with varying levels of alertness and attention\", \"B\": \"Visual hallucinations\", \"C\": \"Parkinsonian motor features\", \"D\": \"Anterograde memory impairment\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the core clinical features (fluctuations, hallucinations, parkinsonism) that differentiate DLB from AD.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q227",
    "question_text": "Rivastigmine is the only cholinesterase inhibitor FDA approved for use in which condition?",
    "options": "{\"A\": \"Alzheimer's disease\", \"B\": \"Lewy body dementia\", \"C\": \"Parkinson disease dementia\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific FDA indications for dementia medications, linking Rivastigmine to Parkinson's Disease Dementia (as well as AD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q103",
    "question_text": "An Alzheimer patient presents with CSF results showing low amyloid beta and high tau levels. What does this indicate?",
    "options": "{\"A\": \"Alzheimer disease\", \"B\": \"Normal aging\", \"C\": \"Frontotemporal dementia\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests interpretation of CSF biomarkers (Amyloid-beta 42, total Tau, phospho-Tau) in the diagnosis of Alzheimer's disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q5",
    "question_text": "A picture of ribboning is presented. What is the most likely diagnosis?",
    "options": "{\"A\": \"Prion disease\", \"B\": \"Alzheimer's disease\", \"C\": \"Multiple sclerosis\", \"D\": \"Amyotrophic lateral sclerosis\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests recognition of the characteristic DWI/FLAIR MRI finding (\"cortical ribboning\") associated with Creutzfeldt-Jakob disease (a prion disease).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q325",
    "question_text": "A husband reported that his wife started to have gait instability that worsened over 5 years, becoming bed-bound and associated with elements of dementia. Which condition is most likely?",
    "options": "{\"A\": \"Fatal familial insomnia (FFI)\", \"B\": \"Variant Creutzfeldt-Jakob disease (vCJD)\", \"C\": \"Familial Creutzfeldt-Jakob disease (CJD)\", \"D\": \"Alzheimer's disease (AD)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a progressive neurological decline involving dementia and motor symptoms over years, consistent with potential familial CJD or FFI, differentiating from more common dementias.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q119",
    "question_text": "What is the best test to check cognitive impairment with Mild Cognitive Impairment (MCI)?",
    "options": "{\"A\": \"MOCA\", \"B\": \"MMSE\", \"C\": \"Serial seven\", \"D\": \"Clock Drawing Test\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the selection and application of cognitive assessment tools (MoCA, MMSE) specifically for evaluating patients with Mild Cognitive Impairment (MCI), a precursor stage to dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q142",
    "question_text": "A patient with progressive myoclonus and dementia is suspected to have which condition?",
    "options": "{\"A\": \"CADASIL\", \"B\": \"Alzheimer\\u2019s disease\", \"C\": \"Frontotemporal dementia\", \"D\": \"Unverricht-Lundborg disease\"}",
    "correct_answer": "D",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Centers on the differential diagnosis of conditions presenting with the combination of dementia and progressive myoclonus.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q114",
    "question_text": "A 63-year-old male has a 4-year history of Parkinson's Disease with visual hallucinations. What is the most likely diagnosis?",
    "options": "{\"A\": \"Parkinson's Disease\", \"B\": \"Dementia with Lewy Bodies\", \"C\": \"Multiple System Atrophy\", \"D\": \"Progressive Supranuclear Palsy\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on differentiating Parkinson's Disease from Dementia with Lewy Bodies, where the timing and prominence of visual hallucinations relative to motor symptoms are key distinguishing features.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q228",
    "question_text": "A Parkinson's patient came with increased hallucinations and memory loss; what is the treatment?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Clozapine\", \"C\": \"Quetiapine\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on managing significant cognitive decline (memory loss) and psychosis (hallucinations) in a Parkinson's patient, characteristic of Parkinson's Disease Dementia (PDD), using appropriate medications (cholinesterase inhibitors, atypical antipsychotics).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q21",
    "question_text": "In a case scenario of a Parkinson's disease patient presenting with hallucinations and memory problems, what is the recommended treatment?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Quetiapine\", \"C\": \"Clozapine\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the pharmacological management of cognitive impairment and psychosis (hallucinations) within the context of Parkinson's disease (PD-Dementia).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q109",
    "question_text": "A patient with Parkinson's disease presents with hallucinations and memory problems. What medication should be given?",
    "options": "{\"A\": \"Clozapine\", \"B\": \"Quetiapine\", \"C\": \"Rivastigmine\", \"D\": \"Memantine\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns the pharmacological treatment choices for managing psychosis (hallucinations) and cognitive decline (memory problems) in Parkinson's disease, indicative of PD-Dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q139",
    "question_text": "Which of the following is a common side effect of cholinesterase inhibitors in individuals with parkinsonism?",
    "options": "{\"A\": \"Nausea\", \"B\": \"Worsening tremor\", \"C\": \"Insomnia\", \"D\": \"Weight gain\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns side effects of cholinesterase inhibitors, a class of drugs primarily used to treat cognitive impairment/dementia associated with parkinsonian syndromes like Parkinson's Disease Dementia (PDD) or Dementia with Lewy Bodies (LBD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q215",
    "question_text": "An 80-year-old patient presents with concerns about his memory function, as he is forgetting names of people and where he is putting his belongings; he is totally independent. What is the diagnosis?",
    "options": "{\"A\": \"Alzheimer disease\", \"B\": \"Normal aging\", \"C\": \"Mild cognitive impairment\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on differentiating subjective memory complaints in a high-functioning elderly individual, assessing for normal aging versus early cognitive impairment/dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q74",
    "question_text": "An 80-year-old patient presents with concerns about his memory function, as he is forgetting names and where he is putting his belongings. He is totally independent. What is the likely diagnosis?",
    "options": "{\"A\": \"Alzheimer disease\", \"B\": \"Mild cognitive impairment (MCI)\", \"C\": \"Normal aging\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of memory complaints in an elderly, independent person, specifically distinguishing Normal Aging, Mild Cognitive Impairment (MCI), and early Dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q207",
    "question_text": "A patient with dementia presents with insomnia and agitation. What medication would you prescribe?",
    "options": "{\"A\": \"Trazodone\", \"B\": \"Haloperidol\", \"C\": \"Lorazepam\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the management of behavioral and psychological symptoms of dementia (BPSD), specifically insomnia and agitation.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q140",
    "question_text": "What is the second most common type of neurodegenerative dementia?",
    "options": "{\"A\": \"Alzheimer's Disease (AD)\", \"B\": \"Lewy Body Dementia (LBD)\", \"C\": \"Frontotemporal Dementia (FTD)\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the epidemiology and relative prevalence of different types of neurodegenerative dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q184",
    "question_text": "A patient with frontotemporal dementia (FTD) shows frontal and temporal atrophy on MRI. What is the most likely diagnosis?",
    "options": "{\"A\": \"Alzheimer's disease\", \"B\": \"Frontotemporal dementia\", \"C\": \"Lewy body dementia\", \"D\": \"Vascular dementia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Direct question correlating clinical syndrome (FTD) and characteristic imaging findings to the diagnosis.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q38",
    "question_text": "An elderly patient presented to the neurology clinic with complaints of progressive memory problems. The physician prescribed medication for him. After 2 weeks, he presented with nausea, anorexia, and diarrhea. Which of the following is the most likely prescribed medication?",
    "options": "{\"A\": \"Memantine\", \"B\": \"Rivastigmine\", \"C\": \"Donepezil\", \"D\": \"Galantamine\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the side effects of a common medication class (cholinesterase inhibitors like Rivastigmine) used to treat dementia symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q66",
    "question_text": "What is the mechanism of action of Donepezil?",
    "options": "{\"A\": \"Acetylcholine esterase inhibitor\", \"B\": \"Acetylcholine esterase agonist\", \"C\": \"NMDA antagonist\", \"D\": \"Dopamine receptor antagonist\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the pharmacological mechanism of a drug primarily used for treating Alzheimer's disease.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q43",
    "question_text": "A young patient with a history of memory loss has a family history of similar issues. Which gene is most likely involved?",
    "options": "{\"A\": \"APP\", \"B\": \"PSEN1\", \"C\": \"MAPT\", \"D\": \"APOE\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links early-onset familial memory loss (suggestive of Alzheimer's disease) to a causative gene (APP - Amyloid Precursor Protein).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q225",
    "question_text": "What is the most likely diagnosis for a patient with a PET scan showing low FOG uptake in the parietal cortex and temporal and frontal regions in advanced stages?",
    "options": "{\"A\": \"Frontotemporal Dementia (FTD)\", \"B\": \"Alzheimer's Disease (AD)\", \"C\": \"Dementia with Lewy Bodies (DLB)\", \"D\": \"Parkinson's Disease (PD)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires interpreting PET scan findings (FDG-PET hypometabolism pattern) to differentiate between types of dementia (likely AD pattern described).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q73",
    "question_text": "Which gene is related to early onset Alzheimer's disease (AD)?",
    "options": "{\"A\": \"APOE\", \"B\": \"APP\", \"C\": \"Presenilin 1\", \"D\": \"Presenilin 2\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks to identify genes specifically linked to early-onset Alzheimer's disease (APP, PSEN1, PSEN2 vs APOE which is risk factor mainly for late-onset).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q111",
    "question_text": "What is the drug that showed evidence to treat visual hallucinations in dementia with Lewy bodies (DLB)?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Quetiapine\", \"C\": \"Donepezil\", \"D\": \"Clonazepam\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the specific pharmacological management of neuropsychiatric symptoms (visual hallucinations) within the context of a specific dementia subtype (DLB).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q119",
    "question_text": "In a scenario about DLB, if a patient developed hallucinations and psychiatric symptoms, which treatment is indicated?",
    "options": "{\"A\": \"Quetiapine\", \"B\": \"Rivastigmine\", \"C\": \"Clozapine\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the treatment of specific symptoms (hallucinations/psychosis) in Dementia with Lewy Bodies.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q20",
    "question_text": "A patient presents with young-onset familial Alzheimer's disease and a family history of the condition. What is the gene associated with this type of Alzheimer's?",
    "options": "{\"A\": \"APP\", \"B\": \"PSEN1\", \"C\": \"PSEN2\", \"D\": \"APOE\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the specific genes (APP, PSEN1, PSEN2) responsible for early-onset familial Alzheimer's disease, a primary dementia syndrome.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q127",
    "question_text": "Which of the following conditions is characterized by 3-repeat tau and ubiquitin?",
    "options": "{\"A\": \"FTD-pick\", \"B\": \"FTD-parkinsonism\", \"C\": \"bvFTD\", \"D\": \"FTD-ALS\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the specific neuropathological proteinopathy (3-repeat tau) underlying a subtype of Frontotemporal Dementia (FTD-Pick's disease), a major dementia category.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q80",
    "question_text": "Which of the following genes is commonly linked to Alzheimer's disease?",
    "options": "{\"A\": \"APOE4\", \"B\": \"APP\", \"C\": \"PSEN1\", \"D\": \"MAPT\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about genes associated with Alzheimer's disease (including the risk factor APOE4 and causative genes like APP/PSEN1), a primary dementia syndrome.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q92",
    "question_text": "Which of the following genes is associated with familial Alzheimer\u2019s disease?",
    "options": "{\"A\": \"APP\", \"B\": \"PSEN1\", \"C\": \"PSEN2\", \"D\": \"Apolipoprotein E\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific genes (like APP, PSEN1, PSEN2) implicated in early-onset familial Alzheimer's disease, a primary dementia syndrome. APOE is a risk factor, not typically causative for familial AD.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q105",
    "question_text": "A patient came with behavioral changes; what is the gene defect?",
    "options": "{\"A\": \"Progranulin/Ch17 (TDP-43)\", \"B\": \"TDP-43\", \"C\": \"FTD-parkinsonism\", \"D\": \"MAPT/Ch17 (4-repeat tau)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links behavioral changes suggestive of Frontotemporal Dementia (FTD) to specific causative gene mutations (e.g., Progranulin/GRN or MAPT), classifying based on the primary clinical syndrome (dementia).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q39",
    "question_text": "A young man with a family history of early onset Alzheimer disease. Which of the following genes increases the risk of sporadic Alzheimer disease?",
    "options": "{\"A\": \"APP\", \"B\": \"Apolipoprotein E\", \"C\": \"PSEN1\", \"D\": \"MAPT\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses specifically on genetic risk factors (ApoE) for sporadic Alzheimer's disease, contrasting with familial genes, placing it within the dementia field due to the disease context.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q49",
    "question_text": "A patient with dementia has insomnia and agitation. What medication would you prescribe?",
    "options": "{\"A\": \"Trazodone\", \"B\": \"Quetiapine\", \"C\": \"Clozapine\", \"D\": \"Risperidone\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the management of behavioral and psychological symptoms of dementia (BPSD), specifically insomnia and agitation.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q59",
    "question_text": "A patient with a history of memory changes and forgetfulness has cerebrospinal fluid (CSF) analysis showing high tau protein and low amyloid levels. What is the most likely diagnosis?",
    "options": "{\"A\": \"Alzheimer's disease\", \"B\": \"Frontotemporal dementia\", \"C\": \"Lewy body dementia\", \"D\": \"Normal pressure hydrocephalus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on using specific CSF biomarkers (Tau, Amyloid) to diagnose Alzheimer's disease, a primary cause of dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q46",
    "question_text": "Which of the following most accurately summarizes the current situation with respect to the use of cholinesterase inhibitors to delay or prevent the progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease or other forms of dementia?",
    "options": "{\"A\": \"Not proven to be effective in delaying or preventing the development of dementia\", \"B\": \"Highly effective in preventing progression to Alzheimer's disease\", \"C\": \"Recommended as first-line treatment for all patients with MCI\", \"D\": \"Shown to reverse cognitive decline in MCI patients\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Discusses the efficacy of a class of drugs (cholinesterase inhibitors) specifically in the context of MCI and its progression to dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q47",
    "question_text": "An individual with mild cognitive impairment is more likely to progress to dementia or Alzheimer disease if he/she:",
    "options": "{\"A\": \"Is an APOE4 carrier.\", \"B\": \"Has atrophic hippocampi on MRI.\", \"C\": \"Has an elevated tau level in the CSF.\", \"D\": \"Has positive amyloid imaging on PET scan.\"}",
    "correct_answer": "D",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of risk factors and biomarkers (genetic, imaging, CSF) that predict progression from Mild Cognitive Impairment (MCI) to dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q63",
    "question_text": "A male patient presents with recent behavioral changes, and MRI shows frontal and temporal atrophy. What is the most likely diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia (FTD)\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Lewy body dementia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links clinical presentation (behavioral changes) and neuroimaging findings (frontotemporal atrophy) to a specific type of dementia (FTD).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q69",
    "question_text": "An elderly male was brought in by his family with urinary incontinence for years and cognitive decline (MMSE 25/30). He has bradykinesia, mild rigidity, and a shuffling gait with magnetic gait. MRI shows ventriculomegaly and mild volume loss. What is your management?",
    "options": "{\"A\": \"Trial of dopaminergic therapy\", \"B\": \"Deep brain stimulation (DBS)\", \"C\": \"Refer for elective shunt\", \"D\": \"Symptomatic treatment only\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the classic triad (cognitive decline, gait disturbance, urinary incontinence) and MRI findings of Normal Pressure Hydrocephalus (NPH), a treatable cause of dementia, and asks about management (ventricular shunting).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q48",
    "question_text": "Cognitive symptoms in Lewy body dementia are treated with which of the following medications?",
    "options": "{\"A\": \"Cholinesterase inhibitors\", \"B\": \"Antidepressants\", \"C\": \"Antipsychotics\", \"D\": \"Mood stabilizers\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the specific pharmacological treatment (cholinesterase inhibitors) for cognitive symptoms in Lewy body dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q88",
    "question_text": "Declarative memory with remembering past experiences is referred to as:",
    "options": "{\"A\": \"Episodic memory\", \"B\": \"Semantic memory\", \"C\": \"Procedural memory\", \"D\": \"Implicit memory\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of specific types of memory, a core concept within cognitive neurology and the assessment of dementia.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q48",
    "question_text": "Fatigue during the daytime and increased sleepiness in a patient with Alzheimer\u2019s disease is due to which of the following?",
    "options": "{\"A\": \"Atrophy in subthalamic nuclei\", \"B\": \"Disturbance in serotonin pathway\", \"C\": \"Decrease in glucose level\", \"D\": \"Suprachiasmatic nucleus degeneration\"}",
    "correct_answer": "D",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: The question focuses on a symptom (sleep disturbance) specifically within the context of Alzheimer's disease pathology.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q256",
    "question_text": "What is the mechanism of action of donepezil?",
    "options": "{\"A\": \"Acetylcholinesterase inhibitor\", \"B\": \"Direct thrombin inhibitor\", \"C\": \"NMDA receptor antagonist\", \"D\": \"ACE inhibitor\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the pharmacology (mechanism of action) of a primary medication used for treating dementia symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q198",
    "question_text": "A 52-year-old woman presents with behavioral changes over the course of 2 years. Her concentration is decreasing, making it difficult to accomplish her work, and she does not care about her poor performance. She has gained 25 pounds in 4 months, is charged at work for telling inappropriate jokes, has stopped bathing, and refuses to take care of her personal hygiene. On examination, she has grasp and palmo-mental reflexes but no other abnormalities. Her MMSE is 29/30, but her clock drawing test was poor. What is the diagnosis?",
    "options": "{\"A\": \"Vascular dementia\", \"B\": \"Frontotemporal dementia (FTD)\", \"C\": \"Normal pressure hydrocephalus (NPH)\", \"D\": \"Presenilin dementia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to diagnose a specific dementia syndrome (Frontotemporal Dementia) based on its characteristic clinical features (prominent behavioral/personality changes, executive dysfunction).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q217",
    "question_text": "Cognitive fluctuation is more common in which of the following conditions?",
    "options": "{\"A\": \"Dementia with Lewy Bodies (DLB)\", \"B\": \"Alzheimer\\u2019s Disease (AD)\", \"C\": \"Frontotemporal Dementia (FTD)\", \"D\": \"Vascular Dementia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of core clinical features used to differentiate between dementia syndromes, specifically recognizing cognitive fluctuations as characteristic of Dementia with Lewy Bodies (DLB).",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q164",
    "question_text": "A 56-year-old male with a history of memory loss for 24 hours and asking the same question repeatedly should undergo which investigation?",
    "options": "{\"A\": \"CT & CTA\", \"B\": \"MRI\", \"C\": \"EEG\", \"D\": \"Carotid Doppler\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the diagnostic workup (preferentially MRI) for an acute amnestic syndrome typical of Transient Global Amnesia (TGA), which falls under the scope of cognitive/memory disorders.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q42",
    "question_text": "In a case of transient global amnesia (TGA) lasting 4 hours, with the patient confused, repeating questions, and preserving identity, what is the next step in management?",
    "options": "{\"A\": \"EEG\", \"B\": \"Brain CT & CTA\", \"C\": \"Lumbar puncture\", \"D\": \"Observation and supportive care\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the appropriate initial investigations for a patient presenting with classic symptoms of Transient Global Amnesia (TGA), an episodic memory disorder.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q41",
    "question_text": "What is the commonest pathological change in neurodegenerative diseases?",
    "options": "{\"A\": \"Tangles\", \"B\": \"Glial cytoplasmic inclusions\", \"C\": \"Lewy bodies\", \"D\": \"Neurofibrillary tangles\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the most frequent neuropathological finding across neurodegenerative diseases. Neurofibrillary tangles (tangles) are characteristic of Alzheimer's disease, the most common cause of dementia and arguably the most prevalent neurodegenerative disease overall, making Dementia the most relevant category.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q57",
    "question_text": "A patient presents with hyperphagia, personality changes, and memory loss. What is the likely diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Normal pressure hydrocephalus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests diagnosis of a dementia syndrome (FTD) based on classic behavioral and cognitive symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q57",
    "question_text": "A patient presents with hyperphagia, personality changes, and memory loss. What is the likely diagnosis?",
    "options": "{\"A\": \"Frontotemporal dementia\", \"B\": \"Alzheimer's disease\", \"C\": \"Vascular dementia\", \"D\": \"Normal pressure hydrocephalus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests diagnosis of a dementia syndrome (FTD) based on classic behavioral and cognitive symptoms.",
    "subspecialty": "Dementia"
  },
  {
    "question_number": "Q19",
    "question_text": "In a case of dermatomyositis, what are the histology findings?",
    "options": "{\"A\": \"Perifascicular atrophy\", \"B\": \"Endomysial inflammation with invasion of non-necrotic fibers\", \"C\": \"Rimmed vacuoles within muscle fibers\", \"D\": \"Granulomatous inflammation\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of characteristic muscle biopsy findings in dermatomyositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q15",
    "question_text": "In the scenario of Kennedy disease (gynecomastia and family history), which of the following is correct?",
    "options": "{\"A\": \"High androgen\", \"B\": \"Normal CK\", \"C\": \"High aldolase\", \"D\": \"High aromatase\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge about Kennedy disease (Spinal and Bulbar Muscular Atrophy), a genetic neuromuscular disorder affecting lower motor neurons and androgen receptors.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q137",
    "question_text": "A young boy with recurrent weakness after exercise improves with periods of rest. How can the diagnosis be reached? (Case of McArdle\u2019s disease)",
    "options": "{\"A\": \"Culture of fibroblast and enzyme assay\", \"B\": \"Acid maltase profile\", \"C\": \"Acyl carnitine profile\", \"D\": \"Phosphofructokinase assay\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with the diagnosis of McArdle's disease (myophosphorylase deficiency), a metabolic myopathy causing exercise intolerance.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q60",
    "question_text": "A post-bariatric surgery patient presents with symptoms of vitamin B12 deficiency, but serum levels are normal. What should be administered?",
    "options": "{\"A\": \"Folate\", \"B\": \"Copper\", \"C\": \"Vitamin B6\", \"D\": \"Thiamine\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses neurological complications, commonly peripheral neuropathy, resulting from nutritional deficiencies (like copper deficiency mimicking B12) post-bariatric surgery.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q554",
    "question_text": "What is a common nerve conduction study (NCS) or electromyography (EMG) finding in ALS?",
    "options": "{\"A\": \"Fasciculations\", \"B\": \"Prolonged F waves\", \"C\": \"Increased sensory action potentials\", \"D\": \"Normal findings\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about specific electrodiagnostic (EMG/NCS) findings characteristic of Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q84",
    "question_text": "The typical age of onset for Hyperkalemic Periodic Paralysis is:",
    "options": "{\"A\": \"First decade\", \"B\": \"Second decade\", \"C\": \"Third decade\", \"D\": \"Any age\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the epidemiology (typical age of onset) of Hyperkalemic Periodic Paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q69",
    "question_text": "What percentage of patients with ocular Myasthenia Gravis have positive AChR-binding antibodies?",
    "options": "{\"A\": \"30%\", \"B\": \"50%\", \"C\": \"70%\", \"D\": \"80%\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the serological diagnosis (antibody frequency) of ocular myasthenia gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q561",
    "question_text": "A 34-year-old man had difficulty climbing stairs and respiratory difficulties requiring BiPap. What is the most likely cause?",
    "options": "{\"A\": \"Acid maltase deficiency\", \"B\": \"Pyruvate kinase deficiency\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns the diagnosis of acid maltase deficiency (Pompe disease), a metabolic myopathy presenting with progressive proximal and respiratory weakness.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q458",
    "question_text": "In a scenario about a patient with eosinophils on pathology, what condition is suggested?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Eosinophilic myositis\", \"C\": \"Dermatomyositis\", \"D\": \"Hypereosinophilic syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks to potentially link a pathological finding (eosinophils, possibly indicating eosinophilic myositis) to a muscle disorder (though Calpainopathy might be an incorrect association provided in the options, the context is muscle pathology).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q487",
    "question_text": "A patient with polymyalgia rheumatica is on steroids (5 mg) post-myocardial infarction and is also taking atorvastatin (40 mg). The patient presents with proximal muscle weakness and cannot rise from a seated position, with a creatine kinase level of 1880. What is the next step in management?",
    "options": "{\"A\": \"Stop steroid\", \"B\": \"Stop atorvastatin\", \"C\": \"Increase steroid dose\", \"D\": \"Order electromyography (EMG)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Involves the differential diagnosis and management of myopathy (statin-induced vs. inflammatory/other) in a patient presenting with proximal weakness and elevated CK.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q38",
    "question_text": "Which of the following is assessed in the examination of femoral nerve function?",
    "options": "{\"A\": \"Hip flexion, knee extension & medial leg sensation\", \"B\": \"Hip lateral rotation\", \"C\": \"Ankle dorsiflexion\", \"D\": \"Plantar flexion\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the clinical examination findings (motor and sensory function) associated with a specific peripheral nerve (femoral nerve).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q30",
    "question_text": "Case of a patient with weak hip adductors, which nerve is affected?",
    "options": "{\"A\": \"Obturator\", \"B\": \"Femoral\", \"C\": \"Sciatic\", \"D\": \"Superior gluteal\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve function (obturator nerve) based on specific muscle weakness (hip adductors).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q54",
    "question_text": "What type of muscle biopsy finding is associated with Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Necrotizing myopathy\", \"B\": \"Ragged-red fibers on Gomori trichrome stain\", \"C\": \"Hyaline degeneration\", \"D\": \"Fiber type grouping\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about characteristic muscle biopsy findings (ragged-red fibers) in Kearns-Sayre syndrome, a mitochondrial myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q55",
    "question_text": "A patient diagnosed with breast cancer underwent chemotherapy and radiation. An EMG showed myokymia and the patient presented with plexopathy. What is your diagnosis?",
    "options": "{\"A\": \"Radiation-induced plexopathy\", \"B\": \"Metastatic brachial plexopathy\", \"C\": \"Chemotherapy-induced peripheral neuropathy\", \"D\": \"Paraneoplastic neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with radiation-induced plexopathy, a neuromuscular complication of cancer therapy, identified by clinical and EMG findings (myokymia).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q140",
    "question_text": "A 34-year-old man had progressive difficulty climbing stairs and respiratory difficulties requiring BiPAP. What is the most likely cause?",
    "options": "{\"A\": \"Acid maltase deficiency\", \"B\": \"Pyruvate kinase deficiency\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the diagnosis of acid maltase deficiency (Pompe disease) based on progressive proximal and respiratory weakness. (Similar/duplicate of Q561).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q21",
    "question_text": "Peripheral neuropathy case: what is the antibody?",
    "options": "{\"A\": \"Anti MAG\", \"B\": \"Anti GD1\", \"C\": \"Anti Hu\", \"D\": \"Anti GM1\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks to identify a specific antibody (e.g., Anti-MAG, Anti-GD1a) associated with a particular type or cause of peripheral neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q123",
    "question_text": "A young man (or child) has muscle stiffness that improves with repeated exercise (myotonia and warm-up phenomena). His father had the same symptoms. What is the most likely diagnosis?",
    "options": "{\"A\": \"Thomsen\\u2019s disease\", \"B\": \"Myotonic dystrophy\", \"C\": \"Paramyotonia congenita\", \"D\": \"Hyperkalemic periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the diagnosis of Thomsen's disease (myotonia congenita, a channelopathy) based on clinical features (myotonia, warm-up phenomenon) and inheritance pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q157",
    "question_text": "A patient with myotonia is being evaluated. Which of the following conditions is associated with myotonia?",
    "options": "{\"A\": \"Diabetes Mellitus (DM)\", \"B\": \"Myotonic dystrophy\", \"C\": \"Hypertension\", \"D\": \"Osteolytic bone lesions\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about systemic conditions potentially associated with myotonia, a primary neuromuscular symptom found in channelopathies and dystrophies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q249",
    "question_text": "In a patient with painful diabetic neuropathy who is nonambulatory and has severe spasticity, which treatment is most likely to provide relief?",
    "options": "{\"A\": \"Addition of benzodiazepines\", \"B\": \"Addition of tizanidine\", \"C\": \"High doses of gabapentin\", \"D\": \"Intrathecal baclofen\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Deals with the management of severe symptoms (painful neuropathy, spasticity) arising from diabetic neuropathy, a common neuromuscular complication.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q150",
    "question_text": "A patient presents with generalized weakness, bilateral ptosis, respiratory involvement, and areflexia. What additional finding would you expect?",
    "options": "{\"A\": \"Sensory involvement\", \"B\": \"Fast repetitive nerve stimulation (RNS) will show a 10% decrement\", \"C\": \"No autonomic symptoms\", \"D\": \"Botulinum toxin A is the most common cause\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a clinical scenario suggestive of a neuromuscular junction disorder (like botulism or LEMS) and asks about expected associated findings or diagnostic features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q166",
    "question_text": "A young lady presents with weakness in knee extension and numbness in the medial aspect of the thigh. Which lower limb nerve is likely affected?",
    "options": "{\"A\": \"Obturator nerve\", \"B\": \"Pudendal nerve\", \"C\": \"Femoral nerve\", \"D\": \"Sciatic nerve\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks to identify the affected peripheral nerve (Femoral) based on specific motor and sensory deficits.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q65",
    "question_text": "A patient presents with bilateral foot drop and left ulnar neuropathy with abductor digiti minimi weakness, progressive over 3 months. Nerve conduction studies showed conduction block in the ulnar nerve and deep peroneal nerve at the head of the fibula. What is the diagnosis?",
    "options": "{\"A\": \"Multifocal Motor Neuropathy (MMN)\", \"B\": \"Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)\", \"C\": \"Charcot-Marie-Tooth disease\", \"D\": \"Amyotrophic Lateral Sclerosis (ALS)\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires differential diagnosis between various neuromuscular disorders (MMN, HNPP, CMT, ALS) based on clinical presentation (multifocal neuropathy) and NCS findings (conduction block suggesting MMN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q116",
    "question_text": "A young boy went for a football match with his friends. Later, he started to have proximal muscle weakness, and his urine turned brown. He was admitted to the hospital with high creatine kinase (CK) levels. Upon review of his chart, it was noted that he was admitted last year with the same presentation. What is the defective enzyme?",
    "options": "{\"A\": \"Acid maltase deficiency\", \"B\": \"Carnitine palmitoyltransferase II deficiency\", \"C\": \"Myophosphorylase deficiency\", \"D\": \"Phosphofructokinase deficiency\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the diagnosis of a metabolic myopathy (likely CPT II deficiency or McArdle's) based on recurrent exercise-induced rhabdomyolysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q39",
    "question_text": "Which of the following is a characteristic feature of Kearns-Sayre Syndrome (KSS)?",
    "options": "{\"A\": \"Chronic progressive external ophthalmoplegia (CPEO)\", \"B\": \"Salt-and-pepper pigmentary retinopathy\", \"C\": \"Mitochondrial myopathy\", \"D\": \"Cardiac conduction defects\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks to identify characteristic clinical features of Kearns-Sayre syndrome, a mitochondrial myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q497",
    "question_text": "A patient with myasthenia gravis and thymus hyperplasia is on pyridostigmine and is experiencing worsening generalized weakness. What is the recommended next step in management?",
    "options": "{\"A\": \"Referral for thymectomy\", \"B\": \"Start azathioprine\", \"C\": \"Low and slow steroid regimen\", \"D\": \"Plasmapheresis or intravenous immunoglobulin\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the next steps in management for a myasthenia gravis patient, considering various treatment options including thymectomy and immunosuppression.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q161",
    "question_text": "Typical scenario of Myasthenia Gravis in a young lady with fluctuating ptosis. What is the best serological test in this case?",
    "options": "{\"A\": \"Single fiber EMG\", \"B\": \"Anti-Ach receptor antibodies\", \"C\": \"Anti-MuSK antibodies\", \"D\": \"Repetitive nerve stimulation test\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the best initial serological test (Anti-AChR antibodies) for diagnosing Myasthenia Gravis based on a typical clinical presentation.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q22",
    "question_text": "In hyperkalemic periodic paralysis, which of the following is a characteristic feature?",
    "options": "{\"A\": \"Usually mild paralysis\", \"B\": \"Triggered by rest\", \"C\": \"Serum potassium is low\", \"D\": \"Myotonia is prominent\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about characteristic features and triggers of hyperkalemic periodic paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q257",
    "question_text": "When should Guillain-Barr\u00e9 syndrome be suspected?",
    "options": "{\"A\": \"Rapidly progressive bilateral limb weakness\", \"B\": \"Hypo/areflexia\", \"C\": \"Facial or bulbar palsy\", \"D\": \"All of the above\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks to identify the hallmark clinical features suggestive of Guillain-Barr\u00e9 Syndrome (GBS), an acute inflammatory polyneuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q96",
    "question_text": "In a scenario of Acute Inflammatory Demyelinating Polyneuropathy (AIDP) on day 5, what will the nerve conduction study (NCS) show?",
    "options": "{\"A\": \"Sural sparing with affected median and ulnar nerves\", \"B\": \"Normal sensory and motor nerve conduction velocities\", \"C\": \"Increased amplitude of compound muscle action potentials\", \"D\": \"Early recruitment of motor units on electromyography\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about characteristic nerve conduction study findings (e.g., demyelinating features, potential sural sparing pattern) in early AIDP (GBS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q521",
    "question_text": "A patient came with right upper limb weakness and intrinsic hand atrophy with diminished reflexes. What is the diagnosis?",
    "options": "{\"A\": \"Multifocal motor neuropathy (MMN)\", \"B\": \"Amyotrophic lateral sclerosis (ALS)\", \"C\": \"Cervical radiculopathy\", \"D\": \"Peripheral nerve entrapment\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a typical presentation possibly suggestive of Multifocal Motor Neuropathy (MMN) or other causes of lower motor neuron dysfunction.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q531",
    "question_text": "A typical case of Hirayama disease presents with right upper limb weakness with preserved brachioradialis and minimal weakness in the left upper limb. What is the associated finding in this patient?",
    "options": "{\"A\": \"Focal cervical cord atrophy\", \"B\": \"Generalized brain atrophy\", \"C\": \"Multiple sclerosis plaques\", \"D\": \"Peripheral nerve demyelination\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about an associated finding (focal cervical cord atrophy on MRI) in Hirayama disease, a condition affecting lower motor neurons in the cervical spine.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q13",
    "question_text": "Which condition is characterized by myotonia that worsens with exercise?",
    "options": "{\"A\": \"Paramyotonia congenita\", \"B\": \"Hyperkalemic periodic paralysis\", \"C\": \"Hypokalemic periodic paralysis\", \"D\": \"Myotonic dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks to identify the specific neuromuscular channelopathy (Paramyotonia congenita) characterized by paradoxical myotonia (worsening with exercise/cold).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q34",
    "question_text": "Which of the following may be elevated in patients with Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Serum creatine kinase (CK)\", \"B\": \"Lactate and pyruvate concentrations\", \"C\": \"Blood glucose levels\", \"D\": \"Serum calcium levels\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about potential laboratory abnormalities (elevated lactate/pyruvate) associated with Kearns-Sayre syndrome, a mitochondrial myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q463",
    "question_text": "A case about ulnar nerve injury presents with claw hand. What is the likely diagnosis?",
    "options": "{\"A\": \"Radial nerve palsy\", \"B\": \"Median nerve palsy\", \"C\": \"Ulnar nerve palsy\", \"D\": \"Brachial plexus injury\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis related to a specific peripheral nerve injury (ulnar nerve) based on a characteristic clinical sign (claw hand).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q165",
    "question_text": "A pregnant lady presents with hyperemesis gravidarum and sensory disturbances in her distal limbs. What is the likely cause?",
    "options": "{\"A\": \"Vitamin B12 deficiency\", \"B\": \"Zinc toxicity\", \"C\": \"Thiamine deficiency\", \"D\": \"Folate deficiency\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links sensory disturbances (likely peripheral neuropathy) to thiamine deficiency (potentially Wernicke-Korsakoff or beriberi) secondary to hyperemesis gravidarum.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q58",
    "question_text": "An elderly patient with volar hand weakness may be suspected of having which condition?",
    "options": "{\"A\": \"Inclusion Body Myositis (IBM)\", \"B\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"C\": \"Myasthenia Gravis\", \"D\": \"Duchenne Muscular Dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Presents a classic clinical feature (finger flexor/volar hand weakness in an older adult) pointing towards the diagnosis of Inclusion Body Myositis (IBM).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q237",
    "question_text": "A patient who underwent radiation therapy for breast cancer 28 months ago presents with numbness in the 3rd and 4th fingers and arm pain. What is the next best step in management?",
    "options": "{\"A\": \"MRI\", \"B\": \"CSF analysis\", \"C\": \"Nerve conduction studies\", \"D\": \"Electromyography\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Involves the diagnostic workup (including NCS) to differentiate radiation-induced plexopathy from tumor recurrence in a patient presenting with neuropathic symptoms post-cancer therapy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q2",
    "question_text": "A patient with a picture of limb-girdle muscular dystrophy (LGMD) underwent three surgeries under general anesthesia without complications. His brother developed malignant hyperthermia after a procedure. What should be communicated to the patient?",
    "options": "{\"A\": \"He is not at risk at all since he underwent three procedures without complications\", \"B\": \"He still has the risk\", \"C\": \"He is at high risk\", \"D\": \"He can safely undergo anesthesia without precautions\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the risk assessment for Malignant Hyperthermia, an anesthetic complication linked to certain genetic neuromuscular disorders (like some LGMDs, central core disease), considering family history and personal history.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q24",
    "question_text": "A 50+ year old male presents with weakness in hand flexors and quadriceps. What is the diagnosis?",
    "options": "{\"A\": \"Inclusion Body Myositis (IBM)\", \"B\": \"Polymyositis\", \"C\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a typical clinical presentation (weakness pattern and age group) characteristic of Inclusion Body Myositis (IBM).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q520",
    "question_text": "In a patient with Acute Inflammatory Demyelinating Polyneuropathy (AIDP), what is the characteristic clinical finding?",
    "options": "{\"A\": \"Progressive, symmetrical muscle weakness with absent deep tendon reflexes\", \"B\": \"Asymmetrical muscle weakness with preserved reflexes\", \"C\": \"Sensory loss without motor involvement\", \"D\": \"Flaccid paralysis with hyperreflexia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the hallmark clinical findings of AIDP (GBS), specifically the pattern of weakness and reflex changes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q33",
    "question_text": "Scenario of progressive bulbar palsy: what is the diagnosis?",
    "options": "{\"A\": \"Progressive bulbar palsy\", \"B\": \"Bulbar onset ALS\", \"C\": \"Myasthenia gravis\", \"D\": \"Brainstem stroke\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the diagnosis/classification of Progressive Bulbar Palsy, a clinical phenotype of Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q38",
    "question_text": "In the context of periodic paralysis, which of the following statements is true regarding serum potassium levels?",
    "options": "{\"A\": \"Always low in hypokalemic periodic paralysis\", \"B\": \"Always high in hyperkalemic periodic paralysis\", \"C\": \"Normal but may be high in hypokalemic periodic paralysis\", \"D\": \"None of the above\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests understanding of the pathophysiology, specifically serum potassium levels during attacks, in different types of periodic paralysis (neuromuscular channelopathies).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q254",
    "question_text": "What percentage of Guillain-Barr\u00e9 syndrome patients experience recurrence?",
    "options": "{\"A\": \"0-1%\", \"B\": \"2-5%\", \"C\": \"10-15%\", \"D\": \"20-25%\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the epidemiology (recurrence rate) of Guillain-Barr\u00e9 Syndrome, an inflammatory polyneuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q428",
    "question_text": "A patient presents with clear symptoms of periodic paralysis lasting for hours. What is the next test that should be performed?",
    "options": "{\"A\": \"Long exercise test\", \"B\": \"Short exercise test\", \"C\": \"Serum potassium measurement\", \"D\": \"Electromyography (EMG)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the appropriate electrodiagnostic test (long exercise test) used for evaluating suspected periodic paralysis (neuromuscular channelopathies).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q32",
    "question_text": "In patients with generalized Myasthenia Gravis, positive AChR-binding antibodies are found in what percentage of cases?",
    "options": "{\"A\": \"30%\", \"B\": \"50%\", \"C\": \"80%\", \"D\": \"97%\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the frequency of positive AChR antibodies in generalized Myasthenia Gravis, a key aspect of diagnosing this neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q35",
    "question_text": "What is the effect of cold in hypokalemic periodic paralysis?",
    "options": "{\"A\": \"May induce an attack\", \"B\": \"Relieves an attack\", \"C\": \"No effect\", \"D\": \"Prevents an attack\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the effect of a specific trigger (cold exposure) in hypokalemic periodic paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q79",
    "question_text": "A patient presents with upper extremity painful neuropathy and atrophy. What is the recommended treatment?",
    "options": "{\"A\": \"Capsaicin cream\", \"B\": \"Duloxetine\", \"C\": \"Amitriptyline\", \"D\": \"Valproic acid\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the pharmacological management options for painful peripheral neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q563",
    "question_text": "A 35-year-old obese female has delayed muscle relaxation, complains of tingling in her hands, and has slight bradycardia in her vital signs. What investigation should be done?",
    "options": "{\"A\": \"TFT\", \"B\": \"Nerve conduction studies\", \"C\": \"Serum calcium levels\", \"D\": \"Electromyography\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Although presenting with neuromuscular symptoms (delayed relaxation/myotonia-like, tingling/neuropathy-like), the constellation and requested investigation (Thyroid Function Tests) point towards diagnosing an underlying systemic condition (hypothyroidism) mimicking neuromuscular disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q67",
    "question_text": "A patient presents with hand stiffness that worsens and becomes weak with exercise and cold. What is the diagnosis?",
    "options": "{\"A\": \"Paramyotonia congenita\", \"B\": \"Myotonia congenita\", \"C\": \"Hyperkalemic periodic paralysis\", \"D\": \"Hypokalemic periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis (Paramyotonia congenita) based on characteristic features of paradoxical myotonia induced by cold and exercise.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q43",
    "question_text": "Which of the following conditions is characterized by paralysis that typically occurs in the first to second decade of life and predominantly affects males?",
    "options": "{\"A\": \"Hypokalemic Periodic Paralysis\", \"B\": \"Hyperkalemic Periodic Paralysis\", \"C\": \"Paramyotonia Congenita\", \"D\": \"Myotonic Dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the typical epidemiology (age of onset, gender predilection) for hypokalemic periodic paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q63",
    "question_text": "In congenital myasthenia gravis, which channel types are involved?",
    "options": "{\"A\": \"Slow channel\", \"B\": \"Fast channel\", \"C\": \"Calcium channel\", \"D\": \"Potassium channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the underlying pathophysiology (types of ion channel defects) in different subtypes of Congenital Myasthenic Syndromes (CMS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q68",
    "question_text": "In an elderly patient presenting with neuropathy and weakness, which of the following is a recommended diagnostic procedure if amyloidosis is suspected?",
    "options": "{\"A\": \"Fat aspiration\", \"B\": \"Immunofixation\", \"C\": \"Plasma electrophoresis\", \"D\": \"TTR gene testing\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the appropriate diagnostic procedures (including tissue biopsy, protein studies, genetic testing) for confirming suspected amyloid neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q301",
    "question_text": "A 55-year-old male has a history of lower limb weakness for days, initially starting with numbness and tingling. Days later, the weakness involved the upper limbs and was associated with hyperhidrosis in the lower limbs and facial involvement. He also has a history of epigastric pain. Examination shows bilateral lower limb weakness. He received an influenza vaccine 2 weeks prior to the onset of symptoms. What is the diagnosis?",
    "options": "{\"A\": \"Acute Intermittent Porphyria (AIP)\", \"B\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\", \"C\": \"Acute spinal cord syndrome\", \"D\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Involves the differential diagnosis between AIDP (GBS) and AIP based on clinical features including autonomic dysfunction, pain, and potential triggers presented in an acute/subacute polyneuropathy scenario.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q519",
    "question_text": "A case of Bell's palsy underwent EMG. Which muscle is likely to show findings?",
    "options": "{\"A\": \"Levator palpebrae\", \"B\": \"Stylohyoid\", \"C\": \"Masseter\", \"D\": \"Temporalis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks to identify a muscle innervated by the facial nerve (Stylohyoid) that would show EMG abnormalities in Bell's palsy, applying knowledge of neuromuscular testing and anatomy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q70",
    "question_text": "A patient presented with falling down and an acetabulum fracture. After admission, he still has a very painful right leg; however, he noticed that he could not dorsiflex his right foot along with decreased sensation of the dorsum of the right foot. What is most likely injured in this patient?",
    "options": "{\"A\": \"Sciatic nerve main trunk\", \"B\": \"Medial portion of sciatic nerve\", \"C\": \"Lateral portion of sciatic nerve\", \"D\": \"Common peroneal nerve\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Requires localization of a peripheral nerve injury (likely common peroneal nerve or its sciatic division) based on motor deficit (foot drop) and sensory loss following trauma.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q151",
    "question_text": "What is the most sensitive test to diagnose myasthenia gravis (MG)?",
    "options": "{\"A\": \"Single fiber EMG\", \"B\": \"Acetylcholine receptor antibodies\", \"C\": \"Repetitive nerve stimulation\", \"D\": \"Chest CT scan for thymoma\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the relative sensitivity of diagnostic tests (Single Fiber EMG vs. antibodies) for Myasthenia Gravis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q119",
    "question_text": "A patient presented with right arm weakness that was slowly progressive for 5 years and then became static, involving multiple muscles while sparing the brachioradialis. The patient denies pain or trauma. What is expected to be found?",
    "options": "{\"A\": \"Segmental atrophy on spinal MRI\", \"B\": \"Increased signal intensity in the cervical spinal cord on T2-weighted MRI\", \"C\": \"Diffuse muscle edema on MRI of the affected arm\", \"D\": \"Normal spinal MRI with only electromyographic abnormalities\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a clinical scenario possibly suggestive of Hirayama disease or another focal motor neuron disorder, asking about expected associated findings (like segmental cord atrophy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q542",
    "question_text": "In a scenario of Acute Inflammatory Demyelinating Polyneuropathy (AIDP) on day 5, what will the nerve conduction study (NCS) show?",
    "options": "{\"A\": \"Sural sparing with affected median and ulnar nerves\", \"B\": \"Normal sensory and motor nerve conduction velocities\", \"C\": \"Reduced compound muscle action potential (CMAP) amplitudes without demyelination\", \"D\": \"Increased distal motor latencies with conduction block\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about characteristic nerve conduction study findings in early AIDP (GBS). (Duplicate of Q96).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q245",
    "question_text": "Anti-MuSK Myasthenia gravis is characterized by which of the following features?",
    "options": "{\"A\": \"Tongue fasciculation and atrophy\", \"B\": \"Less common in females\", \"C\": \"Good response to pyridostigmine\", \"D\": \"Proximal muscle weakness\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about specific clinical features often associated with the MuSK antibody positive subtype of Myasthenia Gravis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q10",
    "question_text": "A patient with ALS presents with fatigue. What is the next best step in management?",
    "options": "{\"A\": \"Pulmonary function test\", \"B\": \"Methylphenidate\", \"C\": \"Refer to assess depression\", \"D\": \"Nocturnal oximetry\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the management of a common symptom (fatigue) in ALS, emphasizing the importance of assessing for respiratory insufficiency as a potential cause.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q98",
    "question_text": "A patient with back pain radiating to the left lower limb and normal ankle reflexes is evaluated. Which muscle is involved?",
    "options": "{\"A\": \"Superior gluteus\", \"B\": \"Iliopsoas\", \"C\": \"Hamstrings\", \"D\": \"Quadriceps\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of neuromuscular anatomy and localization based on radicular pain pattern and specific muscle weakness (likely L5 radiculopathy affecting gluteus medius/minimus or iliopsoas if hip flexion weak, distinguishing from S1 affecting ankle reflex/gastrocnemius).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q64",
    "question_text": "Which of the following electrodiagnostic tests is most helpful in the diagnosis of periodic paralysis?",
    "options": "{\"A\": \"High-frequency repetitive stimulation\", \"B\": \"Long exercise testing\", \"C\": \"Low-frequency repetitive stimulation\", \"D\": \"Short exercise testing\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the specific electrodiagnostic technique (long exercise testing) used to diagnose muscle channelopathies like periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q550",
    "question_text": "A patient has muscle stiffness that worsens with exercise. What is the likely diagnosis?",
    "options": "{\"A\": \"Paramyotonia\", \"B\": \"Myotonic dystrophy\", \"C\": \"Multiple sclerosis\", \"D\": \"Amyotrophic lateral sclerosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes clinical features (exercise-induced stiffness/myotonia) characteristic of specific neuromuscular channelopathies or dystrophies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q431",
    "question_text": "A poorly controlled type 1 diabetic male with an HbA1c of 14% became controlled one week ago and started to complain of pain. What is the best management option?",
    "options": "{\"A\": \"Gabapentin\", \"B\": \"Steroid\", \"C\": \"Skin biopsy\", \"D\": \"Nerve biopsy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes treatment-induced neuropathy of diabetes (TIND) or diabetic neuropathic cachexia, focusing on management of painful neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q41",
    "question_text": "Most common presentation of post-polio syndrome:",
    "options": "{\"A\": \"New muscle weakness and fatigue\", \"B\": \"Asymptomatic\", \"C\": \"Aseptic meningitis\", \"D\": \"Flu-like symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the clinical features of post-polio syndrome, a neuromuscular condition affecting motor neurons.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q41",
    "question_text": "Most common presentation of post-polio syndrome:",
    "options": "{\"A\": \"New onset muscle weakness and fatigue\", \"B\": \"Asymptomatic\", \"C\": \"Aseptic meningitis\", \"D\": \"Flu-like symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the clinical features of post-polio syndrome, a neuromuscular condition affecting motor neurons.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q426",
    "question_text": "A 38-year-old male presents with a history of generalized weakness, a \"spring\" face, and respiratory issues. Examination reveals hyporeflexia. He came to the ER and received potassium supplements, but later repeated the same attacks weekly. His potassium level is 2.6 (low). What is the most accurate management?",
    "options": "{\"A\": \"Acetazolamide\", \"B\": \"Mexiletine\", \"C\": \"Spironolactone\", \"D\": \"Daily potassium dose\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes symptoms suggestive of hypokalemic periodic paralysis and asks for prophylactic treatment (Acetazolamide).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q46",
    "question_text": "A patient with a picture of Myasthenia Gravis (eye, proximal weakness, and bulbar symptoms) and a flat tongue. Which of the following antibodies is supposed to be positive?",
    "options": "{\"A\": \"ACR\", \"B\": \"Anti-MuSK\", \"C\": \"Anti-AChR\", \"D\": \"Anti-GM1\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Relates specific clinical features (prominent bulbar/facial weakness, potentially tongue atrophy) in myasthenia gravis to the associated antibody (Anti-MuSK).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q470",
    "question_text": "How to differentiate between C8 and ulnar neuropathy?",
    "options": "{\"A\": \"Abnormal SNAP\", \"B\": \"Prolonged F-wave\", \"C\": \"Digiti minimi weakness\", \"D\": \"Sensory loss in the medial forearm\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to localize a lesion (radiculopathy vs neuropathy) using clinical signs and electrodiagnostic principles (SNAP preservation in radiculopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q548",
    "question_text": "What is the characteristic clinical presentation of Multifocal Motor Neuropathy (MMN)?",
    "options": "{\"A\": \"Subacute onset of patchy, asymmetrical weakness without sensory involvement\", \"B\": \"Rapidly progressive weakness with sensory loss\", \"C\": \"Bilateral symmetrical weakness with sensory symptoms\", \"D\": \"Isolated sensory symptoms in the lower limbs\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the defining clinical features of Multifocal Motor Neuropathy (MMN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q73",
    "question_text": "What is the nerve supply to the sartorius muscle?",
    "options": "{\"A\": \"Femoral nerve\", \"B\": \"Obturator nerve\", \"C\": \"Genitofemoral nerve\", \"D\": \"Sciatic nerve\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve anatomy and muscle innervation (femoral nerve innervates sartorius).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q114",
    "question_text": "In a scenario with congenital myasthenia gravis, where the patient has hand involvement and proximal upper and lower limb weakness, what is the likely diagnosis?",
    "options": "{\"A\": \"Slow channel myasthenia gravis\", \"B\": \"Fast channel congenital myasthenic syndrome\", \"C\": \"Acetylcholine receptor deficiency syndrome\", \"D\": \"Endplate acetylcholinesterase deficiency\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a specific subtype of congenital myasthenic syndrome based on clinical features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q127",
    "question_text": "A patient presented with back pain, facial sweating, and intermittent epigastric pain associated with progressive distal sensory loss and weakness. What is the diagnosis?",
    "options": "{\"A\": \"Acute inflammatory demyelinating polyneuropathy\", \"B\": \"Acute intermittent porphyria\", \"C\": \"Diabetic peripheral neuropathy\", \"D\": \"Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a constellation of symptoms (autonomic, psychiatric/pain, neuropathy) highly suggestive of Acute Intermittent Porphyria (AIP), a disorder affecting nerve function.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q432",
    "question_text": "What is commonly associated with anti-MuSK antibodies?",
    "options": "{\"A\": \"Normal thyroid function\", \"B\": \"HLA-DRB3, HLA-DR14-DQ5 association\", \"C\": \"Predominant facial and bulbar muscle weakness\", \"D\": \"Poor response to acetylcholinesterase inhibitors\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about specific associations (HLA type) related to MuSK-positive myasthenia gravis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q130",
    "question_text": "An infant with hypotonia, macroglossia, feeding problems, trouble breathing, muscle weakness, and an enlarged heart. What is the defective enzyme?",
    "options": "{\"A\": \"Acid fast Maltase (Acid alpha-glucosidase)\", \"B\": \"Hexosaminidase A\", \"C\": \"Glucose-6-phosphatase\", \"D\": \"Phenylalanine hydroxylase\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic features of Pompe disease (infantile-onset), a metabolic myopathy, and asks for the deficient enzyme.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q342",
    "question_text": "In a scenario about a patient with static weakness sparing the brachioradialis, what would you expect to see on MRI?",
    "options": "{\"A\": \"Spinal Segment Atrophy\", \"B\": \"Diffuse Brain Atrophy\", \"C\": \"Multiple Sclerosis Plaques\", \"D\": \"Normal MRI\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Relates a specific pattern of weakness (potentially Hirayama disease or variant) to expected neuroimaging findings (focal cord atrophy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q52",
    "question_text": "In a case of limb girdle muscular dystrophy type 2A, what is the recommended diagnostic test?",
    "options": "{\"A\": \"Echocardiogram\", \"B\": \"Pulmonary function test\", \"C\": \"Muscle biopsy\", \"D\": \"Genetic testing\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about systemic involvement (cardiac/pulmonary) screening in a specific type of muscular dystrophy (LGMD2A/Calpainopathy, though cardiac involvement is less common than in others).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q41",
    "question_text": "A 70-year-old male patient came with progressive spastic lower limb weakness that progressed over time to involve the upper limb, with fasciculations present. What is the most likely diagnosis?",
    "options": "{\"A\": \"Primary Lateral Sclerosis (PLS)\", \"B\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"C\": \"Hereditary Spastic Paraplegia\", \"D\": \"Multiple Sclerosis\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes clinical features (mixed UMN and LMN signs) characteristic of Amyotrophic Lateral Sclerosis (ALS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q186",
    "question_text": "What is the most common cause of femoral neuropathy?",
    "options": "{\"A\": \"Trauma\", \"B\": \"Diabetes mellitus\", \"C\": \"Lumbar radiculopathy\", \"D\": \"Claw hand\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the etiology of a specific peripheral mononeuropathy (femoral neuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q261",
    "question_text": "Kearns-Sayre syndrome",
    "options": "{\"A\": \"Is characterized by progressive external ophthalmoplegia, pigmentary retinopathy, and onset before age 20\", \"B\": \"Is an autosomal recessive disorder affecting the peripheral nerves\", \"C\": \"Primarily affects the lower motor neurons causing muscle atrophy\", \"D\": \"Is caused by mutations in the dystrophin gene\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Names a specific mitochondrial myopathy, implying a question about its features, diagnosis, or genetics.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q78",
    "question_text": "In a patient with Amyotrophic Lateral Sclerosis (ALS), what is a characteristic finding on EMG?",
    "options": "{\"A\": \"Slow conduction velocity\", \"B\": \"H reflex\", \"C\": \"Fibrillation\", \"D\": \"Prolonged distal latency\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of characteristic electrodiagnostic findings (fibrillations indicating active denervation) in ALS.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q47",
    "question_text": "A case with features of POEM presents with lower limb edema and neuropathy. What is the likely associated factor?",
    "options": "{\"A\": \"VEGF\", \"B\": \"LRRK2\", \"C\": \"\\u03b1-synuclein\", \"D\": \"Parkin\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the key pathogenetic factor (VEGF) in POEMS syndrome, a condition characterized by polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q247",
    "question_text": "In the management of acute attacks of hypokalemic periodic paralysis, potassium is typically given orally at what dosage?",
    "options": "{\"A\": \"5-10 mEq every 15-30 minutes\", \"B\": \"10-20 mEq every 15-30 minutes\", \"C\": \"20-30 mEq every 15-30 minutes\", \"D\": \"30-40 mEq every 15-30 minutes\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the acute treatment protocol (potassium dosing) for a specific neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q544",
    "question_text": "In a scenario of AIDP, what are the early findings in nerve conduction studies (NCS)?",
    "options": "{\"A\": \"Prolonged or absent F wave with absent H reflex\", \"B\": \"Increased amplitude of compound muscle action potential (CMAP)\", \"C\": \"Normal conduction velocity with reduced sensory nerve action potential (SNAP) amplitude\", \"D\": \"Early recruitment of motor units on electromyography\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about specific early electrodiagnostic markers (abnormal late responses) in Acute Inflammatory Demyelinating Polyneuropathy (AIDP).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q31",
    "question_text": "A diabetic patient presents with features of small fiber neuropathy (pain worse at night, intact reflexes). What is the best treatment?",
    "options": "{\"A\": \"Pregabalin\", \"B\": \"Amitriptyline\", \"C\": \"Duloxetine\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a common type of peripheral neuropathy (small fiber) in diabetes and asks for symptomatic treatment options.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q250",
    "question_text": "What is one of the diagnostic criteria for Guillain-Barr\u00e9 syndrome?",
    "options": "{\"A\": \"Routine laboratory tests\", \"B\": \"Exclude other causes\", \"C\": \"CSF examination\", \"D\": \"Nerve conduction studies\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Pertains to the diagnostic workup and criteria for Guillain-Barr\u00e9 Syndrome (GBS), a common autoimmune neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q138",
    "question_text": "Vitamin B6 deficiency can lead to which type of peripheral neuropathy?",
    "options": "{\"A\": \"Sensory neuropathy\", \"B\": \"Motor neuropathy\", \"C\": \"Mixed neuropathy\", \"D\": \"Axonal neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Links a specific vitamin deficiency (B6 toxicity or deficiency can cause neuropathy) to the resulting type of peripheral neuropathy (sensory axonal).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q193",
    "question_text": "Distal acquired demyelinating symmetric neuropathy (DADS) is characterized by which of the following?",
    "options": "{\"A\": \"Proximal weakness\", \"B\": \"Sensory deficits more than motor deficits\", \"C\": \"Upper limb predominance\", \"D\": \"Presence of anti-MAG antibodies\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the key features and associations (anti-MAG antibodies) of a specific subtype of chronic demyelinating neuropathy (DADS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q270",
    "question_text": "EMG",
    "options": "{\"A\": \"Measures nerve conduction velocity\", \"B\": \"Records electrical activity of muscles at rest and during contraction\", \"C\": \"Is primarily used to assess brain activity\", \"D\": \"Detects abnormalities in cerebrospinal fluid\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Likely relates to electromyography, a core diagnostic tool in neuromuscular medicine.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q376",
    "question_text": "An anti-MuSK patient who developed hepatotoxicity with azathioprine, what medication should be given?",
    "options": "{\"A\": \"Rituximab\", \"B\": \"Prednisolone\", \"C\": \"Monthly IVIG\", \"D\": \"Mycophenolate mofetil\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns the treatment strategy for a specific subtype of myasthenia gravis (MuSK-positive), particularly after failure or complications with other therapies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q474",
    "question_text": "A 40-year-old male patient presents with left arm weakness, thenar and hypothenar atrophy, fasciculations, and normal sensory examination. What is the likely diagnosis?",
    "options": "{\"A\": \"Multifocal motor neuropathy (MMN)\", \"B\": \"Limb onset amyotrophic lateral sclerosis (ALS)\", \"C\": \"Cervical radiculopathy\", \"D\": \"Spinal muscular atrophy\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Presents a clinical scenario requiring differential diagnosis between two motor neuron disorders/neuropathies (MMN vs ALS) based on clinical features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q444",
    "question_text": "A patient has a fracture in the acetabulum and notices numbness on the dorsum of the foot with weak dorsiflexion. Where is the lesion likely located?",
    "options": "{\"A\": \"Lateral aspect of the sciatic nerve (Peroneal division)\", \"B\": \"Medial aspect of the sciatic nerve (Tibial division)\", \"C\": \"Sciatic trunk\", \"D\": \"Common peroneal nerve at the fibular neck\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires localization of a peripheral nerve injury (sciatic nerve, likely peroneal division) based on mechanism (trauma) and resulting neurological deficit.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q76",
    "question_text": "In congenital myasthenic syndromes, what is the gene defect that causes worsening of symptoms with acetylcholinesterase inhibitors?",
    "options": "{\"A\": \"DOK7\", \"B\": \"Rapsyn\", \"C\": \"Slow channel (CHRNE)\", \"D\": \"Fast channel\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific genetic subtypes of congenital myasthenic syndromes and their differential response to treatment (AChE inhibitors worsen slow-channel CMS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q126",
    "question_text": "A patient presents with left wrist drop and has a history of right wrist drop that improved, as well as a right foot drop. She has a positive family history of similar presentations. Which of the following genes is expected to be found?",
    "options": "{\"A\": \"PMP22 duplication\", \"B\": \"PMP22 deletion\", \"C\": \"MFN2 mutation\", \"D\": \"GJB1 mutation\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic features of Hereditary Neuropathy with liability to Pressure Palsies (HNPP), linking the clinical picture to the underlying genetic defect (PMP22 deletion).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q480",
    "question_text": "A male patient with diabetes who is on metformin and has multiple comorbidities developed anemia with high MCV and neuropathy. What is the mechanism of developing this neuropathy?",
    "options": "{\"A\": \"Metformin related (metformin caused B12 deficiency)\", \"B\": \"Diabetic neuropathy\", \"C\": \"Alcohol-related neuropathy\", \"D\": \"Nutritional deficiency\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires differentiating potential causes of neuropathy in a diabetic patient, specifically identifying metformin-induced B12 deficiency as a cause.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q536",
    "question_text": "A patient who underwent bariatric surgery developed weakness and large fiber neuropathy, with normal B12 and methylmalonic acid levels. What is the likely deficiency?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Copper\", \"C\": \"Vitamin D\", \"D\": \"Magnesium\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes neurological complications (neuropathy) following bariatric surgery, pointing towards a specific nutritional deficiency (Copper deficiency can cause myeloneuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q63",
    "question_text": "A patient presents with channelopathy. What is the best workup?",
    "options": "{\"A\": \"Long exercise test\", \"B\": \"Short exercise test\", \"C\": \"Electromyography\", \"D\": \"Genetic testing\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the appropriate diagnostic approach (specific EMG exercise tests) for suspected muscle channelopathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q61",
    "question_text": "What is the effect of oral potassium in the management of Hypokalemic Periodic Paralysis?",
    "options": "{\"A\": \"Prevents attack\", \"B\": \"Induces attack\", \"C\": \"Has no effect\", \"D\": \"Relieves attack\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the acute management (potassium supplementation relieves attacks) of hypokalemic periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q58",
    "question_text": "A patient develops myotonia after repetitive exercise and subsequently experiences weakness. There is a positive family history. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paramyotonia congenita\", \"B\": \"Myotonic dystrophy\", \"C\": \"Myotonia congenita\", \"D\": \"Hyperkalemic periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes clinical features (exercise/cold-induced myotonia followed by weakness) characteristic of Paramyotonia Congenita.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q47",
    "question_text": "What is a common presenting feature of Multifocal Motor Neuropathy (MMN)?",
    "options": "{\"A\": \"Upper motor neuron signs\", \"B\": \"Wrist drop\", \"C\": \"Sensory loss\", \"D\": \"Severe pain\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about typical clinical signs (e.g., wrist drop due to radial nerve involvement) in Multifocal Motor Neuropathy (MMN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q142",
    "question_text": "A 25-year-old male complains of a 14-month history of left-hand weakness. The weakness was progressive for 5 months and then became static. On examination, the affected hand muscles show intact elbow flexion and shoulder abduction, with sensory function intact. What is the diagnosis?",
    "options": "{\"A\": \"Hirayama disease\", \"B\": \"Multifocal motor neuropathy (MMN)\", \"C\": \"Amyotrophic lateral sclerosis (ALS)\", \"D\": \"Cervical spondylotic myelopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a clinical presentation (young male, unilateral distal upper limb weakness/atrophy, sparing brachioradialis, stabilization) characteristic of Hirayama disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q233",
    "question_text": "Congenital myasthenia gravis with distal and proximal weakness, facial involvement worsened with acetylcholinesterase inhibitor?",
    "options": "{\"A\": \"DOK7\", \"B\": \"RAPSN\", \"C\": \"CHRNE (Slow Channel)\", \"D\": \"FCMS (Fast Channel)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Repeats the concept of Q76, linking worsening with AChE inhibitors to slow-channel congenital myasthenic syndrome (associated with CHRNE gene mutations).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q530",
    "question_text": "In a scenario typical for paramyotonia congenita, what is the gene involved?",
    "options": "{\"A\": \"Sodium channel (SCN4A)\", \"B\": \"Chloride channel (CLCN1)\", \"C\": \"Dystrophin (DMD)\", \"D\": \"Ryanodine receptor (RYR1)\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects the clinical diagnosis of paramyotonia congenita to its underlying genetic cause (mutations in the SCN4A gene).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q455",
    "question_text": "A patient with dysferlinopathy presents with a CK level elevated 35 times the normal and mild upper limb weakness, mainly in the lower limbs, with significant calf atrophy and weak dorsiflexion. What is the likely diagnosis?",
    "options": "{\"A\": \"Miyoshi Myopathy (LGMD2B)\", \"B\": \"Becker Muscular Dystrophy\", \"C\": \"Facioscapulohumeral Muscular Dystrophy\", \"D\": \"Limb-Girdle Muscular Dystrophy type 1\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes clinical features (distal weakness, calf atrophy, high CK) associated with dysferlinopathy, specifically pointing towards the Miyoshi Myopathy phenotype.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q129",
    "question_text": "A young boy went for a football match with his friends. Later, he started to have proximal muscle weakness, and his urine turned brown. He had a history of similar symptoms during his previous admission. What is the defective enzyme?",
    "options": "{\"A\": \"Myophosphorylase deficiency (McArdle disease)\", \"B\": \"Carnitine palmitoyltransferase II deficiency\", \"C\": \"Acid maltase deficiency\", \"D\": \"Phosphofructokinase deficiency\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes exercise-induced rhabdomyolysis, asking to differentiate between metabolic myopathies based on trigger (prolonged exercise suggests CPT II, short intense exercise suggests McArdle).* Option B (CPT II) is often triggered by prolonged exercise/fasting. Option A (McArdle) by short, intense exercise. The scenario fits either, but CPT II is arguably more common for prolonged activity like a football match.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q420",
    "question_text": "An infant presents with respiratory issues, electrical myotonia, and macroglossia. What is the likely diagnosis?",
    "options": "{\"A\": \"Pompe\", \"B\": \"Myotonic dystrophy\", \"C\": \"Congenital myotonia\", \"D\": \"Hypothyroidism\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes features suggestive of infantile-onset Pompe disease (hypotonia, macroglossia, respiratory/cardiac issues), although 'electrical myotonia' is atypical for Pompe (more common in myotonic dystrophies or channelopathies). Assuming Pompe is the intended answer based on other classic features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q98",
    "question_text": "A young man who had abdominal pain around 1 week back and had a flu vaccine recently presented with a 5-day history of progressive distal dysesthesias and facial hyperhidrosis. Later on, he was tripping while walking and had weakness with decreased DTR on examination. What is the diagnosis?",
    "options": "{\"A\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\", \"B\": \"Myasthenia Gravis\", \"C\": \"Multiple Sclerosis\", \"D\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a classic presentation of Guillain-Barr\u00e9 Syndrome (AIDP variant), including antecedent events, progressive weakness, areflexia, sensory symptoms, and autonomic features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q131",
    "question_text": "A patient with symptoms suggestive of chronic inflammatory demyelinating polyneuropathy (CIDP) was not responding to intravenous immunoglobulin (IVIG) and was found to have positive neurofascin 155 antibodies. What is the treatment for this patient?",
    "options": "{\"A\": \"Rituximab\", \"B\": \"Plasma exchange\", \"C\": \"Corticosteroids\", \"D\": \"Azathioprine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the specific treatment (Rituximab) for a subtype of CIDP defined by Neurofascin-155 antibodies, known to respond poorly to IVIG.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q189",
    "question_text": "A young lady post-vaginal hysterectomy presents with weakness in hip adductors and hip flexion. Which nerve is likely affected?",
    "options": "{\"A\": \"Obturator nerve\", \"B\": \"Femoral nerve\", \"C\": \"Sciatic nerve\", \"D\": \"Lumbosacral plexus\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires localization of nerve injury (Obturator and potentially Femoral) based on surgical context and specific muscle weakness.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q369",
    "question_text": "In a Guillain-Barr\u00e9 syndrome scenario, what is the predicting factor for intubation?",
    "options": "{\"A\": \"Presence of dysautonomia\", \"B\": \"Rapid progression of limb weakness\", \"C\": \"Cranial nerve involvement\", \"D\": \"Elevated cerebrospinal fluid protein\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about prognostic factors indicating severity and need for respiratory support in Guillain-Barr\u00e9 Syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q110",
    "question_text": "In a scenario of AIDP, what are the early findings in NCS?",
    "options": "{\"A\": \"Prolonged or absent F wave with absent H Reflex\", \"B\": \"Increased conduction velocity with normal F wave latency\", \"C\": \"Normal sensory nerve action potentials with reduced motor amplitudes\", \"D\": \"Decreased distal motor latency with normal F wave\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeats the concept of Q544, asking about early electrodiagnostic signs in AIDP.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q471",
    "question_text": "A patient wakes up from sleep with right upper limb pain followed by weakness and multiple nerve involvement. What is the likely diagnosis?",
    "options": "{\"A\": \"Multifocal motor neuropathy (MMN)\", \"B\": \"Parsonage-Turner syndrome\", \"C\": \"Brachial plexopathy due to trauma\", \"D\": \"Cervical radiculopathy\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes the characteristic presentation of Neuralgic Amyotrophy (Parsonage-Turner syndrome).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q68",
    "question_text": "A patient with Sj\u00f6gren's disease presents with neurological symptoms. Which of the following is a possible presentation?",
    "options": "{\"A\": \"Present with polyneuropathy\", \"B\": \"Radiculopathy\", \"C\": \"Cranial neuropathy\", \"D\": \"Small fiber neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links a systemic autoimmune disease (Sj\u00f6gren's) to its common neurological manifestations, particularly sensory ganglionopathy or polyneuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q141",
    "question_text": "A 40-year-old female has proximal muscle weakness and progressive dysphagia. On examination, she has a weak cough and edematous eyes. What is the treatment? (This case is suggestive of dermatomyositis.)",
    "options": "{\"A\": \"Plasmapheresis\", \"B\": \"IV methylprednisolone\", \"C\": \"IVIG\", \"D\": \"Methotrexate\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes clinical features suggestive of inflammatory myopathy (likely dermatomyositis given eye edema mention) and asks for acute treatment (steroids/IVIG).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q57",
    "question_text": "Which factor is known to trigger an attack in Paramyotonia Congenita?",
    "options": "{\"A\": \"Rest\", \"B\": \"Exercise\", \"C\": \"Cold exposure\", \"D\": \"Glucose intake\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about a specific trigger (cold exposure) for symptoms in Paramyotonia Congenita.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q47",
    "question_text": "A 52-year-old female with dyslipidemia on statin had pneumonia and was admitted to the hospital. After starting on erythromycin, she developed weakness. What is the factor that increases the risk of toxic myopathy?",
    "options": "{\"A\": \"Old age\", \"B\": \"Female\", \"C\": \"Recent infection\", \"D\": \"Concomitant use of erythromycin\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on drug interactions (statin + macrolide like erythromycin) increasing the risk of statin-induced toxic myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q518",
    "question_text": "A female patient presents with right Bell's palsy. You performed the blink reflex test, and the EMG showed axonal injury. Which muscle is involved?",
    "options": "{\"A\": \"Masseter\", \"B\": \"Stylohyoid\", \"C\": \"Temporalis\", \"D\": \"Levator palpebrae\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Assesses knowledge of facial nerve anatomy and function (Bell's palsy) and related electrodiagnostic tests (blink reflex involves orbicularis oculi, innervated by facial nerve; stylohyoid is also facial nerve).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q539",
    "question_text": "A young patient came with weakness and is unable to extend his elbow and has toe walking; ECG showed RBBB. What is the diagnosis?",
    "options": "{\"A\": \"Emery-Dreifuss muscular dystrophy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Becker muscular dystrophy\", \"D\": \"Limb-girdle muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes the classic triad (early contractures, muscle weakness, cardiac conduction defect) of Emery-Dreifuss muscular dystrophy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q454",
    "question_text": "A clear scenario about MMN presents with severe weakness and no atrophy, asking about the diagnosis, but there are no NCS findings. What is the likely diagnosis?",
    "options": "{\"A\": \"Amyotrophic lateral sclerosis\", \"B\": \"Multifocal motor neuropathy without conduction block\", \"C\": \"Chronic inflammatory demyelinating polyneuropathy\", \"D\": \"Spinal muscular atrophy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes Multifocal Motor Neuropathy (MMN), focusing on clinical features.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q534",
    "question_text": "A patient came with channelopathy. What is the best workup?",
    "options": "{\"A\": \"Long exercise test\", \"B\": \"Short exercise test\", \"C\": \"Genetic testing\", \"D\": \"Nerve conduction study\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeats concept of Q63 regarding diagnostic EMG tests for channelopathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q187",
    "question_text": "Scenario of recurrent painless multifocal mononeuropathies at common compression sites. PMP-22 deletion was detected. What is the expected biopsy finding?",
    "options": "{\"A\": \"Onion bulb formation\", \"B\": \"Axonal degeneration\", \"C\": \"Demyelination (Tomacula / sausage-like thickenings)\", \"D\": \"Normal findings\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links the genetic diagnosis of HNPP (PMP22 deletion) to its characteristic nerve biopsy finding (tomacula/focal myelin thickenings).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q199",
    "question_text": "What is the most common myopathy in elderly individuals above 50 years of age?",
    "options": "{\"A\": \"Inclusion body myositis\", \"B\": \"Polymyositis\", \"C\": \"Dermatomyositis\", \"D\": \"Muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the most prevalent myopathy (Inclusion Body Myositis - IBM) in a specific age group.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q483",
    "question_text": "A typical scenario of a patient presents with decreased sensation and bilateral weakness in the lower limbs with areflexia. The patient had a history of diarrhea 10 days prior. What is the diagnosis?",
    "options": "{\"A\": \"Acute inflammatory demyelinating polyneuropathy (AIDP)\", \"B\": \"Chronic inflammatory demyelinating polyneuropathy (CIDP)\", \"C\": \"Multiple sclerosis\", \"D\": \"Spinal cord infarction\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a classic presentation of AIDP (GBS), including the post-infectious trigger.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q526",
    "question_text": "What is the first-line treatment for Acute Inflammatory Demyelinating Polyneuropathy (AIDP)?",
    "options": "{\"A\": \"Plasmapheresis\", \"B\": \"IV Immunoglobulin (IVIG)\", \"C\": \"Corticosteroids\", \"D\": \"Anticonvulsants\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the primary immunomodulatory treatments (IVIG or Plasmapheresis) for AIDP (GBS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q201",
    "question_text": "A patient presents with subacute flaccid quadriplegia following diarrheal illnesses, with sparing of the face and sensation. What is the most likely diagnosis?",
    "options": "{\"A\": \"AMAN (Acute Motor Axonal Neuropathy)\", \"B\": \"GBS\", \"C\": \"AMSAN\", \"D\": \"CIDP\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes features (pure motor, post-diarrheal - often Campylobacter) suggestive of the AMAN variant of Guillain-Barr\u00e9 Syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q50",
    "question_text": "A typical case of Hirayama disease presents with right upper limb weakness, preserved brachioradialis, and minimal weakness in the left upper limb. What is the associated finding in this patient?",
    "options": "{\"A\": \"Focal cervical cord atrophy\", \"B\": \"Generalized brain atrophy\", \"C\": \"Demyelination of peripheral nerves\", \"D\": \"Cerebellar degeneration\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links the clinical syndrome of Hirayama disease to its characteristic imaging finding.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q28",
    "question_text": "What is the most common myopathy disease in patients above 50 years of age?",
    "options": "{\"A\": \"Inclusion Body Myositis (IBM)\", \"B\": \"Polymyositis\", \"C\": \"Dermatomyositis\", \"D\": \"Muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Repeats the concept of Q199 asking for the most common myopathy (IBM) in older adults.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q14",
    "question_text": "Which of the following muscles is innervated by the ulnar nerve?",
    "options": "{\"A\": \"Adductor pollicis\", \"B\": \"Flexor carpi ulnaris\", \"C\": \"Flexor digitorum profundus (digits 4, 5)\", \"D\": \"Lumbricals (III, IV)\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve anatomy and specific muscle innervation by the ulnar nerve.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q443",
    "question_text": "A lady with a history of treated breast cancer presents with one week of numbness in the 4th and 5th digits, and weakness in her hand and forearm. A chest and neck CT is normal. What should be done next?",
    "options": "{\"A\": \"Plexus MRI\", \"B\": \"NCS/EMG\", \"C\": \"PET Scan\", \"D\": \"Ultrasound of the brachial plexus\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the next diagnostic step (NCS/EMG) to evaluate symptoms suggestive of ulnar neuropathy or lower brachial plexopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q48",
    "question_text": "A young man came to the ER who went to sleep at 10 PM and woke up at midnight with weakness in his whole body, which resolved after a few hours. His history is recurrent with sparing of cranial nerves and respiratory muscles. What is the most useful test to be done?",
    "options": "{\"A\": \"Short exercise test\", \"B\": \"Serum potassium measurement\", \"C\": \"Electromyography (EMG)\", \"D\": \"Nerve conduction study\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes symptoms suggestive of periodic paralysis and asks for the relevant diagnostic test (exercise testing).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q79",
    "question_text": "Which of the following is a function of the femoral nerve?",
    "options": "{\"A\": \"Hip flexion (via Iliopsoas, partly femoral)\", \"B\": \"Knee extension (via Quadriceps)\", \"C\": \"Medial area of thigh decreased sensation (Saphenous nerve, branch of femoral)\", \"D\": \"Ankle dorsiflexion (via Tibialis anterior)\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the motor and sensory functions associated with the femoral nerve.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q562",
    "question_text": "A young man played football for one day, developed generalized weakness mainly in the proximal limbs, and the next day his urine changed color to dark brown and he had muscle pain. What is the most likely cause?",
    "options": "{\"A\": \"CPT II deficiency\", \"B\": \"Urea cycle disorder\", \"C\": \"Acid maltase deficiency\", \"D\": \"McArdle disease\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Similar to Q129, describes exercise-induced rhabdomyolysis, pointing towards a metabolic myopathy like CPT II deficiency.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q244",
    "question_text": "A patient presents with weakness that is induced by cold exposure. Which channel is likely affected?",
    "options": "{\"A\": \"Sodium channel\", \"B\": \"Potassium channel\", \"C\": \"Calcium channel\", \"D\": \"Chloride channel\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific trigger (cold) for muscle weakness/stiffness to the underlying affected ion channel (Sodium channel in Paramyotonia Congenita or potassium channels in some periodic paralyses).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q231",
    "question_text": "In a case of dysautonomia with carpal tunnel syndrome (CTS), what is the most appropriate diagnostic test?",
    "options": "{\"A\": \"Protein electrophoresis\", \"B\": \"Abdominal fat aspiration\", \"C\": \"EMG/NCS\", \"D\": \"Immunofixation\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Suggests systemic amyloidosis as a cause for combined autonomic neuropathy and CTS, pointing towards biopsy (abdominal fat pad) for diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q504",
    "question_text": "In a case of a patient with colchicine toxicity-induced myopathy, who presents with high CK levels and EMG findings of prominent fibrillations, positive sharp waves, and excessively polyphasic motor action potentials in the proximal muscles that are brief and small in amplitude, what is the cause?",
    "options": "{\"A\": \"Colchicine\", \"B\": \"Statins\", \"C\": \"Alcohol\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on recognizing the clinical and EMG features of toxic myopathy caused by a specific drug (colchicine).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q56",
    "question_text": "In congenital Myotonic dystrophy type 1 (DM1), which of the following symptoms is typically absent on EMG?",
    "options": "{\"A\": \"Hypotonia\", \"B\": \"Myotonia\", \"C\": \"Delayed motor skills\", \"D\": \"Failure to thrive\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a specific feature of congenital myotonic dystrophy type 1: electrical myotonia is often absent on EMG early in life, despite clinical hypotonia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q133",
    "question_text": "A young healthy man presents with sudden foot drop. Nerve conduction studies show normal sensory and motor function, except for a drop in amplitude across the fibular head from 5 to 1.9 with reduced velocity in the motor peroneal nerve. What is the pathology and prognosis?",
    "options": "{\"A\": \"Demyelination with rapid recovery (Conduction block)\", \"B\": \"Demyelination with poor recovery\", \"C\": \"Axonal with rapid recovery\", \"D\": \"Axonal with partial recovery\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Interprets NCS findings (conduction block across fibular head) to determine the pathophysiology (demyelination) and predict prognosis for a common peroneal neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q147",
    "question_text": "In the same scenario, a patient with weakness symptoms suggestive of Anti-MuSK myasthenia gravis was on mycophenolic acid and steroids with no benefit. After switching to azathioprine and developing hepatotoxicity, what should be tested before initiating treatment with the above chosen medication? (Referring to Rituximab from Q376)",
    "options": "{\"A\": \"Hepatitis B screening\", \"B\": \"Complete blood count\", \"C\": \"Renal function tests\", \"D\": \"Thyroid function tests\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Relates to the necessary safety screening (Hepatitis B) before initiating Rituximab therapy, often used for refractory MuSK MG.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q445",
    "question_text": "What is the recommended treatment for Inclusion Body Myositis (IBM)?",
    "options": "{\"A\": \"Supportive care\", \"B\": \"High-dose corticosteroids\", \"C\": \"Intravenous immunoglobulin (IVIG)\", \"D\": \"Immunosuppressive therapy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the management approach for Inclusion Body Myositis, which is primarily supportive as it doesn't respond well to immunosuppression.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q78",
    "question_text": "A 16-year-old presented with calf hypertrophy. Which of the following conditions is most likely?",
    "options": "{\"A\": \"FSH (Facioscapulohumeral muscular dystrophy)\", \"B\": \"LGMD2A (Calpainopathy)\", \"C\": \"LGMD1B (Laminopathy)\", \"D\": \"Becker muscular dystrophy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a clinical sign (calf hypertrophy) to potential underlying muscular dystrophies. While common in Duchenne/Becker, it can be seen in some LGMDs. The options provided make this tricky, as none are the most classic cause. Assuming it's testing differential of muscular dystrophies based on signs.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q482",
    "question_text": "A young patient presents with proximal painful weakness, and a biopsy result shows CD+8 lymphocytes. What is the likely diagnosis?",
    "options": "{\"A\": \"Polymyositis\", \"B\": \"Dermatomyositis\", \"C\": \"Inclusion body myositis\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects specific muscle biopsy findings (endomysial inflammation with CD8+ T cells) to the diagnosis of Polymyositis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q382",
    "question_text": "A patient presents with moderate muscle weakness, hyperkeratosis on the hands, and lung crackles. What is the most likely antibody associated with this condition?",
    "options": "{\"A\": \"MDA antibody\", \"B\": \"Anti-synthase antibody\", \"C\": \"Anti-Mi-2 antibody\", \"D\": \"Anti-SRP antibody\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of specific antibodies (like anti-synthetase or anti-MDA5) associated with subtypes of inflammatory myopathies (dermatomyositis/polymyositis) based on clinical features (muscle weakness, skin changes, lung involvement).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q546",
    "question_text": "A 55-year-old patient presented with ptosis, extraocular muscle weakness, dysphagia, and proximal weakness. What is the most likely genetic abnormality?",
    "options": "{\"A\": \"GCG Repeat\", \"B\": \"D4Z4\", \"C\": \"CTG Repeat\", \"D\": \"CAG Repeat\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The clinical description strongly suggests Oculopharyngeal Muscular Dystrophy (OPMD), and the question asks for the associated genetic abnormality (GCG repeat expansion in the PABPN1 gene).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q77",
    "question_text": "A young woman who was recently diagnosed with diabetes mellitus (DM) was not controlled at all after admission to the hospital with diabetic ketoacidosis (DKA) and an HbA1c of 14. After her blood sugar was controlled adequately, she developed peripheral painful neuropathy. What is the recommended treatment?",
    "options": "{\"A\": \"Gabapentin\", \"B\": \"Steroids\", \"C\": \"Carbamazepine\", \"D\": \"Amitriptyline\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the management of a specific type of peripheral neuropathy (treatment-induced neuropathy of diabetes or painful diabetic neuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q6",
    "question_text": "In hypokalemic periodic paralysis, which of the following is true regarding the incidence of paralysis?",
    "options": "{\"A\": \"Predominantly male\", \"B\": \"Equal incidence in males and females\", \"C\": \"Occurs in the 1st-2nd decade\", \"D\": \"Occurs in the 1st decade\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the epidemiology and typical age of onset for hypokalemic periodic paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q65",
    "question_text": "In a scenario of Charcot-Marie-Tooth disease type 2 (CMT2), what would you find?",
    "options": "{\"A\": \"Decrease in amplitude of sensory nerve action potentials\", \"B\": \"Normal motor nerve conduction velocity\", \"C\": \"Increased amplitude of sensory nerve action potentials\", \"D\": \"Axonal degeneration\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the characteristic electrophysiological findings (axonal pattern: decreased amplitudes, relatively preserved velocities) in CMT type 2, a hereditary neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q136",
    "question_text": "A 40-year-old previously healthy male developed gastrointestinal symptoms, then had generalized weakness and decreased reflexes. He has bilateral ptosis and dilated pupils. What is the diagnosis?",
    "options": "{\"A\": \"Botulism\", \"B\": \"Myasthenia Gravis\", \"C\": \"Guillain-Barr\\u00e9 Syndrome\", \"D\": \"Lambert-Eaton Myasthenic Syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a classic presentation of Botulism (acute descending paralysis with prominent bulbar and autonomic features following GI upset), a disorder affecting the neuromuscular junction.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q61",
    "question_text": "A patient presents with peripheral neuropathy and transient central nervous system (CNS) symptoms. Which condition is most likely?",
    "options": "{\"A\": \"Charcot-Marie-Tooth disease type 1 (CMT1)\", \"B\": \"Charcot-Marie-Tooth disease type 2 (CMT2)\", \"C\": \"Charcot-Marie-Tooth disease type X (CMTX)\", \"D\": \"Tangier disease\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on differentiating hereditary neuropathies based on clinical features, specifically the presence of transient CNS symptoms which can be seen in CMTX.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q81",
    "question_text": "In Paramyotonia Congenita, the effect of cold exposure is:",
    "options": "{\"A\": \"Induces attack\", \"B\": \"Relieves attack\", \"C\": \"No effect\", \"D\": \"Prevents attack\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a key clinical feature (cold-induced paradoxical myotonia) of Paramyotonia Congenita, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q49",
    "question_text": "Spinobulbar muscular atrophy (Kennedy's Disease) is primarily caused by which genetic mutation?",
    "options": "{\"A\": \"CAG expansion in the DMPK gene\", \"B\": \"CAG expansion in the androgen-receptor (AR) gene\", \"C\": \"CTG repeat in the DMPK gene\", \"D\": \"CAG repeat in the CTG gene\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the specific genetic cause (CAG repeat expansion in the AR gene) of Spinobulbar Muscular Atrophy (Kennedy's Disease), a motor neuron disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q167",
    "question_text": "A 31-year-old male has hand grip myotonia, facial weakness, significant atrophy of facial muscles, ptosis without ophthalmoplegia, and distal arm weakness. What else is associated?",
    "options": "{\"A\": \"Cancer\", \"B\": \"Diabetes mellitus\", \"C\": \"Myotonic dystrophy\", \"D\": \"Normal androgen levels\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes the classic features of Myotonic Dystrophy type 1 and asks about associated systemic complications (like Diabetes Mellitus).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q421",
    "question_text": "A young male has a history of unilateral upper limb weakness that has progressed over 5 years. Examination reveals involvement of all hand muscles with sparing of the brachioradialis. What are the other associated features?",
    "options": "{\"A\": \"Sensory loss in the affected limb\", \"B\": \"Upper motor neuron signs in the lower limbs\", \"C\": \"Cold paresis and tremor of the affected hand\", \"D\": \"Cranial nerve involvement\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The clinical description (slowly progressive, focal distal upper limb weakness/atrophy in a young male, specific muscle involvement pattern) is highly suggestive of Hirayama disease, a focal lower motor neuron disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q50",
    "question_text": "In Hyperkalemic Periodic Paralysis, the duration of paralysis is typically:",
    "options": "{\"A\": \"Hours to days\", \"B\": \"Minutes to hours\", \"C\": \"Seconds to minutes\", \"D\": \"Days to weeks\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about a key clinical feature (duration of attacks) of hyperkalemic periodic paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q62",
    "question_text": "If single-fiber EMG is normal in clinically affected muscles, what can be concluded?",
    "options": "{\"A\": \"The diagnosis of MG is confirmed.\", \"B\": \"The diagnosis of MG is excluded.\", \"C\": \"Further testing is required.\", \"D\": \"The patient has ocular MG.\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the interpretation of single-fiber EMG (SFEMG) results, a specialized neuromuscular diagnostic test, particularly its sensitivity and implications for diagnosing Myasthenia Gravis (MG).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q104",
    "question_text": "In a scenario about dermatomyositis, which antibody is associated with the condition?",
    "options": "{\"A\": \"Anti-synthetase\", \"B\": \"Anti-MDA5\", \"C\": \"Anti-Mi2\", \"D\": \"Anti-SRP\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of antibodies associated with dermatomyositis (Anti-Mi2 is highly specific, though others can be seen), an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q153",
    "question_text": "A 55-year-old patient presented with progressive numbness and burning sensation in the lower limbs, along with two cutaneous nodules\u2014one in the upper trunk and one on the scalp. There are no autonomic features, normal reflexes, and normal proprioception. What is the diagnosis?",
    "options": "{\"A\": \"Amyloidosis\", \"B\": \"Fabry disease\", \"C\": \"Neurofibromatosis\", \"D\": \"Sarcoidosis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of peripheral neuropathy presenting with specific associated features (cutaneous nodules), considering systemic disorders like amyloidosis or inherited conditions like Fabry disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q53",
    "question_text": "In a case of Spinal Muscular Atrophy (SMA), which of the following is a supportive finding?",
    "options": "{\"A\": \"Neurogenic finding on EMG\", \"B\": \"Abnormal respiratory function test\", \"C\": \"Cardiomyopathy\", \"D\": \"Elevated creatine kinase levels\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about findings that support the diagnosis of Spinal Muscular Atrophy (SMA), a motor neuron disease, including characteristic EMG patterns.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q76",
    "question_text": "In Parsonage-Turner syndrome, which plexus is affected?",
    "options": "{\"A\": \"Upper brachial plexus\", \"B\": \"Both the upper and lower plexus\", \"C\": \"Lower brachial plexus\", \"D\": \"Lumbar plexus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the typical anatomical localization (brachial plexus, often upper trunk) of Parsonage-Turner syndrome (neuralgic amyotrophy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q16",
    "question_text": "A case scenario about central core myopathy mentions a family history of malignant hyperthermia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Central core myopathy\", \"B\": \"Malignant hyperthermia\", \"C\": \"Myotonic dystrophy\", \"D\": \"Becker muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests the known association between Central Core Myopathy (often due to RYR1 mutations) and susceptibility to Malignant Hyperthermia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q148",
    "question_text": "What is the most common myopathy in patients older than 50 years?",
    "options": "{\"A\": \"Inclusion Body Myositis (IBM)\", \"B\": \"Dermatomyositis\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Becker muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the epidemiology of myopathies, specifically identifying Inclusion Body Myositis (IBM) as the most common acquired myopathy in older adults.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q121",
    "question_text": "A 55-year-old patient is complaining of generalized weakness, weight gain, and tingling in her hands. She has slight bradycardia and on examination, she had delayed relaxation with deep tendon reflexes. What test should be ordered?",
    "options": "{\"A\": \"Thyroid test\", \"B\": \"Acetylcholine receptor antibody test\", \"C\": \"Vitamin B12 level\", \"D\": \"Electromyography (EMG)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: The clinical picture (weakness, weight gain, tingling, bradycardia, delayed reflexes) strongly suggests hypothyroidism, which can cause both myopathy and neuropathy. The question asks for the key diagnostic test.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q17",
    "question_text": "In a case scenario of POEMS syndrome, what will you find in the serum?",
    "options": "{\"A\": \"Anti-GM1\", \"B\": \"Anti-MAG\", \"C\": \"VEGF\", \"D\": \"Monoclonal protein\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of a key diagnostic marker (elevated Vascular Endothelial Growth Factor - VEGF) for POEMS syndrome, a multisystem disorder featuring polyneuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q553",
    "question_text": "A patient presents with flaccid weakness. What is a possible cause?",
    "options": "{\"A\": \"West Nile virus\", \"B\": \"Guillain-Barr\\u00e9 syndrome\", \"C\": \"Myasthenia gravis\", \"D\": \"Stroke\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of acute flaccid weakness, listing several key neuromuscular causes (GBS, MG) and an infectious cause mimicking motor neuron disease (WNV).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q424",
    "question_text": "A patient on statin therapy develops necrotizing myositis. What is the most likely cause?",
    "options": "{\"A\": \"Age-related changes\", \"B\": \"Erythromycin interaction\", \"C\": \"Hypothyroidism\", \"D\": \"Vitamin D deficiency\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns a specific type of myopathy (immune-mediated necrotizing myopathy or toxic myopathy exacerbated by drug interaction) associated with statin use.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q484",
    "question_text": "A female patient complains of hand numbness that wakes her from sleep and improves with shaking her hand. What is the likely diagnosis?",
    "options": "{\"A\": \"Carpal tunnel syndrome (CTS)\", \"B\": \"Ulnar nerve entrapment\", \"C\": \"Cervical radiculopathy\", \"D\": \"Peripheral neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes classic symptoms of Carpal Tunnel Syndrome (CTS), a common entrapment neuropathy, and asks for the diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q108",
    "question_text": "A male patient presented to the outpatient clinic for evaluation of limb weakness. He has upper limb weakness that started 6 years ago, initially affecting the right hand and progressively involving all three limbs. On physical examination, he has muscle atrophy, absent triceps reflex, and intact brachioradialis reflex. Sensory examination was normal. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Amyotrophic lateral sclerosis\", \"B\": \"Multifocal motor neuron disease with conduction block\", \"C\": \"Hirayama disease\", \"D\": \"Cervical spondylotic myelopathy\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Presents a differential diagnosis for progressive, focal motor weakness and atrophy, focusing on conditions affecting lower motor neurons or peripheral nerves (ALS, MMN, Hirayama disease).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q99",
    "question_text": "A patient post hip replacement surgery presents with right lower limb weakness. Examination showed hip flexion and extension 5/5, foot dorsal flexion 0/5, plantarflexion 3/5 with sensory loss of the lateral leg. EMG/NCS showed involvement of the anterior tibial, gastrocnemius, and short head of biceps femoris. What is the most likely injured nerve?",
    "options": "{\"A\": \"Tibial nerve\", \"B\": \"Peroneal nerve\", \"C\": \"Sciatic nerve\", \"D\": \"Femoral nerve\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires localization of a peripheral nerve injury (sciatic nerve) based on correlating clinical examination findings (muscle weakness pattern, sensory loss) and EMG results post-surgery.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q109",
    "question_text": "A 50-year-old male patient is complaining of chronic progressive bilateral ptosis associated with difficulty swallowing and difficulty speaking. On physical examination, he has mild weakness over shoulder and pelvic muscles bilaterally. Muscle biopsy shows internuclear tubular filaments. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Oculopharyngeal muscular dystrophy.\", \"B\": \"External progressive ophthalmoplegia.\", \"C\": \"Kearns-Sayre syndrome.\", \"D\": \"Myotonia congenita.\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Combines clinical features (ptosis, dysphagia, dysarthria, proximal weakness) and characteristic muscle biopsy findings to diagnose Oculopharyngeal Muscular Dystrophy (OPMD).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q86",
    "question_text": "A patient with typical features of myasthenia gravis has negative ACHR antibody and Anti-MUSK tests. What lab investigation should be sent next to confirm the diagnosis?",
    "options": "{\"A\": \"P/Q calcium channel antibody\", \"B\": \"Serum calcium\", \"C\": \"Serum sodium\", \"D\": \"LRP4 antibody\"}",
    "correct_answer": "D",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the diagnostic algorithm for Myasthenia Gravis, specifically the next step (testing for LRP4 antibodies) in cases of seronegative MG.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q85",
    "question_text": "A male patient presented with symptoms suggestive of proximal muscle weakness. He has two cousins with the same presentation. EMG showed prolonged motor unit action potentials (MUAPs). Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Inherited myopathy.\", \"B\": \"Spinal muscular atrophy.\", \"C\": \"Myasthenia gravis.\", \"D\": \"Polymyositis.\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Integrates clinical information (proximal weakness, family history) with EMG findings (prolonged MUAPs suggesting myopathy or possibly chronic reinnervation) to point towards an inherited muscle disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q59",
    "question_text": "In a patient with median nerve conduction studies (NCS) at the elbow and wrist, what is the likely finding?",
    "options": "{\"A\": \"Conduction block\", \"B\": \"Temporal dispersion\", \"C\": \"Reduced amplitude\", \"D\": \"Prolonged distal latency\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the interpretation of nerve conduction study (NCS) findings like conduction block or temporal dispersion, which are crucial for diagnosing peripheral nerve disorders, particularly demyelinating neuropathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q94",
    "question_text": "A patient with Limb-Girdle Muscular Dystrophy (LGMD) and a positive family history is likely to have which of the following conditions?",
    "options": "{\"A\": \"Dysferlinopathy\", \"B\": \"Calpainopathy\", \"C\": \"Laminopathy\", \"D\": \"Sarcoglycanopathy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about specific genetic subtypes (e.g., Dysferlinopathy, Calpainopathy) that fall under the umbrella category of Limb-Girdle Muscular Dystrophy (LGMD).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q122",
    "question_text": "In a case of acute inflammatory demyelinating polyneuropathy (AIDP) with prior diarrhea 4 weeks ago, what type is indicated if only motor function is affected with intact sensory function?",
    "options": "{\"A\": \"Acute motor axonal neuropathy (AMAN)\", \"B\": \"Acute motor-sensory axonal neuropathy (AMSAN)\", \"C\": \"Acute inflammatory demyelinating polyneuropathy (AIDP)\", \"D\": \"Miller Fisher syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the sub-classification of Guillain-Barr\u00e9 syndrome (GBS) variants, specifically identifying the Acute Motor Axonal Neuropathy (AMAN) subtype based on clinical presentation (pure motor deficit) and electrophysiology (axonal).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q57",
    "question_text": "Which muscle is tested in L5 EMG testing?",
    "options": "{\"A\": \"Tibialis anterior\", \"B\": \"Gastrocnemius\", \"C\": \"Gluteus medius\", \"D\": \"Extensor hallucis longus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of clinical neurophysiology (EMG) procedures and the specific muscles typically examined to assess the integrity of the L5 nerve root.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q123",
    "question_text": "In a case of Dermatomyositis, which of the following findings is typically observed?",
    "options": "{\"A\": \"Perifascicular atrophy\", \"B\": \"Rimmed vacuoles\", \"C\": \"Muscle fiber necrosis\", \"D\": \"Endomysial inflammation\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the characteristic histopathological finding (perifascicular atrophy) on muscle biopsy in Dermatomyositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q109",
    "question_text": "A case of Facioscapulohumeral muscular dystrophy is presented. What is the likely diagnosis?",
    "options": "{\"A\": \"Facioscapulohumeral Muscular Dystrophy\", \"B\": \"Becker Muscular Dystrophy\", \"C\": \"Duchenne Muscular Dystrophy\", \"D\": \"Myotonic Dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on recognizing Facioscapulohumeral Muscular Dystrophy (FSHD) based on its typical clinical presentation (facial, scapular, and upper arm weakness).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q77",
    "question_text": "Paramyotonia is associated with which type of channel?",
    "options": "{\"A\": \"Sodium Channel (SCN4A)\", \"B\": \"Chloride Channel\", \"C\": \"Potassium Channel\", \"D\": \"Calcium Channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the underlying genetic/channel basis (voltage-gated sodium channel gene SCN4A) for the neuromuscular disorder paramyotonia congenita.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q253",
    "question_text": "What is a potential early complication of Guillain-Barr\u00e9 syndrome?",
    "options": "{\"A\": \"Choking\", \"B\": \"Constipation\", \"C\": \"Cardiac arrhythmias\", \"D\": \"Respiratory failure\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of complications of Guillain-Barr\u00e9 syndrome, a core neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q525",
    "question_text": "A young female came with dilated pupils, dysphagia, and descending weakness; what is the diagnosis?",
    "options": "{\"A\": \"Presynaptic NMJ disorder\", \"B\": \"Myasthenia gravis\", \"C\": \"Guillain-Barr\\u00e9 syndrome\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms classic for botulism, a presynaptic neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q251",
    "question_text": "Which of the following is a treatment option for Guillain-Barr\u00e9 syndrome?",
    "options": "{\"A\": \"Plasma exchange\", \"B\": \"Intravenous immunoglobulin\", \"C\": \"Corticosteroids\", \"D\": \"Supportive care\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about standard treatments for Guillain-Barr\u00e9 syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q77",
    "question_text": "The chromosome associated with the genetic basis of Hyperkalemic Periodic Paralysis is:",
    "options": "{\"A\": \"1q21\", \"B\": \"17q13.1\", \"C\": \"7p15\", \"D\": \"12q24\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Although genetic, it specifically asks about the location for a channelopathy causing periodic paralysis, a neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q20",
    "question_text": "A patient presents with weak facial muscles (cannot blow air) and weakness in the arm flexors and extensors, along with right foot drop and winging of the scapula. What is the most likely diagnosis?",
    "options": "{\"A\": \"Facioscapulohumeral muscular dystrophy (FSHD)\", \"B\": \"Amyotrophic lateral sclerosis (ALS)\", \"C\": \"Myasthenia gravis\", \"D\": \"Muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes classic signs of Facioscapulohumeral muscular dystrophy (FSHD), a specific type of muscular dystrophy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q537",
    "question_text": "A patient came with a history of multifocal neuropathy multiplex. A biopsy showed necrosis and inflammatory cells in the vessels. What is the diagnosis?",
    "options": "{\"A\": \"Vasculitic neuropathy\", \"B\": \"Diabetic neuropathy\", \"C\": \"Charcot-Marie-Tooth disease\", \"D\": \"Amyloid neuropathy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of vasculitic neuropathy based on clinical presentation (mononeuritis multiplex) and biopsy findings.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q345",
    "question_text": "A patient presents with urinary incontinence and symptoms suggesting autonomic dysfunction along with painful neuropathy. Nerve conduction studies indicate axonal neuropathy with carpal tunnel syndrome. What is the most appropriate investigation?",
    "options": "{\"A\": \"Abdominal fat pad biopsy\", \"B\": \"Electrophoresis\", \"C\": \"Genetic testing\", \"D\": \"MRI of the spine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The constellation of autonomic dysfunction, painful axonal neuropathy, and CTS strongly suggests amyloid neuropathy, a specific neuromuscular diagnosis confirmed by fat pad biopsy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q23",
    "question_text": "In a case of inclusion body myositis (IBM), what are the histology findings?",
    "options": "{\"A\": \"Rimmed vacuoles\", \"B\": \"Perifascicular atrophy\", \"C\": \"Endomysial inflammation\", \"D\": \"Necrotizing myopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of pathognomonic histological findings in Inclusion Body Myositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q138",
    "question_text": "A child presented with proximal muscle weakness and was diagnosed with laminopathy (or LMNA mutation) based on genetic testing. What is expected to be seen in examination?",
    "options": "{\"A\": \"Elbow and ankle contractures\", \"B\": \"Distal muscle atrophy\", \"C\": \"Facial muscle weakness\", \"D\": \"Sensory loss in a glove and stocking distribution\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about clinical features (contractures) associated with a specific genetic myopathy (laminopathy/LGMD1B).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q75",
    "question_text": "A nerve conduction study (NCS) shows a drop in amplitude. Which of the following could explain this finding?",
    "options": "{\"A\": \"Conduction block\", \"B\": \"Temporal dispersion\", \"C\": \"Demyelination\", \"D\": \"Axonal loss\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests interpretation of nerve conduction study findings (amplitude drop), relating it to underlying pathophysiology like conduction block or temporal dispersion.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q37",
    "question_text": "In paramyotonia congenita, what clinical feature is observed in cold conditions?",
    "options": "{\"A\": \"Increased muscle strength\", \"B\": \"Stiffness of the tongue, eyelids, face, and limb muscles\", \"C\": \"Flaccid weakness\", \"D\": \"Normal muscle function\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of a specific clinical feature (paradoxical myotonia triggered by cold) in paramyotonia congenita, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q90",
    "question_text": "A patient is admitted with proximal myopathy and high CK levels (around 6000). A biopsy shows necrotizing pathology. Which of the following factors would increase the risk of this condition in the patient?",
    "options": "{\"A\": \"Age older than 50\", \"B\": \"Female gender\", \"C\": \"Taking erythromycin\", \"D\": \"Taking metformin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes necrotizing myopathy and asks about risk factors, possibly implying immune-mediated necrotizing myopathy (IMNM) or statin-related issues, both neuromuscular conditions.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q25",
    "question_text": "Case of a lady post-hysterectomy presented with weakness in hip flexion and knee extension, what is the most likely injury in her procedure?",
    "options": "{\"A\": \"Femoral nerve\", \"B\": \"Obturator nerve\", \"C\": \"Sciatic nerve\", \"D\": \"Lateral femoral cutaneous nerve\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests localization of a peripheral nerve injury (femoral nerve) based on motor weakness pattern following surgery.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q383",
    "question_text": "A 20-year-old presents with respiratory symptoms, an aneurysm, PAS on pathology, negative forearm exercise diagnosis, and no clinical but electrical myotonia. What is the likely diagnosis?",
    "options": "{\"A\": \"Pompe\", \"B\": \"McArdle disease\", \"C\": \"Myotonic dystrophy\", \"D\": \"Mitochondrial myopathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes features pointing towards Pompe disease (acid maltase deficiency), a metabolic myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q461",
    "question_text": "In LGMD1B, what physical findings are typically observed?",
    "options": "{\"A\": \"Elbow and ankle contractures\", \"B\": \"Facial muscle weakness\", \"C\": \"Distal muscle atrophy\", \"D\": \"Scapular winging\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about specific physical findings (contractures) in a subtype of Limb-Girdle Muscular Dystrophy (LGMD1B/Laminopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q501",
    "question_text": "A patient presents with gradual proximal weakness, has a history of being on a statin and 5 mg of steroids for several years. Laboratory tests show CK levels at 1800, and NCS/EMG reveals fibrillation and reduced MUAP. What is the most likely diagnosis?",
    "options": "{\"A\": \"Statin myopathy\", \"B\": \"Steroid-induced myopathy\", \"C\": \"Polymyositis\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks to differentiate between potential causes of myopathy (statin vs. steroid) based on clinical history and EMG findings.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q502",
    "question_text": "An 8-year-old child presents with proximal weakness and a Gower sign. Which of the following is an appropriate investigation?",
    "options": "{\"A\": \"Serum creatine kinase (CK) level\", \"B\": \"Brain MRI\", \"C\": \"Nerve conduction studies\", \"D\": \"Muscle biopsy as the first step\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes classic signs of a muscular dystrophy (likely Duchenne) in a child and asks about the appropriate next diagnostic step (likely CK level or genetic testing).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q234",
    "question_text": "A 57-year-old male is referred to neurology consultation from the gastro team. He has a complaint of dysphagia with a negative GI workup and is found to have wrist flexion and knee extension weakness. CK was 700. What is your diagnosis?",
    "options": "{\"A\": \"Dermatomyositis\", \"B\": \"IBM\", \"C\": \"Polymyositis\", \"D\": \"FSHD\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Inclusion Body Myositis (IBM) based on its characteristic pattern of weakness (finger flexors, quadriceps) and dysphagia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q255",
    "question_text": "Which variant of Guillain-Barr\u00e9 syndrome is characterized by bilateral facial weakness and paraesthesias?",
    "options": "{\"A\": \"Classic sensorimotor\", \"B\": \"Pure motor\", \"C\": \"Miller Fisher syndrome\", \"D\": \"Pure sensory\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of specific variants within the Guillain-Barr\u00e9 syndrome spectrum (facial diplegia with paresthesias variant).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q528",
    "question_text": "The same patient is asking about the antibody associated with his condition. What is the antibody?",
    "options": "{\"A\": \"Anti-GM1\", \"B\": \"Anti-AQP4\", \"C\": \"Anti-MAG\", \"D\": \"Anti-NMDA receptor\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about a specific antibody (Anti-GM1) associated with certain variants of Guillain-Barr\u00e9 syndrome (e.g., AMAN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q299",
    "question_text": "A patient presents with progressive hand muscle weakness and severe atrophy, with plantars upgoing in the lower limbs. What is the most likely diagnosis?",
    "options": "{\"A\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"B\": \"Myelitis\", \"C\": \"Myelopathy\", \"D\": \"Peripheral Neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes classic signs of Amyotrophic Lateral Sclerosis (ALS), combining lower motor neuron (hand weakness/atrophy) and upper motor neuron (upgoing plantars) signs.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q38",
    "question_text": "Which of the following is NOT a characteristic feature of Myotonic dystrophy?",
    "options": "{\"A\": \"Early-onset cataracts\", \"B\": \"Proximal muscle weakness\", \"C\": \"Myotonia of the tongue and fingers\", \"D\": \"Cardiac arrhythmias (AV block)\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the typical features of Myotonic Dystrophy, a common neuromuscular genetic disorder. Proximal weakness is less characteristic than distal weakness early on.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q527",
    "question_text": "What is the most common presentation of post-polio syndrome?",
    "options": "{\"A\": \"Asymptomatic\", \"B\": \"Aseptic meningitis\", \"C\": \"Flu-like symptoms\", \"D\": \"New muscle weakness and fatigue\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the clinical presentation of post-polio syndrome, a condition affecting motor neurons long after initial polio infection. (Note: the provided options seem incorrect; PPS typically presents with new weakness, fatigue, pain).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q381",
    "question_text": "In a scenario typical for GBS, the patient presents with bone pain and recent vaccination. What would you expect to see on day 5 during nerve conduction studies (NCS) or electromyography (EMG)?",
    "options": "{\"A\": \"Normal CMAP, SNAP, and latency\", \"B\": \"Prolonged latency, normal CMAP, absent SNAPs\", \"C\": \"Reduced recruitment and late reflexes\", \"D\": \"Decreased CMAP amplitude with normal SNAPs\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of expected early electrodiagnostic findings (NCS/EMG) in Guillain-Barr\u00e9 syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q246",
    "question_text": "A patient with a history of HCV presents with peripheral neuropathy. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Cryoglobulinemia\", \"B\": \"Anti MAG\", \"C\": \"Gm1 antibody\", \"D\": \"Diabetic neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of causes of neuropathy associated with Hepatitis C, specifically cryoglobulinemic vasculitis causing neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q559",
    "question_text": "A 16-year-old patient has difficulty climbing stairs, a positive Gower sign, and scapular winging. What is the most likely diagnosis?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Dysferlinopathy\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Becker muscular dystrophy\"}",
    "correct_answer": "D",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes symptoms suggestive of a muscular dystrophy (proximal weakness, Gower's, scapular winging) and asks for the most likely diagnosis among options including specific LGMDs and dystrophinopathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q134",
    "question_text": "A 35-year-old patient has had 8-10 years of complaints of distal lower limb weakness and sensory disturbance in a glove and stocking pattern. Nerve conduction studies show no response (NR) in motor and sensory of radial, tibial, peroneal, and sural nerves. Ulnar and median nerves show normal amplitude but slow conduction velocity (CV) in the 20s. What is the diagnosis?",
    "options": "{\"A\": \"Charcot-Marie-Tooth disease (CMT)\", \"B\": \"Hereditary neuropathy with liability to pressure palsies (HNPP)\", \"C\": \"Chronic inflammatory demyelinating polyneuropathy (CIDP)\", \"D\": \"MADSAM (multifocal acquired demyelinating sensory and motor neuropathy)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires interpretation of clinical history and complex NCS findings (severe axonal loss distally, demyelination proximally) to differentiate between hereditary and acquired neuropathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q94",
    "question_text": "A young man who had abdominal pain around 1 week back and had a flu vaccine 2 weeks ago presented with a 5-day history of progressive distal dysesthesias and facial hyperhidrosis. Later on, he was tripping while walking and had weakness with decreased deep tendon reflexes (DTR) on examination. What is the management?",
    "options": "{\"A\": \"IV IG\", \"B\": \"Prednisolone\", \"C\": \"Plasma exchange\", \"D\": \"None of the above\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a likely case of Guillain-Barr\u00e9 syndrome (post-infectious/vaccine, progressive weakness, areflexia, autonomic features) and asks for appropriate management.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q154",
    "question_text": "A patient with a history of back of throat pain and tongue pain experiences episodic syncope. What is your next step?",
    "options": "{\"A\": \"Refer to ENT for laryngoscope\", \"B\": \"MRI brain\", \"C\": \"EEG with photic stimulation\", \"D\": \"Cardiac evaluation with Holter monitoring\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes symptoms suggestive of glossopharyngeal neuralgia triggering syncope, a condition involving a cranial nerve.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q179",
    "question_text": "In a scenario with amyloidosis, what is the next step in management?",
    "options": "{\"A\": \"Fat aspiration\", \"B\": \"Nerve conduction studies\", \"C\": \"Serum protein electrophoresis\", \"D\": \"Bone marrow biopsy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnostic procedure (fat pad biopsy/aspiration) for suspected amyloidosis presenting with neurological symptoms (likely neuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q120",
    "question_text": "A patient was started on Atorvastatin, developed proximal muscle pain and weakness, and was found to have a CK level of 7500 and necrotizing myopathy on biopsy. What should be done?",
    "options": "{\"A\": \"Discontinue Atorvastatin\", \"B\": \"Switch Atorvastatin to Simvastatin\", \"C\": \"Stop Atorvastatin and start steroid\", \"D\": \"Plasmapheresis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the management of statin-induced necrotizing myopathy, a specific type of toxic/immune myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q135",
    "question_text": "A patient with right hand grip weakness and numbness had a right foot drop 4 weeks ago and developed a left foot drop that improved 1 week ago. What is the next step in management?",
    "options": "{\"A\": \"Imuran\", \"B\": \"Pulse steroid\", \"C\": \"IVIG\", \"D\": \"Nerve conduction studies\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a pattern suggestive of mononeuritis multiplex (multiple individual nerve involvements) and asks for management, often implying an underlying inflammatory/vasculitic process requiring immunotherapy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q143",
    "question_text": "A patient with weakness symptoms suggestive of Anti-MuSK myasthenia gravis was on mycophenolic acid and steroids with no benefit. After switching to azathioprine, the patient developed hepatotoxicity. What should be given next?",
    "options": "{\"A\": \"Rituximab infusion\", \"B\": \"Monthly IVIG\", \"C\": \"3,4 Dalfampridine\", \"D\": \"Plasma exchange\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on treatment sequencing for a specific subtype of myasthenia gravis (MuSK-positive), a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q232",
    "question_text": "A patient experiences leg cramps at the beginning of exercise that improve with rest. What test is most appropriate for diagnosis?",
    "options": "{\"A\": \"MRI\", \"B\": \"Ischemic forearm test\", \"C\": \"Nerve conduction study (NCS)\", \"D\": \"Serum creatine kinase (CK)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes symptoms suggestive of a metabolic myopathy affecting glycogenolysis (like McArdle disease) and asks for the relevant diagnostic test (ischemic forearm exercise test).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q201",
    "question_text": "What is the most common deficit that occurs post elbow joint trauma?",
    "options": "{\"A\": \"Wrist drop\", \"B\": \"Claw hand\", \"C\": \"Cheralgia Paraesthetica\", \"D\": \"Volkmann\\u2019s ischemic contracture\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve injury localization (likely ulnar nerve causing claw hand) related to trauma at a specific joint.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q71",
    "question_text": "In the same previous scenario, with a lesion distal to a nerve root, what is most useful in localization?",
    "options": "{\"A\": \"Decreased sensory nerve amplitude in the superficial peroneal nerve supplied area\", \"B\": \"Impaired NCS parameter in common peroneal supplied muscle\", \"C\": \"Impaired parameter for tibial innervated muscle\", \"D\": \"Normal sensory nerve action potentials in the sural nerve\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests the use of sensory nerve action potentials (SNAPs) in localizing a peripheral nerve lesion distal to the dorsal root ganglion.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q300",
    "question_text": "A patient has myotonia symptoms since age 10 for 5 years. The father had myotonia, and there is no mention of weakness. What is the diagnosis?",
    "options": "{\"A\": \"Thomson\", \"B\": \"Myotonic dystrophy\", \"C\": \"Paramyotonia congenita\", \"D\": \"Hyperkalemic periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Differentiates between myotonia congenita (Thomsen disease - myotonia without weakness) and myotonic dystrophy based on clinical features and family history.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q81",
    "question_text": "In a dysferlinopathy scenario, which condition is indicated by gastrocnemius muscle atrophy?",
    "options": "{\"A\": \"Dysferlinopathy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Becker muscular dystrophy\", \"D\": \"Facioscapulohumeral muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a specific physical finding (gastrocnemius atrophy, often hypertrophy initially) to a specific muscular dystrophy (Dysferlinopathy - LGMD2B/Miyoshi Myopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q250",
    "question_text": "Which of the following is NOT included in the Guillain-Barr\u00e9 syndrome (GBS) spectrum?",
    "options": "{\"A\": \"Bilateral facial palsy with paraesthesias\", \"B\": \"Pure sensory variant\", \"C\": \"Miller Fisher syndrome\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the conditions considered part of the GBS spectrum versus unrelated neuromuscular disorders (Myasthenia Gravis).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q469",
    "question_text": "A patient presents with episodic weakness that worsens while eating tomatoes and bananas. What ion channel is likely involved in this condition?",
    "options": "{\"A\": \"Na channel\", \"B\": \"Ca channel\", \"C\": \"Cl channel\", \"D\": \"K channel\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes symptoms of hyperkalemic periodic paralysis (triggered by potassium-rich foods) and asks for the underlying ion channel defect (Sodium channel - SCN4A).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q118",
    "question_text": "A patient diagnosed with lung cancer and treated for it presents with left hand weakness and numbness. CT of the neck and chest is unremarkable. Nerve conduction studies (NCS) show reduced sensory nerve action potential (SNAP) and compound muscle action potential (CMAP) in the distal ulnar, radial, and median distribution. What is the next best step in management?",
    "options": "{\"A\": \"Pulse steroid\", \"B\": \"Cervical MRI\", \"C\": \"IVIG\", \"D\": \"Electromyography (EMG)\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on diagnosing and managing a likely plexopathy or distal neuropathy (indicated by NCS) in the context of cancer history, requiring differentiation between paraneoplastic, radiation-induced, or other causes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q465",
    "question_text": "A patient with hypertension and bulbar weakness presents with generalized weakness. What is the likely antibody involved?",
    "options": "{\"A\": \"Anti Hu\", \"B\": \"Anti Yo\", \"C\": \"P/Q calcium channel\", \"D\": \"Anti-MuSK\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links clinical features (bulbar and generalized weakness, often with autonomic features like hypertension in LEMS) to the associated antibody (P/Q-type calcium channel antibodies) for Lambert-Eaton Myasthenic Syndrome.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q158",
    "question_text": "A patient who recently underwent right femoral replacement surgery has weakness in hip adductors and slight hip flexor weakness. Where is the lesion?",
    "options": "{\"A\": \"Sciatic nerve\", \"B\": \"Femoral nerve\", \"C\": \"Obturator nerve\", \"D\": \"Common peroneal nerve\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests localization of peripheral nerve injury (obturator nerve for adductors) based on post-surgical weakness pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q59",
    "question_text": "In Hyperkalemic Periodic Paralysis, the degree of paralysis is usually described as:",
    "options": "{\"A\": \"Mild\", \"B\": \"Severe\", \"C\": \"Occasionally severe\", \"D\": \"Variable severity\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the clinical characteristics (severity of attacks) of Hyperkalemic Periodic Paralysis, a neuromuscular channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q159",
    "question_text": "In Hereditary Neuropathy with Liability to Pressure Palsies (HNPP), which nerve is most commonly affected?",
    "options": "{\"A\": \"Median nerve\", \"B\": \"Ulnar nerve\", \"C\": \"Fibular nerve\", \"D\": \"Radial nerve\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the most commonly affected nerve (fibular/peroneal nerve at the fibular head) in HNPP, a hereditary peripheral neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q258",
    "question_text": "A case of hypokalemic periodic paralysis is presented. What is the most helpful diagnostic test?",
    "options": "{\"A\": \"Long exercise test\", \"B\": \"Short exercise test\", \"C\": \"Serum potassium measurement during attack\", \"D\": \"Genetic testing for CACNA1S mutations\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the specific electrodiagnostic test (long exercise test) used to aid in the diagnosis of hypokalemic periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q78",
    "question_text": "What is the most common subtype of acetylcholine receptor (AchR) antibody?",
    "options": "{\"A\": \"Binding\", \"B\": \"Modulating\", \"C\": \"Blocking\", \"D\": \"Neutralizing\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge about the specific subtypes of AChR antibodies used in the diagnosis of Myasthenia Gravis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q558",
    "question_text": "A Filipino man who did intense exercise then developed generalized weakness with an intact level of consciousness. What is the most useful test to send for?",
    "options": "{\"A\": \"Serum potassium level\", \"B\": \"Serum creatinine level\", \"C\": \"Serum glucose level\", \"D\": \"Serum calcium level\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a scenario highly suggestive of hypokalemic periodic paralysis (triggered by exercise, common in Asian males) and asks for the key diagnostic test (serum potassium).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q163",
    "question_text": "A 40-year-old male with proximal upper and lower limb weakness associated with tremors and tongue atrophy and fasciculation. Labs reported elevated creatine kinase levels. What else is associated?",
    "options": "{\"A\": \"Typical scenario of Kennedy disease\", \"B\": \"Serum androgens\", \"C\": \"Diabetes mellitus\", \"D\": \"Normal androgen levels\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes the classic phenotype of Kennedy's disease (Spinal and Bulbar Muscular Atrophy - SBMA), a neuromuscular disorder, and asks about associated features (related to androgen receptor).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q427",
    "question_text": "A scenario is suggestive of amyloidosis with autonomic symptoms, lower limb pain, and carpal tunnel syndrome. Which test will confirm the diagnosis?",
    "options": "{\"A\": \"Fat pad biopsy\", \"B\": \"Immune fixation\", \"C\": \"Protein electrophoresis\", \"D\": \"Nerve biopsy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Similar to Q345, identifies clinical features of amyloid neuropathy and asks for the confirmatory diagnostic test (fat pad biopsy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q516",
    "question_text": "A patient presents with proximal weakness and there is no history of statin use. A pathology slide is provided for analysis. Which of the following conditions could be indicated by the findings?",
    "options": "{\"A\": \"Antimicrotubule-associated myopathy\", \"B\": \"Myasthenia gravis\", \"C\": \"Lambert-Eaton myasthenic syndrome\", \"D\": \"Duchenne muscular dystrophy\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires interpretation of muscle pathology (not shown, but implied) to diagnose a cause of proximal weakness, likely an inflammatory or other myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q545",
    "question_text": "In a patient with AIDP, what cerebrospinal fluid (CSF) finding is expected?",
    "options": "{\"A\": \"Elevated protein with normal cell count\", \"B\": \"Normal protein levels\", \"C\": \"Increased white blood cell count\", \"D\": \"Presence of red blood cells\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic CSF finding (albuminocytologic dissociation) in Acute Inflammatory Demyelinating Polyneuropathy (AIDP), a variant of GBS.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q198",
    "question_text": "An 18-year-old patient presented with progressive limb weakness. On examination, he has normal facial muscle strength, bilateral weakness on shoulder abduction with scapular winging, and hip extension weakness. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Caveolin-3 related.\", \"B\": \"Calpain-3 related.\", \"C\": \"Fascioscapulohumeral muscular dystrophy.\", \"D\": \"Scapuloperoneal muscular dystrophy.\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes a pattern of weakness (sparing face, involving shoulder girdle and hip extensors) and asks to identify the most likely underlying muscular dystrophy, likely pointing towards Calpainopathy (LGMD2A) given the options and pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q162",
    "question_text": "A patient presents with upper limb numbness and pinprick sensation around the shoulder. The preserved position sense and weakness suggest which diagnosis?",
    "options": "{\"A\": \"Syringomyelia\", \"B\": \"Myoshi disease\", \"C\": \"CIDP\", \"D\": \"DADS\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Although syringomyelia involves the spinal cord, the differential includes CIDP/DADS (Distal acquired demyelinating symmetric neuropathy), which are neuromuscular conditions. The pattern of sensory loss (spinothalamic) with preserved posterior column function is key to diagnosing syringomyelia, but the question requires differentiation from neuromuscular mimics.* (Reclassified to Neuroanatomy as Syringomyelia is the likely intended answer based on cape-like sensory loss)",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q69",
    "question_text": "In a vague scenario going with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in an elderly female with neuropathy and paraproteinemia, what is the recommended treatment?",
    "options": "{\"A\": \"Monthly IVIg\", \"B\": \"Periodic plasma exchange\", \"C\": \"Prednisolone\", \"D\": \"Azathioprine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about treatment options for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a core neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q54",
    "question_text": "A young patient with distal myopathy (posterior calf) has a high CK level of 7000. Which of the following conditions could be the diagnosis?",
    "options": "{\"A\": \"Nemaline myopathy\", \"B\": \"Miyoshi myopathy\", \"C\": \"Nonaka myopathy\", \"D\": \"Distal muscular dystrophy, tibial form\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of specific distal myopathies (Miyoshi) based on clinical presentation (posterior calf involvement) and CK levels.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient presents with weakness in hand flexors and quadriceps femoris. What is the diagnosis?",
    "options": "{\"A\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"B\": \"Inclusion Body Myositis (IBM)\", \"C\": \"Myasthenia Gravis (MG)\", \"D\": \"Muscular Dystrophy\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests recognition of the characteristic pattern of weakness (finger flexors, quadriceps) seen in Inclusion Body Myositis (IBM).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q57",
    "question_text": "What is the typical age demographic affected by Multifocal Motor Neuropathy (MMN)?",
    "options": "{\"A\": \"Children under 12\", \"B\": \"Young adults, with 2/3 being 45 years or less\", \"C\": \"Elderly individuals over 65\", \"D\": \"Middle-aged adults, ages 45-65\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the epidemiology (specifically age demographics) of Multifocal Motor Neuropathy (MMN), a specific neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q58",
    "question_text": "A 45-year-old woman with breast cancer is treated with radiation therapy to the left axilla for lymph node metastases. A year later, she notes the gradual onset of numbness in the left hand extending proximally in the arm, followed by loss of muscle bulk in the arm. Examination shows weakness and sensory loss primarily in a C6-C7 distribution. Which of the following findings is more likely to suggest a radiation-induced problem than recurrent tumor in this patient?",
    "options": "{\"A\": \"Concurrent myelopathy\", \"B\": \"EMG myokymia\", \"C\": \"Ipsilateral Horner syndrome\", \"D\": \"Normal plexus MRI\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on differentiating radiation-induced plexopathy from tumor recurrence using clinical and electrodiagnostic (EMG myokymia) findings, a core neuromuscular diagnostic challenge.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q57",
    "question_text": "Which diagnostic study is used to identify focal motor conduction block in MMN?",
    "options": "{\"A\": \"MRI\", \"B\": \"Nerve conduction studies (NCS)\", \"C\": \"Sural nerve biopsy\", \"D\": \"Blood tests\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the key diagnostic electrophysiological finding (conduction block on NCS) specific to Multifocal Motor Neuropathy (MMN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q200",
    "question_text": "A patient presented to the outpatient clinic with complaints of wrist drop. Examination showed weakness in finger extension, with normal wrist and elbow flexion and extension, and normal sensation. Where is the site of the lesion?",
    "options": "{\"A\": \"Radial nerve at axillary area\", \"B\": \"Radial nerve at spiral groove\", \"C\": \"Posterior interosseous nerve\", \"D\": \"Brachial plexus\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires localization of a peripheral nerve lesion (Posterior Interosseous Nerve, a branch of the radial nerve) based on a specific pattern of motor weakness.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q202",
    "question_text": "In a scenario involving a female patient with ocular myasthenia gravis, what is the best sensitive test to confirm the diagnosis?",
    "options": "{\"A\": \"Single fiber EMG\", \"B\": \"AChR antibody\", \"C\": \"Ice pack test\", \"D\": \"Repetitive nerve stimulation\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the most sensitive diagnostic test (Single Fiber EMG) for ocular myasthenia gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q78",
    "question_text": "A patient with hypokalemic periodic paralysis has a potassium level of 2.6. After administering potassium, what is the next step in treatment?",
    "options": "{\"A\": \"Daily potassium supplement\", \"B\": \"Acetazolamide\", \"C\": \"Dextrose infusion\", \"D\": \"Sodium bicarbonate\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the prophylactic treatment (Acetazolamide) for hypokalemic periodic paralysis, a channelopathy affecting muscle.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q385",
    "question_text": "A case of a patient with cramps and stiffness that relieve with movements is noted, with a similar history in the father. What is the most likely diagnosis?",
    "options": "{\"A\": \"Thomson syndrome\", \"B\": \"Paramyotonia\", \"C\": \"Myotonic dystrophy\", \"D\": \"Hyperkalemic periodic paralysis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests diagnosis of a specific type of myotonia (Thomsen disease, a chloride channelopathy) based on clinical features (warm-up phenomenon) and inheritance pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q26",
    "question_text": "In a case scenario of a patient with findings suggestive of dermatomyositis (hints: dermal lesions, myopathy), what is the expected biopsy finding?",
    "options": "{\"A\": \"Rimmed vacuole\", \"B\": \"Perifascicular atrophy\", \"C\": \"Endomysial inflammation\", \"D\": \"Necrotizing myopathy\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic muscle biopsy finding (perifascicular atrophy) in dermatomyositis, an inflammatory myopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q419",
    "question_text": "In the context of neuromyopathies, which medication is commonly associated with treatment?",
    "options": "{\"A\": \"Chloroquine\", \"B\": \"Prednisone\", \"C\": \"Azathioprine\", \"D\": \"Methotrexate\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Although vague (\"treatment\"), chloroquine is known to cause a toxic myopathy and neuropathy. Assuming the question implies association (either treatment or cause), it relates to drug effects on muscle/nerve. Given the limited info, Neuromuscular is the likely intended category, possibly testing toxic myopathy/neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q124",
    "question_text": "A young patient had recurrent weakness induced by exercise that improves after a period of rest. How can the diagnosis (Case of McArdle disease) be reached?",
    "options": "{\"A\": \"Fibroblast culture with enzyme microarray\", \"B\": \"Acid maltase profile\", \"C\": \"Acyl carnitine profile\", \"D\": \"Pyruvate kinase assay\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the diagnostic approach for McArdle disease (myophosphorylase deficiency), a metabolic myopathy causing exercise intolerance. The specific tests mentioned relate to diagnosing muscle enzyme deficiencies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q422",
    "question_text": "A Filipino male patient presents with a history of generalized weakness upon waking. What laboratory test should be ordered?",
    "options": "{\"A\": \"Potassium level\", \"B\": \"Thyroid function tests\", \"C\": \"Complete blood count\", \"D\": \"Serum electrolytes\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The presentation (episodic weakness, particularly upon waking, in a specific demographic) is highly suggestive of hypokalemic periodic paralysis, often secondary to thyrotoxicosis in this population. Testing potassium is key, and TFTs are crucial for the underlying cause. This relates to channelopathies affecting muscle.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q538",
    "question_text": "What is the treatment for Inclusion Body Myositis (IBM)?",
    "options": "{\"A\": \"Steroid\", \"B\": \"IVIG\", \"C\": \"Supportive treatment\", \"D\": \"Immunosuppressants\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the management approach for Inclusion Body Myositis (IBM), specifically that it is generally refractory to immunotherapy and relies on supportive care.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q555",
    "question_text": "A patient with proximal upper and lower limb weakness and dysmorphic features underwent a muscle biopsy that showed central core. What is the likely diagnosis?",
    "options": "{\"A\": \"RYR1-related myopathy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Nemaline myopathy\", \"D\": \"Mitochondrial myopathy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects a specific muscle biopsy finding (central cores) with the associated genetic myopathy (RYR1-related myopathy/Central Core Disease).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q117",
    "question_text": "A 16-year-old patient has difficulty climbing stairs, a positive Gower sign, and on examination has bilateral scapular winging. His parents are first-degree cousins, and his sister is affected as well. What is the most likely diagnosis?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Dysferlinopathy\", \"C\": \"Duchenne muscular dystrophy\", \"D\": \"Facioscapulohumeral muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the diagnosis of limb-girdle muscular dystrophy (specifically Calpainopathy/LGMD2A given AR inheritance and phenotype) based on clinical features, age, and inheritance pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q183",
    "question_text": "A 35-year-old male has progressive asymmetric weakness starting in the right leg that ascends to both arms, with no sensory, ocular, or autonomic features. On examination, there is brisk deep tendon reflexes with atrophy and fasciculation. What is the diagnosis?",
    "options": "{\"A\": \"Amyotrophic Lateral Sclerosis (ALS)\", \"B\": \"Multiple Sclerosis\", \"C\": \"Guillain-Barr\\u00e9 Syndrome\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the recognition of the classic clinical presentation of Amyotrophic Lateral Sclerosis (ALS), involving both upper and lower motor neuron signs.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q543",
    "question_text": "What is a hallmark finding in the cerebrospinal fluid (CSF) of patients with CIDP?",
    "options": "{\"A\": \"Elevated protein with normal cell count\", \"B\": \"Increased white blood cell count\", \"C\": \"Decreased glucose levels\", \"D\": \"Presence of oligoclonal bands\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic CSF finding (albuminocytologic dissociation) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q111",
    "question_text": "A patient with proximal upper and lower limb weakness and dysmorphic features underwent a muscle biopsy that showed central core. What is the likely diagnosis?",
    "options": "{\"A\": \"RYR1-related myopathy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Nemaline myopathy\", \"D\": \"Mitochondrial myopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects a specific muscle biopsy finding (central cores) with the associated genetic myopathy (RYR1-related myopathy/Central Core Disease). Duplicate of",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q555",
    "question_text": "Which of the following is the most common cause of ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q462",
    "question_text": "A patient presents with a long face and central core on pathology. What condition might this suggest?",
    "options": "{\"A\": \"Central Core Disease\", \"B\": \"Duchenne Muscular Dystrophy\", \"C\": \"Myotonic Dystrophy\", \"D\": \"Nemaline Myopathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links a clinical feature sometimes seen (long face, although non-specific) with a definitive pathology finding (central core) to diagnose Central Core Disease (a congenital myopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q146",
    "question_text": "A 40-year-old man had renal tubular acidosis (RTA) and a right acetabular fracture, and developed right ankle dorsiflexion weakness with decreased sensation over the dorsum of the right foot. What structure is most likely affected?",
    "options": "{\"A\": \"Lateral portion of sciatic nerve\", \"B\": \"Medial portion of sciatic nerve\", \"C\": \"Tibial nerve\", \"D\": \"Common peroneal nerve\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires localization of a peripheral nerve injury (lateral sciatic/peroneal division) based on motor and sensory deficits following trauma.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q429",
    "question_text": "A patient with hypokalemic periodic paralysis has a potassium level of 2.3 mEq/L. What is the first-line treatment?",
    "options": "{\"A\": \"Acetazolamide\", \"B\": \"Spironolactone\", \"C\": \"Daily potassium supplementation\", \"D\": \"Potassium chloride infusion\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the first-line prophylactic treatment (Acetazolamide) for hypokalemic periodic paralysis, a muscle channelopathy. Note Q78 asks for treatment *after* acute K+ correction.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q532",
    "question_text": "In a patient with AIDP, what is the expected nerve conduction study (NCS) finding at day 5?",
    "options": "{\"A\": \"Sural sparing with affected median and ulnar nerves\", \"B\": \"Normal conduction velocities\", \"C\": \"Prolonged F waves with preserved H reflexes\", \"D\": \"Increased sensory action potentials\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of early electrodiagnostic findings (specifically mentioning sural sparing) in Acute Inflammatory Demyelinating Polyneuropathy (AIDP/GBS).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q464",
    "question_text": "A patient presents with upper limb and lower limb weakness and numbness with bilateral lower limb edema. What is the likely diagnosis?",
    "options": "{\"A\": \"POEMS syndrome\", \"B\": \"Guillain-Barr\\u00e9 syndrome\", \"C\": \"Multiple sclerosis\", \"D\": \"Amyotrophic lateral sclerosis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests recognition of POEMS syndrome based on the constellation of polyneuropathy, organomegaly (implied by edema perhaps, although edema is a specific criterion), endocrinopathy, M-protein, and skin changes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q481",
    "question_text": "A patient with high CK levels and myositis is currently on statin therapy. What is the recommended management?",
    "options": "{\"A\": \"Continue statin\", \"B\": \"Stop statin\", \"C\": \"Increase statin dose\", \"D\": \"Switch to a different statin\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses the management of potential statin-induced myopathy/myositis, a common clinical scenario involving medication effects on muscle.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q552",
    "question_text": "A 15-year-old male has myotonia and weakness that improves after exercise; his father has the same condition. What is the diagnosis?",
    "options": "{\"A\": \"Thomsen disease\", \"B\": \"Becker disease\", \"C\": \"Myotonic dystrophy\", \"D\": \"Paramyotonia congenita\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests diagnosis of a specific myotonia congenita (Thomsen disease) based on clinical features (warm-up phenomenon) and inheritance pattern (AD).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q387",
    "question_text": "SMA",
    "options": "{\"A\": \"A sensory neuropathy\", \"B\": \"A motor neuron disease\", \"C\": \"A demyelinating polyneuropathy\", \"D\": \"A neuromuscular junction disorder\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Likely refers to Spinal Muscular Atrophy. Without further context or a question, classifying based on the disease itself, which is a motor neuron disease, placing it under Neuromuscular.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q560",
    "question_text": "A young man presents with myotonia that improves after exercise. His father had the same diagnosis. What is the most likely diagnosis?",
    "options": "{\"A\": \"Thomsen's disease\", \"B\": \"Myotonic dystrophy\", \"C\": \"Becker muscular dystrophy\", \"D\": \"Congenital myotonia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests diagnosis of Thomsen's disease (a form of myotonia congenita) based on the characteristic warm-up phenomenon and likely autosomal dominant inheritance.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q36",
    "question_text": "A patient with myotonia presents. What condition is associated with it?",
    "options": "{\"A\": \"Diabetes (high risk for type II DM)\", \"B\": \"Hypertension\", \"C\": \"Malignancy\", \"D\": \"Osteolytic bone lesions\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of systemic associations with myotonic dystrophy (specifically type 1), the most common adult muscular dystrophy featuring myotonia, which includes an increased risk of diabetes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q137",
    "question_text": "In a patient with Amyotrophic Lateral Sclerosis (ALS), which of the following findings is typically observed in nerve conduction studies (NCS) or electromyography (EMG)?",
    "options": "{\"A\": \"Fasciculations\", \"B\": \"Normal SNAPs\", \"C\": \"Increased CMAP amplitude\", \"D\": \"Decreased latency\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses knowledge of typical electrodiagnostic findings in ALS, specifically preserved sensory nerve action potentials (Normal SNAPs) and the presence of lower motor neuron findings like fasciculations (though Normal SNAPs is a more specific NCS finding listed).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q298",
    "question_text": "A patient presents with back pain and L5 radiculopathy. Which muscle is involved?",
    "options": "{\"A\": \"Gluteus medius\", \"B\": \"Tibialis anterior\", \"C\": \"Extensor hallucis longus\", \"D\": \"Peroneus longus\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the myotomal innervation of specific muscles, specifically identifying a muscle innervated by the L5 root (Gluteus medius).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q224",
    "question_text": "What is the first-line treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?",
    "options": "{\"A\": \"Prednisolone\", \"B\": \"IVIG\", \"C\": \"Plasmapheresis\", \"D\": \"Supportive care\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the standard first-line immunomodulatory treatments (Steroids, IVIG, PLEX are all considered first-line) for CIDP.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q303",
    "question_text": "A 20-year-old male has a history of limb weakness. Examination reveals significant weakness of the posterior thigh and scapular muscles with winging of the scapula, sparing the face. Muscle biopsy shows eosinophilia. What is the diagnosis?",
    "options": "{\"A\": \"Calpain 2A\", \"B\": \"Lamin 1B\", \"C\": \"Calvin 1C\", \"D\": \"Dysferlin 2B\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a pattern of weakness suggestive of limb-girdle muscular dystrophy (LGMD), likely Dysferlinopathy (LGMD2B) given posterior thigh involvement and possibly Calpainopathy (LGMD2A) given scapular winging. The mention of \"Calpain 2A\" suggests testing knowledge of specific LGMD subtypes. Eosinophilia on biopsy is unusual for typical LGMDs and might be a distractor or indicate a different myopathy, but the options point towards LGMD.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q206",
    "question_text": "In a patient diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), what is the characteristic clinical presentation?",
    "options": "{\"A\": \"Symmetrical sensorimotor polyneuropathy with proximal and distal motor involvement\", \"B\": \"Asymmetrical weakness with sensory loss\", \"C\": \"Rapidly progressive weakness over days\", \"D\": \"Isolated sensory symptoms\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the typical clinical phenotype of CIDP.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q61",
    "question_text": "A 15-year-old male has myotonia and weakness that improves after exercise; his father has the same condition. What is the diagnosis?",
    "options": "{\"A\": \"Thomsen disease\", \"B\": \"Becker disease\", \"C\": \"Myotonic dystrophy\", \"D\": \"Paramyotonia congenita\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests diagnosis of a specific myotonia congenita (Thomsen disease) based on clinical features (warm-up phenomenon) and inheritance pattern (AD). Duplicate of",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q552",
    "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of facial expression?",
    "options": "{\"A\": \"Trigeminal nerve (Cranial Nerve V)\", \"B\": \"Facial nerve (Cranial Nerve VII)\", \"C\": \"Glossopharyngeal nerve (Cranial Nerve IX)\", \"D\": \"Vagus nerve (Cranial Nerve X)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q523",
    "question_text": "A 55-year-old patient came with lower limb paresthesia and heaviness that is getting worse, reaching to the upper limb, and intermittent abdominal pain, hyperhidrosis; he received a vaccine 2 weeks ago. What is the diagnosis?",
    "options": "{\"A\": \"AIDP\", \"B\": \"AIP\", \"C\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\", \"D\": \"Multiple Sclerosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The constellation of ascending sensorimotor symptoms, autonomic features (pain, hyperhidrosis), and recent potential trigger (vaccination) strongly suggests AIDP (GBS), but the autonomic features also raise suspicion for AIP (Acute Intermittent Porphyria). This tests differentiation between these acute neuropathies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q46",
    "question_text": "A case scenario of findings suggestive of multifocal motor neuropathy (MMN) is presented. What is the diagnosis?",
    "options": "{\"A\": \"MMN\", \"B\": \"CIDP\", \"C\": \"HNPP\", \"D\": \"HMSN\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to recognize the clinical syndrome of MMN based on presented findings (presumably asymmetric weakness without sensory loss, possibly conduction block mentioned).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q242",
    "question_text": "What is the treatment of choice for acute attacks of hypokalemic periodic paralysis?",
    "options": "{\"A\": \"Spironolactone\", \"B\": \"Acetazolamide\", \"C\": \"Potassium\", \"D\": \"Calcium gluconate\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the acute management (potassium administration) of an attack of hypokalemic periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q80",
    "question_text": "In a patient with a stab wound resulting in ulnar neuropathy, what would you expect to find in nerve conduction studies (NCS) after 5 days?",
    "options": "{\"A\": \"Decreased recruitment\", \"B\": \"Fibrillations\", \"C\": \"Insertional activity\", \"D\": \"Complex repetitive discharges\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the timeline of electrodiagnostic findings (specifically denervation potentials like fibrillations) following acute axonal nerve injury.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q219",
    "question_text": "A patient with hypokalemic periodic paralysis has a potassium level of 2.6. After you give potassium to the patient, what is the treatment?",
    "options": "{\"A\": \"Daily potassium supplement\", \"B\": \"Acetazolamide\", \"C\": \"Spironolactone\", \"D\": \"Beta-blockers\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the prophylactic treatment (Acetazolamide) for hypokalemic periodic paralysis after acute correction. Duplicate of",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q78",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Arterial dissection\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q343",
    "question_text": "In a scenario about botulism with an increment on high-frequency repetitive nerve stimulation (RNS), what is the pathology?",
    "options": "{\"A\": \"Prevent acetylcholine release from presynaptic vesicles\", \"B\": \"Block postsynaptic acetylcholine receptors\", \"C\": \"Cause demyelination of peripheral nerves\", \"D\": \"Induce muscle fiber necrosis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the pathophysiology of botulism (impaired presynaptic ACh release) and its characteristic RNS finding (increment at high rates).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q63",
    "question_text": "A decrement greater than 10% in CMAP during a Two-hertz to 5-Hz RNS study is indicative of what condition?",
    "options": "{\"A\": \"Normal neuromuscular transmission\", \"B\": \"Neuromuscular transmission defect\", \"C\": \"Ocular Myasthenia Gravis\", \"D\": \"Congenital myasthenic syndrome\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests interpretation of repetitive nerve stimulation (RNS) studies, specifically identifying a significant decrement as indicative of a neuromuscular junction transmission defect (e.g., Myasthenia Gravis).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q493",
    "question_text": "A 57-year-old male presented with progressive proximal weakness, progressive external ophthalmoplegia, cardiomyopathy, and parkinsonism. No gastrointestinal symptoms were noted. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Myasthenia gravis\", \"B\": \"Kearns-Sayre syndrome\", \"C\": \"POLG-related mitochondrial disorder\", \"D\": \"Parkinson\\u2019s disease\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes a complex multisystem disorder. The combination of PEO, cardiomyopathy, and parkinsonism points towards mitochondrial disease, possibly POLG-related disorders or Kearns-Sayre (though onset age is late for typical KSS). This falls under neuromuscular due to the myopathy/PEO component.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q27",
    "question_text": "A Filipino male had sudden generalized weakness after vigorous exercise. What laboratory test should be ordered?",
    "options": "{\"A\": \"K levels\", \"B\": \"Thyroid function tests\", \"C\": \"Complete blood count\", \"D\": \"Serum electrolytes\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: The presentation strongly suggests hypokalemic periodic paralysis (potentially thyrotoxic periodic paralysis given the demographic), requiring assessment of potassium levels.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q467",
    "question_text": "A patient taking a multivitamin is experiencing sensory neuronopathy. Which vitamin is most likely involved?",
    "options": "{\"A\": \"Vitamin B6\", \"B\": \"Vitamin B12\", \"C\": \"Vitamin B1\", \"D\": \"Vitamin E\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of vitamin toxicity causing specific neurological syndromes, specifically pyridoxine (B6) toxicity causing sensory neuronopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q551",
    "question_text": "A patient presents with scapular winging and weakness. He has very high CK levels, and a muscle biopsy showed eosinophils. What is the likely diagnosis?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Dermatomyositis\", \"C\": \"Facioscapulohumeral muscular dystrophy\", \"D\": \"Polymyositis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests diagnosis of a muscular dystrophy (likely Calpainopathy/LGMD2A given scapular winging) but adds a confusing element (eosinophils on biopsy, which is atypical for LGMD but can be seen in inflammatory or parasitic myositis). Assuming the core is LGMD diagnosis based on weakness pattern.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q473",
    "question_text": "A patient presented with dysphagia, tongue fasciculation, and an exaggerated jaw reflex for 18 months, with other neurological examinations normal. What is the diagnosis?",
    "options": "{\"A\": \"Progressive bulbar palsy\", \"B\": \"Bulbar onset ALS\", \"C\": \"Myasthenia gravis\", \"D\": \"Brainstem stroke\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests recognition of Progressive Bulbar Palsy (PBP), a variant of ALS, based on isolated bulbar upper and lower motor neuron signs.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q45",
    "question_text": "A case scenario of a patient with myopathy and malignant hyperthermia is presented. What is the likely diagnosis?",
    "options": "{\"A\": \"Central core myopathy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Becker muscular dystrophy\", \"D\": \"Myotonic dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the association between specific congenital myopathies (notably Central Core Disease and Multi-minicore disease, both often RYR1-related) and susceptibility to malignant hyperthermia.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q11",
    "question_text": "An elderly patient with uncontrolled diabetes presents with foot drop, thigh pain, and weight loss. What is the most important management step?",
    "options": "{\"A\": \"IVIG\", \"B\": \"Tight glycemic control and foot care\", \"C\": \"Extensive physiotherapy\", \"D\": \"Pain management\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes diabetic amyotrophy (lumbosacral radiculoplexus neuropathy). Asks for management, emphasizing glycemic control as crucial for this specific diabetic neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q177",
    "question_text": "A patient who had a mastectomy presents with arm pain and dysesthesia over the fourth and fifth fingers. What is the next best step in management?",
    "options": "{\"A\": \"Physical therapy\", \"B\": \"Nerve conduction studies\", \"C\": \"Pain management\", \"D\": \"Surgical intervention\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Scenario suggests potential brachial plexus injury (lower trunk/medial cord, affecting ulnar nerve territory C8-T1) related to surgery or positioning. Asks for the next step, which often involves electrodiagnosis (NCS) to confirm and localize the lesion.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q557",
    "question_text": "A case of Hirayama disease presents with weakness in distal hand and forearm muscles that progressed over 18 months and then became static. What is the diagnosis?",
    "options": "{\"A\": \"Amyotrophic lateral sclerosis\", \"B\": \"Hirayama disease\", \"C\": \"Multiple sclerosis\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests recognition of Hirayama disease (cervical flexion myelopathy), a specific motor neuron disorder affecting young males, based on its characteristic clinical presentation and course.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q149",
    "question_text": "A 22-year-old Filipino male presented with generalized weakness after heavy exercise. On examination, he shows hypotonia, areflexia, and weakness. What is the next best step in management?",
    "options": "{\"A\": \"K level\", \"B\": \"CT brain\", \"C\": \"LP\", \"D\": \"Toxicology screen\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Classic presentation for hypokalemic periodic paralysis (possibly thyrotoxic given demographic), requiring urgent potassium level check.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q160",
    "question_text": "What histological finding is associated with a sural nerve biopsy in HNPP?",
    "options": "{\"A\": \"Axonal degeneration\", \"B\": \"Focal sausage-like thickenings of myelin termed tomacula\", \"C\": \"Demyelination of all nerve fibers\", \"D\": \"Increased number of Schwann cells\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the pathognomonic nerve biopsy finding (tomacula) in Hereditary Neuropathy with Liability to Pressure Palsies (HNPP).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q466",
    "question_text": "A patient with myasthenia gravis (MG) presents. What is the most sensitive test for diagnosing this condition?",
    "options": "{\"A\": \"Acetylcholine antibodies\", \"B\": \"Single fiber EMG\", \"C\": \"Repetitive nerve stimulation\", \"D\": \"Edrophonium (Tensilon) test\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the relative sensitivity of diagnostic tests for Myasthenia Gravis, identifying Single Fiber EMG as the most sensitive overall.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q374",
    "question_text": "In an anti-MuSK case, which statement is true?",
    "options": "{\"A\": \"Normal thymus pathology\", \"B\": \"Associated with HLA DRB8\", \"C\": \"Predominantly affects ocular muscles\", \"D\": \"Responds well to acetylcholinesterase inhibitors\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests specific knowledge about MuSK-positive Myasthenia Gravis, including its typical lack of thymic pathology and potential HLA associations.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q65",
    "question_text": "A 20-year-old patient presents with a 10-year history of lower limb proximal weakness and difficulty standing from a sitting position. He has siblings with the same problem. EMG findings are not available, and CK levels are 2800. What is the most likely diagnosis?",
    "options": "{\"A\": \"Inflammatory myopathy\", \"B\": \"Limb-girdle muscular dystrophy\", \"C\": \"Spinal Muscular Atrophy (SMA)\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a chronic, progressive proximal weakness starting in childhood/adolescence with high CK and likely recessive inheritance pattern (siblings affected), most suggestive of a limb-girdle muscular dystrophy. While not an option, it forces differentiation from other neuromuscular causes.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q549",
    "question_text": "A 35-year-old patient presented with posterior thigh weakness and calf weakness and is unable to perform plantar flexion. CK levels are 35 times the normal limit. What is the likely diagnosis?",
    "options": "{\"A\": \"Dysferlinopathy\", \"B\": \"Becker muscular dystrophy\", \"C\": \"Charcot-Marie-Tooth disease\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of Dysferlinopathy (LGMD2B/Miyoshi Myopathy) based on the pattern of weakness (posterior compartment involvement) and markedly elevated CK levels.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q14",
    "question_text": "A patient presents with weakness provoked by exercise but then improves shortly after. What is the likely diagnosis?",
    "options": "{\"A\": \"Myophosphorylase deficiency\", \"B\": \"Myasthenia gravis\", \"C\": \"Lambert-Eaton syndrome\", \"D\": \"Duchenne muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the characteristic brief improvement after initial exercise intolerance (\"second wind\" phenomenon) seen in McArdle disease (Myophosphorylase deficiency).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q164",
    "question_text": "A long scenario describes an elderly patient with peripheral neuropathy, organomegaly, and limb edema. Which condition is most likely?",
    "options": "{\"A\": \"POEMS syndrome\", \"B\": \"CIDP\", \"C\": \"DADS\", \"D\": \"Myoshi disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests recognition of POEMS syndrome based on its key features (Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes - edema is common).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q116",
    "question_text": "In a scenario with stiffness and difficulty walking with an episode of loss of consciousness, where EMG showed neuromyotonia and the patient is now fully conscious with normal mental status, what is the diagnosis?",
    "options": "{\"A\": \"Morvan syndrome\", \"B\": \"Isaac syndrome\", \"C\": \"Stiff person syndrome\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests differentiation between Isaac syndrome (acquired neuromyotonia) and Morvan syndrome (neuromyotonia plus CNS features like encephalopathy/LOC). The LOC points towards Morvan.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q144",
    "question_text": "In a scenario suggestive of Botulism, what is the pathophysiology responsible?",
    "options": "{\"A\": \"Irreversible blockage of presynaptic ACH receptor\", \"B\": \"Irreversible blockage of postsynaptic ACH receptor\", \"C\": \"Irreversible blockage of protein that is responsible for acetylcholine release\", \"D\": \"Inhibition of acetylcholinesterase enzyme\"}",
    "correct_answer": "C",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the mechanism of action of botulinum toxin (cleavage of SNARE proteins preventing presynaptic ACh release).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q384",
    "question_text": "A 23-year-old male presents with respiratory failure and a cerebral aneurysm. Electromyography (EMG) shows myotonia without clinical myotonia. What is the diagnosis?",
    "options": "{\"A\": \"Pompe disease\", \"B\": \"Myotonic dystrophy\", \"C\": \"Amyotrophic lateral sclerosis\", \"D\": \"Duchenne muscular dystrophy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The combination of respiratory failure, CNS aneurysm (less common association), and electrical myotonia points strongly towards Myotonic Dystrophy type 1 (DM1). Pompe disease causes respiratory failure but not typically myotonia or aneurysms.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q12",
    "question_text": "A patient with Anti-Musk antibodies is likely to present with which of the following symptoms?",
    "options": "{\"A\": \"Tongue weakness and atrophy\", \"B\": \"Muscle cramps\", \"C\": \"Fatigue\", \"D\": \"Ptosis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific clinical phenotype often associated with MuSK Myasthenia Gravis, which frequently includes prominent bulbar (tongue) and facial weakness, sometimes with atrophy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q125",
    "question_text": "A patient has selective weakness of biceps, hip flexors, and knee flexors, sparing the deltoid. What is the diagnosis?",
    "options": "{\"A\": \"Facioscapulohumeral muscular dystrophy\", \"B\": \"Limb-girdle muscular dystrophy\", \"C\": \"Inclusion body myositis\", \"D\": \"Polymyositis\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests recognition of specific patterns of muscle involvement. While FSHD involves biceps, the combination with hip/knee flexors isn't typical. This pattern might suggest certain LGMDs or potentially IBM (though IBM usually involves finger flexors/quads more). Needs options, but focuses on myopathy diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q292",
    "question_text": "A 26-year-old male presented with proximal weakness and bilateral scapular winging, painless, with no clear history of facial asymmetry. What is the diagnosis? Attached pedigree of AR pattern:",
    "options": "{\"A\": \"LGMD2A (Calpainopathy)\", \"B\": \"LGMD1B\", \"C\": \"FSHD\", \"D\": \"LGMD2C\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Combines clinical phenotype (proximal weakness, scapular winging, no facial weakness) with inheritance pattern (AR pedigree) to diagnose a specific Limb Girdle Muscular Dystrophy (LGMD2A/Calpainopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q256",
    "question_text": "A 50-year-old male presents with a history of progressive lower limb weakness with tingling and numbness for 3 months, which then became static. Later, he experienced sudden right foot drop. Examination reveals weakness with areflexia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Lambert-Eaton Myasthenic Syndrome\", \"B\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\", \"C\": \"Multifocal Motor Neuropathy (MMN)\", \"D\": \"Amyotrophic Lateral Sclerosis (ALS)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The initial progressive sensorimotor symptoms suggest CIDP. The later superimposed acute foot drop suggests a potential superimposed process or a variant like Multifocal Acquired Demyelinating Sensory and Motor Neuropathy (MADSAM/Lewis-Sumner), but CIDP remains a strong possibility for the initial phase.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q130",
    "question_text": "A patient presented with dysphasia, dysarthria, and proximal muscle weakness, and was found to have anti-Musk antibody. What will you find?",
    "options": "{\"A\": \"Normal thymus\", \"B\": \"Associated with HLA DRB8\", \"C\": \"Predominantly affects women\", \"D\": \"Poor response to acetylcholinesterase inhibitors\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of characteristics associated with MuSK Myasthenia Gravis, specifically the typical absence of thymic pathology.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q133",
    "question_text": "What should be regularly assessed in a patient with Guillain-Barr\u00e9 syndrome?",
    "options": "{\"A\": \"Muscle strength\", \"B\": \"Autonomic function\", \"C\": \"Blood pressure\", \"D\": \"Respiratory function\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about essential monitoring parameters (respiratory function - implied by muscle strength, autonomic function, blood pressure) in acute GBS management.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q423",
    "question_text": "A scenario is suggestive of Mononeuritis multiplex with pathology showing monoclonal cells and necrotizing vasculitis. What is the likely diagnosis?",
    "options": "{\"A\": \"Vasculitic neuropathy\", \"B\": \"Chronic inflammatory demyelinating polyneuropathy\", \"C\": \"Amyloid neuropathy\", \"D\": \"Diabetic neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Connects the clinical pattern of Mononeuritis Multiplex with specific pathology findings (necrotizing vasculitis) to identify Vasculitic Neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q430",
    "question_text": "In a scenario suggesting periodic paralysis in a Filipino patient with generalized muscle weakness, what is the next investigation to be performed?",
    "options": "{\"A\": \"Potassium level\", \"B\": \"Thyroid function tests\", \"C\": \"Electromyography (EMG)\", \"D\": \"Serum calcium level\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Identifies the key initial investigation (potassium level) for suspected periodic paralysis, especially relevant in the context of potential thyrotoxic periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q524",
    "question_text": "A young male patient came with eyelid myotonia that increased after eating ice cream or being exposed to cold. What is the diagnosis?",
    "options": "{\"A\": \"Paramyotonia congenita\", \"B\": \"Myotonic dystrophy\", \"C\": \"Hypokalemic periodic paralysis\", \"D\": \"Congenital myasthenic syndrome\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of Paramyotonia Congenita based on paradoxical myotonia (worsening with cold/exercise).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q74",
    "question_text": "A man who developed progressive weakness of the right hand showed severe weakness and muscle atrophy in the right arm, along with decreased reflexes and fasciculation. The left arm showed hyporeflexia, while the lower limb was not affected and sensory examination was normal. What is the most appropriate treatment?",
    "options": "{\"A\": \"Riluzole\", \"B\": \"IVIG\", \"C\": \"Prednisolone\", \"D\": \"Plasma exchange\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes findings consistent with a focal onset motor neuron disease, likely ALS (or a variant like brachial amyotrophic diplegia). Asks for the disease-modifying treatment for ALS (Riluzole).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q475",
    "question_text": "A patient with multifocal motor neuropathy (MMN) is being considered for treatment. What is the first-line management option?",
    "options": "{\"A\": \"IVIG\", \"B\": \"Physiotherapy\", \"C\": \"Steroid\", \"D\": \"PLEX\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the specific first-line treatment (IVIG) for Multifocal Motor Neuropathy (MMN), noting its typical lack of response to steroids.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q535",
    "question_text": "What is the first abnormality typically seen in nerve conduction studies (NCS) or electromyography (EMG) in AIDP?",
    "options": "{\"A\": \"Prolonged or absent F wave and absent H reflexes\", \"B\": \"Decreased distal latency\", \"C\": \"Increased sensory nerve action potentials\", \"D\": \"Normal findings\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the earliest and most common electrodiagnostic abnormalities in AIDP/GBS, which are often abnormalities of late responses (F waves, H reflexes).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q48",
    "question_text": "What is the most sensitive test for diagnosing Myasthenia Gravis (MG)?",
    "options": "{\"A\": \"Single fiber EMG (SFEMG)\", \"B\": \"Anti-Cholinesterase antibody\", \"C\": \"Anti-MuSK antibody\", \"D\": \"Two-hertz to 5-Hz RNS studies\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of diagnostic test sensitivity for MG. Single fiber EMG (SFEMG) is the most sensitive test for MG diagnosis, detecting neuromuscular transmission defects earlier than antibody or repetitive nerve stimulation studies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q67",
    "question_text": "In a scenario of LGM1B (laminopathy) with elevated heart enzyme levels, what is the expected finding?",
    "options": "{\"A\": \"Contracture of elbow and ankle\", \"B\": \"Late contracture in LGMD1B (AD)\", \"C\": \"Early contracture in Emery-Dreifuss dystrophy (X-linked)\", \"D\": \"Cardiac conduction defects\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the clinical features associated with Laminopathies (like LGMD1B and Emery-Dreifuss), specifically the presence and timing of contractures and cardiac involvement.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q547",
    "question_text": "In a scenario of facioscapulohumeral muscular dystrophy (FSH), what is the likely diagnosis?",
    "options": "{\"A\": \"Facioscapulohumeral muscular dystrophy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Myotonic dystrophy\", \"D\": \"Becker muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of FSHD based on a presented scenario (presumably including facial and scapular weakness).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q18",
    "question_text": "In paramyotonia congenita, what happens to the amplitude of the compound muscle action potential (CMAP) with exposure to cold?",
    "options": "{\"A\": \"Increases\", \"B\": \"Decreases\", \"C\": \"Remains unchanged\", \"D\": \"Fluctuates\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific electrophysiological response (CMAP decrement) to cold exposure seen in paramyotonia congenita.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q418",
    "question_text": "A patient presents with symmetrical proximal and distal weakness, numbness in toes and fingers, fasciculations, and foot drop during the course of the disease. What is the diagnosis?",
    "options": "{\"A\": \"Lambert-Eaton Myasthenic Syndrome (LEMS)\", \"B\": \"Multifocal Motor Neuropathy (MMN)\", \"C\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\", \"D\": \"Amyotrophic Lateral Sclerosis (ALS)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes symmetric proximal and distal sensorimotor neuropathy, fitting well with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Fasciculations are less typical for pure CIDP but can occur.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q425",
    "question_text": "A patient presents with ocular muscle weakness, ptosis, mild facial weakness, and proximal weakness. What is the likely diagnosis?",
    "options": "{\"A\": \"Oculopharyngeal muscular dystrophy (OPMD)\", \"B\": \"Myasthenia gravis\", \"C\": \"Chronic progressive external ophthalmoplegia (CPEO)\", \"D\": \"Lambert-Eaton myasthenic syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The combination of ptosis, ophthalmoparesis (ocular muscle weakness), facial weakness, and proximal (often dysphagia, but proximal limb weakness can occur) suggests OPMD, especially if onset is later in life.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q66",
    "question_text": "A patient presented with progressive inability to drink with a straw, proximal weakness, scapular winging, and impaired foot dorsiflexion. What is the most likely diagnosis?",
    "options": "{\"A\": \"Facioscapulohumeral dystrophy\", \"B\": \"Limb girdle muscular dystrophy\", \"C\": \"Amyotrophic lateral sclerosis\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests recognition of Facioscapulohumeral Dystrophy (FSHD) based on the characteristic combination of facial weakness (inability to use straw), scapular winging, and often asymmetric limb weakness (like foot drop).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q472",
    "question_text": "Anti-striatal antibody in Myasthenia Gravis (MG) indicates:",
    "options": "{\"A\": \"Thymoma\", \"B\": \"Ocular MG\", \"C\": \"Resistance to steroid therapy\", \"D\": \"Early onset MG\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the clinical correlation of anti-striated muscle antibodies in Myasthenia Gravis, which is strongly associated with the presence of thymoma, especially in older patients.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q112",
    "question_text": "What is the medication that causes neuropathy and myopathy?",
    "options": "{\"A\": \"Dapsone\", \"B\": \"Chloroquine\", \"C\": \"Hydralazine\", \"D\": \"Colchicine\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of drugs that can cause both myopathy and neuropathy, with Chloroquine being a classic example.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q132",
    "question_text": "A Filipino patient has muscle stiffness and intermittent weakness. What should be tested for him?",
    "options": "{\"A\": \"Potassium level\", \"B\": \"Thyroid function tests\", \"C\": \"Serum calcium\", \"D\": \"Creatine kinase\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: The combination of stiffness (myotonia?) and intermittent weakness in this demographic raises suspicion for periodic paralysis (possibly thyrotoxic hypokalemic) or a myotonic disorder. Checking potassium is crucial for periodic paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q113",
    "question_text": "In a scenario involving amyloidosis, what is the next step in management?",
    "options": "{\"A\": \"Fat aspiration\", \"B\": \"Bone marrow biopsy\", \"C\": \"Serum protein electrophoresis\", \"D\": \"Echocardiography\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of diagnostic procedures for systemic amyloidosis, where abdominal fat pad aspiration/biopsy is a common and relatively non-invasive method to confirm the diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q188",
    "question_text": "In a patient with sensory and autonomic neuropathy, a family history of restricted cardiomyopathy is noted. What is the likely diagnosis?",
    "options": "{\"A\": \"Amyloidosis\", \"B\": \"CIDP\", \"C\": \"DADS\", \"D\": \"Charcot-Marie-Tooth disease\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests recognition of hereditary amyloidosis (especially Transthyretin amyloidosis - ATTR) based on the combination of sensorimotor/autonomic neuropathy and cardiomyopathy, often with a family history.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q239",
    "question_text": "A case presents with stiffness induced by exercise, and the patient experiences forced eye closure when sneezing, along with percussion myotonia and eyelid myotonia. Which channel is likely affected?",
    "options": "{\"A\": \"Sodium channel\", \"B\": \"Potassium channel\", \"C\": \"Calcium channel\", \"D\": \"Chloride channel\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes clinical myotonia (stiffness, percussion myotonia, lid lag). The pattern doesn't strongly differentiate channel types, but options require knowledge of channels linked to myotonia. Chloride channel (CLCN1) causes Myotonia Congenita (Thomsen/Becker). Sodium channel (SCN4A) causes Paramyotonia Congenita and Hyperkalemic Periodic Paralysis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q93",
    "question_text": "A middle-aged female has a history of diarrhea two weeks prior to presentation and now has paresthesia and weakness. What is the most likely diagnosis?",
    "options": "{\"A\": \"Acute inflammatory demyelinating polyneuropathy (AIDP)\", \"B\": \"Chronic inflammatory demyelinating polyneuropathy (CIDP)\", \"C\": \"Multiple sclerosis\", \"D\": \"Myasthenia gravis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests recognition of the typical presentation of AIDP (GBS), including the common antecedent infection (diarrhea often implies Campylobacter jejuni).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q51",
    "question_text": "In a case scenario of a patient with findings suggestive of hereditary motor and sensory neuropathy type 1 (HMSN1) who has a PMP22 duplication, what would the biopsy findings most likely show?",
    "options": "{\"A\": \"Onion bulb\", \"B\": \"Sausage-like demyelination\", \"C\": \"Axonal injury\", \"D\": \"Normal findings\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic nerve biopsy finding ('onion bulbs') in chronic demyelinating neuropathies like Charcot-Marie-Tooth type 1A (CMT1A), caused by PMP22 duplication.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q12",
    "question_text": "A patient presents with hand extension weakness but no sensory loss. Which nerve is likely affected?",
    "options": "{\"A\": \"Posterior Interosseous Nerve (PIN)\", \"B\": \"Radial nerve\", \"C\": \"Median nerve\", \"D\": \"Ulnar nerve\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests localization of a peripheral nerve lesion based on pure motor deficit (wrist/finger extension weakness without sensory loss points to the Posterior Interosseous Nerve - PIN).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q184",
    "question_text": "A patient has difficulty blowing air in the mouth and presents with an asymmetrical right foot drop. What is the most likely diagnosis?",
    "options": "{\"A\": \"FSHD (Facioscapulohumeral Muscular Dystrophy)\", \"B\": \"CIDP\", \"C\": \"Myoshi disease\", \"D\": \"DADS\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests recognition of FSHD based on the combination of facial weakness (\"difficulty blowing air\") and asymmetric distal limb weakness (foot drop).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q66",
    "question_text": "What is the typical recovery pattern following an episode of Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)?",
    "options": "{\"A\": \"Gradual worsening over months\", \"B\": \"Complete recovery within days or weeks\", \"C\": \"Permanent weakness\", \"D\": \"Progressive disability\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the clinical course of typical HNPP episodes, which usually involve relatively rapid recovery.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q346",
    "question_text": "An adult presents with a history of gait issues. Examination shows significant weakness and atrophy of the gastrocnemius muscle with mild weakness in the upper limbs. What is the diagnosis?",
    "options": "{\"A\": \"Dysferlin 2B\", \"B\": \"Becker muscular dystrophy\", \"C\": \"Charcot-Marie-Tooth disease\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The prominent calf (gastrocnemius) weakness/atrophy points towards Miyoshi myopathy, which is caused by mutations in the DYSF gene (Dysferlin). LGMD2B is the limb-girdle phenotype also caused by DYSF mutations.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q34",
    "question_text": "A young patient presents with distal myopathy (posterior calf) and a high creatine kinase level of 7000. What is the likely diagnosis?",
    "options": "{\"A\": \"Nemaline myopathy\", \"B\": \"Miyoshi myopathy\", \"C\": \"Nonaka myopathy\", \"D\": \"Limb-girdle muscular dystrophy\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests recognition of Miyoshi myopathy, a form of dysferlinopathy, based on its characteristic presentation (posterior calf weakness) and markedly elevated CK. Duplicate of",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q54",
    "question_text": "Which cranial nerve is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q241",
    "question_text": "Dermatomyositis is associated with which of the following findings?",
    "options": "{\"A\": \"Rimmed vacuoles\", \"B\": \"Perifascular inflammation\", \"C\": \"Endomysial inflammation\", \"D\": \"Neurogenic atrophy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the characteristic histopathological finding (perifascicular inflammation/atrophy) in dermatomyositis muscle biopsies.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q29",
    "question_text": "What is the most common gene associated with familial Amyotrophic Lateral Sclerosis (ALS)?",
    "options": "{\"A\": \"C9orf72\", \"B\": \"SOD1\", \"C\": \"TARDBP\", \"D\": \"FUS\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the genetics of familial ALS, identifying C9orf72 as the most common genetic cause.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q556",
    "question_text": "In a scenario with congenital myasthenia gravis (MG), the patient has hand involvement and proximal upper and lower limb weakness. What is the likely diagnosis?",
    "options": "{\"A\": \"Slow channel myasthenic syndrome\", \"B\": \"End-plate acetylcholinesterase deficiency\", \"C\": \"Dok-7 myasthenia\", \"D\": \"Choline acetyltransferase deficiency\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of specific subtypes of Congenital Myasthenic Syndromes (CMS). Slow-channel CMS often presents with prominent distal (hand) and proximal weakness and can have specific EMG findings.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q40",
    "question_text": "Case scenario of a patient with inner arm and forearm tingling sensation, thenar muscle weakness, and pain when raising the arm. Where is the localization?",
    "options": "{\"A\": \"C8-T1\", \"B\": \"C7, C8\", \"C\": \"C5-C6\", \"D\": \"T1-T2\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests localization within the brachial plexus or nerve roots based on sensory (medial arm/forearm - C8/T1) and motor (thenar - C8/T1 via median nerve) symptoms, likely pointing to the lower trunk or medial cord (C8-T1).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q11",
    "question_text": "In ulnar neuropathy, what will you find on day 5 in nerve conduction studies (NCS)?",
    "options": "{\"A\": \"Decreased recruitment\", \"B\": \"Fibrillation\", \"C\": \"Complex repetitive discharges\", \"D\": \"Conduction block\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the timeline of electrodiagnostic findings after acute axonal injury. Fibrillations typically appear later (1-3 weeks). After 5 days, one might see decreased recruitment or conduction block if demyelinating, but decreased recruitment is a general sign of axonal loss or conduction failure.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q72",
    "question_text": "In the context of Inclusion Body Myositis (IBM), what is the primary treatment approach?",
    "options": "{\"A\": \"Supportive care\", \"B\": \"Prednisone\", \"C\": \"Physical therapy\", \"D\": \"Immunosuppressants\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the management of IBM, emphasizing its general resistance to immunotherapy and the importance of supportive care/physical therapy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q34",
    "question_text": "A 55-year-old patient presented with ptosis, extraocular muscle weakness, dysphagia, and proximal weakness. What is the likely diagnosis?",
    "options": "{\"A\": \"GCG Repeat\", \"B\": \"D4Z4\", \"C\": \"Acetylcholine receptor antibody testing\", \"D\": \"Muscle-specific kinase (MuSK) antibody testing\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a classic constellation of symptoms suggestive of a neuromuscular junction disorder (like myasthenia gravis) or myopathy, requiring diagnosis within the neuromuscular field (though the options are genetic tests for other conditions, the clinical picture drives the classification).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q113",
    "question_text": "In a patient with Acute Inflammatory Demyelinating Polyneuropathy (AIDP), what is the first abnormality typically seen in nerve conduction studies (NCS) or electromyography (EMG)?",
    "options": "{\"A\": \"F wave abnormalities\", \"B\": \"Conduction block\", \"C\": \"Temporal dispersion\", \"D\": \"Reduced CMAP amplitude\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of specific electrodiagnostic findings (particularly early changes like F wave abnormalities) characteristic of AIDP (Guillain-Barr\u00e9 Syndrome), a primary neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q49",
    "question_text": "A patient with shoulder pain and weakness in the forearm and arm is evaluated. What is the most commonly involved structure?",
    "options": "{\"A\": \"Upper trunk\", \"B\": \"Lower trunk\", \"C\": \"Upper and lower trunk\", \"D\": \"Brachial plexus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on anatomical localization within the peripheral nervous system (brachial plexus) based on the distribution of motor and sensory symptoms, a core concept in neuromuscular medicine.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q48",
    "question_text": "A 35-year-old patient presented with posterior thigh weakness and calf weakness, and he cannot perform plantar flexion. His CK level is 35 times the normal value. What is the likely diagnosis?",
    "options": "{\"A\": \"Dysferlinopathy\", \"B\": \"Becker muscular dystrophy\", \"C\": \"Inclusion body myositis\", \"D\": \"Limb-girdle muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on diagnosing a specific myopathy based on clinical presentation (pattern of weakness) and CK levels.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q52",
    "question_text": "In a patient with Type 2 Charcot-Marie-Tooth disease, what is the typical feature?",
    "options": "{\"A\": \"SNAP drop\", \"B\": \"Affects upper limbs more than lower limbs\", \"C\": \"Demyelinating neuropathy\", \"D\": \"Early onset sensory ataxia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the electrophysiological characteristics (SNAP amplitude reduction in axonal neuropathy) differentiating subtypes of a specific inherited neuropathy (CMT).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q35",
    "question_text": "A patient with C5-C6 radiculopathy is evaluated. Which muscle is involved?",
    "options": "{\"A\": \"Infraspinatus\", \"B\": \"Biceps brachii\", \"C\": \"Deltoid\", \"D\": \"Triceps brachii\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of specific muscle innervation by cervical nerve roots (myotomes), essential for localizing peripheral nerve or root lesions, falling under neuromuscular localization.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q238",
    "question_text": "A patient presents 2 days postpartum with flaccid paralysis, decreased reflexes, and normal sensation. What is the most appropriate next step in management?",
    "options": "{\"A\": \"Nerve Conduction Study (NCS)\", \"B\": \"Lumbar Puncture (LP)\", \"C\": \"MRI of the cervical spine\", \"D\": \"Magnesium level\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the diagnostic workup of acute flaccid paralysis. While the presentation is acute, the core possibilities involve peripheral nerve (GBS) or neuromuscular junction issues (potential electrolyte imbalance like hypomagnesemia or effects of MgSO4 if used for eclampsia), making Neuromuscular the best fit for the underlying pathology being investigated.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q59",
    "question_text": "The same patient is asking about the treatment. What is the most effective treatment for this condition?",
    "options": "{\"A\": \"IV immunoglobulin (IVIG)\", \"B\": \"Plasmapheresis (PLEX)\", \"C\": \"Corticosteroids\", \"D\": \"Cyclophosphamide\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of primary treatments (IVIG, PLEX) for inflammatory neuropathies like GBS or CIDP (likely following Q172). These are core neuromuscular treatments.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q172",
    "question_text": "A 44-year-old female presents with a 3-week history of left leg numbness and right hand and arm areflexia on the left ankle and knee. An EMG showed peroneal nerve involvement, while radial and ulnar nerves were asymptomatic. The ESR was high, and the MRI was normal. What is the most likely diagnosis?",
    "options": "{\"A\": \"Chronic inflammatory demyelinating polyneuropathy (CIDP)\", \"B\": \"Mononeuritis multiplex\", \"C\": \"Subacute inflammatory demyelination\", \"D\": \"Guillain-Barr\\u00e9 syndrome (GBS)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing mononeuritis multiplex based on the pattern of multifocal, asymmetric peripheral nerve involvement and elevated inflammatory markers.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q234",
    "question_text": "What is the characteristic presentation of monomelic amyotrophy?",
    "options": "{\"A\": \"Distal upper limb weakness and muscle wasting\", \"B\": \"Symmetrical weakness in the lower limbs\", \"C\": \"Rapidly progressive weakness with sensory loss\", \"D\": \"Isolated sensory symptoms in the upper limbs\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the typical clinical features of monomelic amyotrophy (Hirayama disease), a focal lower motor neuron disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q144",
    "question_text": "In anti-MuSK positive myasthenia gravis, which muscle group is most commonly affected?",
    "options": "{\"A\": \"Bulbar\", \"B\": \"Distal\", \"C\": \"Ocular\", \"D\": \"Proximal\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the specific clinical phenotype (predominant bulbar involvement) associated with MuSK-positive Myasthenia Gravis, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q149",
    "question_text": "A young male presents with neck and shoulder pain, along with decreased sensation in the medial wrist affecting the 4th and 5th fingers. What is the likely diagnosis?",
    "options": "{\"A\": \"C6 radiculopathy\", \"B\": \"C7 radiculopathy\", \"C\": \"Ulnar nerve injury\", \"D\": \"Median nerve injury\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires localization of a lesion (likely ulnar nerve or C8/T1 root) based on the distribution of sensory symptoms in the peripheral nervous system.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q233",
    "question_text": "An image of nerve conduction studies (NCS) of the median nerve shows:",
    "options": "{\"A\": \"Conduction block\", \"B\": \"Temporal dispersion\", \"C\": \"Normal conduction\", \"D\": \"Prolonged latency\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires interpretation of electrodiagnostic findings (NCS), a core tool in neuromuscular diagnosis.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q148",
    "question_text": "What is the treatment for Lambert-Eaton myasthenic syndrome (LEMS) assuming it is paraneoplastic?",
    "options": "{\"A\": \"Prednisolone + pyridostigmine\", \"B\": \"3,4-Diaminopyridine (3-4 DAP) + Azathioprine\", \"C\": \"3,4-DAP + Prednisolone\", \"D\": \"Plasmapheresis\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the specific pharmacological treatment of Lambert-Eaton Myasthenic Syndrome, a disorder of the neuromuscular junction.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q187",
    "question_text": "A 35-year-old female with a known case of Myasthenia Gravis for 5 years presents with worsening generalized weakness. She has positive acetylcholine antibodies and thymic hyperplasia on CT chest. Currently, she is on pyridostigmine every 4 hours. What is the most appropriate management?",
    "options": "{\"A\": \"Referral to surgery for thymectomy\", \"B\": \"IVIG\", \"C\": \"Start steroids low and slow\", \"D\": \"Increase pyridostigmine dose\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with the long-term management strategy (thymectomy indication) for Myasthenia Gravis based on antibody status and thymic findings.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q236",
    "question_text": "A 2-month-old infant had apnea, macroglossia, and cardiac disease. What is the likely diagnosis?",
    "options": "{\"A\": \"Pompe Disease\", \"B\": \"Congenital Hypothyroidism\", \"C\": \"Beckwith-Wiedemann Syndrome\", \"D\": \"Congenital Myotonic Dystrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the recognition of Pompe disease (acid maltase deficiency), a metabolic myopathy (neuromuscular disorder), based on its characteristic infantile presentation.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q48",
    "question_text": "A scenario typical for paramyotonia congenita is presented. What is the gene involved?",
    "options": "{\"A\": \"Sodium channel\", \"B\": \"Calcium channel\", \"C\": \"Potassium channel\", \"D\": \"Chloride channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the genetic basis (specifically the type of ion channel gene mutation) underlying paramyotonia congenita, a muscle channelopathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q129",
    "question_text": "What is the typical recovery time for Guillain-Barr\u00e9 syndrome?",
    "options": "{\"A\": \"Recovery can continue for more than 3 years after onset\", \"B\": \"Recovery is usually complete within 6 months\", \"C\": \"Recovery is rare\", \"D\": \"Recovery takes less than 1 year\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the prognosis and typical recovery course of Guillain-Barr\u00e9 Syndrome (GBS), an autoimmune peripheral neuropathy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q230",
    "question_text": "In a patient with Amyotrophic Lateral Sclerosis (ALS), what is a key clinical finding?",
    "options": "{\"A\": \"Combination of upper motor neuron (UMN) and lower motor neuron (LMN) findings\", \"B\": \"Isolated sensory loss\", \"C\": \"Normal reflexes with muscle wasting\", \"D\": \"Flaccid paralysis without atrophy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the defining clinical characteristic (combination of UMN and LMN signs) of Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q468",
    "question_text": "A patient is losing the clutch, has Lhermitte sign, and experiences ataxia that worsens at night. The blood film is abnormal. What is the diagnosis?",
    "options": "{\"A\": \"Subacute combined degeneration (B12 deficiency)\", \"B\": \"Syphilis\", \"C\": \"Multiple sclerosis\", \"D\": \"Tabes dorsalis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes symptoms (Lhermitte's, sensory ataxia) indicative of posterior column dysfunction, strongly suggesting Subacute Combined Degeneration (spinal cord and peripheral nerve demyelination) due to B12 deficiency.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q45",
    "question_text": "What is the treatment for Inclusion Body Myositis (IBM)?",
    "options": "{\"A\": \"Steroid\", \"B\": \"IVIG\", \"C\": \"Supportive treatment\", \"D\": \"Immunosuppressants\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the management of Inclusion Body Myositis, a specific neuromuscular disorder (inflammatory myopathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q8",
    "question_text": "A patient with myotonic dystrophy presents with shoulder pain. What is the most appropriate management for this patient?",
    "options": "{\"A\": \"Melxiten for pain\", \"B\": \"Amantadine\", \"C\": \"IVIG\", \"D\": \"Extensive physiotherapy\"}",
    "correct_answer": "D",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on managing a symptom (pain) in the context of a specific inherited neuromuscular disorder (myotonic dystrophy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q7",
    "question_text": "After radiation therapy, a patient presents with shoulder abduction weakness (4/5), impaired sensation in the lateral thumb and lateral forearm, and improved function in the index and third fingers. Which nerve is likely impaired?",
    "options": "{\"A\": \"Suprascapular/long thoracic\", \"B\": \"Axillary and lateral antebrachial\", \"C\": \"Radial\", \"D\": \"Musculocutaneous\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses localization of peripheral nerve injury (likely radiation-induced brachial plexopathy or specific nerve damage) based on motor and sensory deficits.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q28",
    "question_text": "A question about Kennedy disease is presented.",
    "options": "{\"A\": \"It is an autosomal dominant disorder\", \"B\": \"It primarily affects sensory neurons\", \"C\": \"It is characterized by motor neuron degeneration and androgen receptor mutation\", \"D\": \"It presents with early cognitive decline\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Kennedy disease (Spinal and Bulbar Muscular Atrophy) is an X-linked neuromuscular disorder characterized by motor neuron degeneration.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q44",
    "question_text": "A patient came with a history of mononeuropathy multiplex. Biopsy showed necrosis and inflammatory cells in the vessels. What is the diagnosis?",
    "options": "{\"A\": \"Vasculitic neuropathy\", \"B\": \"Diabetic neuropathy\", \"C\": \"Guillain-Barr\\u00e9 syndrome\", \"D\": \"Charcot-Marie-Tooth disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the diagnosis of vasculitic neuropathy based on clinical presentation (mononeuritis multiplex) and specific pathological findings on nerve biopsy.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q52",
    "question_text": "A patient presents with scapular winging and weakness, and he has very high CK levels. Muscle biopsy showed eosinophils. What is the likely diagnosis?",
    "options": "{\"A\": \"Calpainopathy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Polymyositis\", \"D\": \"Facioscapulohumeral muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on diagnosing a muscular dystrophy or myopathy based on clinical features (scapular winging, high CK) and specific muscle biopsy findings (eosinophils, suggesting potentially eosinophilic myositis or a specific dystrophy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q5",
    "question_text": "A patient with a known case of diabetes mellitus presents with peripheral neuropathy and has impaired sensation for pinprick up to mid-shin. What test would be best for diagnosis?",
    "options": "{\"A\": \"Nerve Conduction Study (NCS)\", \"B\": \"MRI of the spine\", \"C\": \"Epidermal nerve fiber density\", \"D\": \"Quantitative sensory testing\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns the diagnostic workup of peripheral neuropathy, specifically distinguishing between large fiber (detectable by NCS) and small fiber neuropathy (requiring tests like epidermal nerve fiber density) in a diabetic patient.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q9",
    "question_text": "A patient came with neuropathy after a mild car accident, with PMP 22 deletion. What are the pathology findings?",
    "options": "{\"A\": \"Onion bulb\", \"B\": \"Sausage shaped\", \"C\": \"Demyelination with remyelination\", \"D\": \"Axonal degeneration\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the specific histopathological finding (sausage-shaped thickenings or 'tomacula') associated with Hereditary Neuropathy with liability to Pressure Palsies (HNPP), caused by PMP22 deletion.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q47",
    "question_text": "A young patient presented with weakness and cannot extend his elbow; he has toe walking, and ECG showed RBBB. What is the diagnosis?",
    "options": "{\"A\": \"Emery-Dreifuss muscular dystrophy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Becker muscular dystrophy\", \"D\": \"Limb-girdle muscular dystrophy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnosis based on a constellation of findings (contractures, weakness pattern, cardiac involvement) characteristic of Emery-Dreifuss muscular dystrophy, a neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q19",
    "question_text": "In a patient with a familial history of amyotrophic lateral sclerosis (ALS), which gene mutations are commonly associated?",
    "options": "{\"A\": \"SOD1\", \"B\": \"C9orf72\", \"C\": \"TARDBP\", \"D\": \"FUS\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the genetic basis of familial ALS, a motor neuron disease classified under neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q57",
    "question_text": "In a typical scenario of a stiff person, EMG showed continuous contractions. What is the antibody?",
    "options": "{\"A\": \"Anti-GAD\", \"B\": \"Anti-AChR\", \"C\": \"Anti-MuSK\", \"D\": \"Anti-Hu\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the characteristic autoantibody (Anti-GAD) associated with Stiff Person Syndrome, a rare autoimmune neuromuscular disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q32",
    "question_text": "A 22-year-old female patient presented with difficulty walking and climbing stairs; however, she has normal lifestyle function. Her parents are relatives, and her brother and sister have similar complaints. Genetic study for the family revealed a positive SMN1 gene mutation. Which of the following will correspond to the patient\u2019s diagnosis?",
    "options": "{\"A\": \"Abnormal pulmonary function test\", \"B\": \"Neurogenic change in EMG\", \"C\": \"Elevated serum creatine kinase\", \"D\": \"Demyelinating sensory neuropathy\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the clinical and diagnostic features (characteristic neurogenic EMG changes) of Spinal Muscular Atrophy (SMA), a hereditary disorder primarily affecting motor neurons and muscle function.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q47",
    "question_text": "In a case scenario of a patient with inner arm and forearm tingling sensation, thenar muscle weakness, and pain when raising the arm, where is the localization?",
    "options": "{\"A\": \"C8-T1\", \"B\": \"C7\", \"C\": \"Upper brachial plexus\", \"D\": \"T1 dermatome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires localization within the peripheral nervous system (lower brachial plexus or C8/T1 nerve roots) based on a pattern of sensory and motor symptoms.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q45",
    "question_text": "A middle-aged man presents to the outpatient clinic with a history of peripheral neuropathy. His past medical history is significant for asthma and recurrent sinusitis. Laboratory tests show positive P-ANCA. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Polyarteritis nodosa\", \"B\": \"Wegener granulomatosis\", \"C\": \"Churg-Strauss syndrome\", \"D\": \"Microscopic polyangiitis\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing a systemic condition (EGPA/Churg-Strauss) presenting with peripheral neuropathy and characteristic systemic features/serology.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q94",
    "question_text": "A patient with shoulder pain had weakness in the forearm and arm. What is the most commonly involved structure?",
    "options": "{\"A\": \"Upper trunk\", \"B\": \"Lower trunk\", \"C\": \"Posterior cord\", \"D\": \"Lateral cord\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of brachial plexus anatomy and localization based on the distribution of weakness (likely upper trunk involvement - Erb's palsy pattern).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q82",
    "question_text": "An elderly thin female presents with foot drop and decreased sensation in the first and second toes. What is the likely cause?",
    "options": "{\"A\": \"Tibial nerve injury\", \"B\": \"Peroneal nerve injury\", \"C\": \"Femoral nerve injury\", \"D\": \"Sciatic nerve injury\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires identification of the injured peripheral nerve (common peroneal) based on classic clinical signs (foot drop) and sensory loss pattern, considering a common mechanism (compression at fibular head).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q33",
    "question_text": "A 35-year-old male presented to the clinic due to weakness that started in the last 3 years and progressed. His weakness is described as difficulty in climbing stairs and standing from a chair. He has a family history of similar weakness. Physical examination showed mild weakness in shoulder abduction bilaterally and lower limb weakness bilaterally. Reflexes were depressed in the knee and ankle bilaterally, and EMG showed lower limb fibrillation. What is the next step in management?",
    "options": "{\"A\": \"Riluzole\", \"B\": \"Corticosteroid\", \"C\": \"Nusinersen\", \"D\": \"Physical therapy\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes a clinical scenario suggestive of an inherited neuromuscular disorder (like limb-girdle muscular dystrophy or possibly SMA variant) and asks about potential treatments relevant to different diagnoses within this category.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q92",
    "question_text": "A patient with back pain radiating to the left lower limb and normal ankle reflex. What muscle is involved?",
    "options": "{\"A\": \"Superior gluteus\", \"B\": \"Iliopsoas\", \"C\": \"Tibialis anterior\", \"D\": \"Quadratus lumborum\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Involves clinical localization of a probable radiculopathy (sparing S1 due to normal ankle reflex, likely L5 or higher) by relating it to potentially affected muscles.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q48",
    "question_text": "A young patient with congenital myasthenia gravis (MG) has a history suggestive of slow channel type. What is the recommended treatment?",
    "options": "{\"A\": \"Pyridostigmine\", \"B\": \"3,4 DAP\", \"C\": \"Fluoxetine\", \"D\": \"Quinidine\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the specific treatment (Quinidine or Fluoxetine for slow-channel) for a subtype of congenital myasthenic syndrome, a neuromuscular junction disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q99",
    "question_text": "In a scenario of Miller Fisher syndrome, what is the associated antibody?",
    "options": "{\"A\": \"GQ1b\", \"B\": \"GM1\", \"C\": \"GD1a\", \"D\": \"GQ1a\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific antibody (anti-GQ1b) associated with Miller Fisher syndrome, a variant of Guillain-Barr\u00e9 syndrome (autoimmune neuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q166",
    "question_text": "Typical case of a young lady with diurnal proximal muscle weakness with dysarthria and tongue fasciculations. What is the likely diagnosis?",
    "options": "{\"A\": \"Lambert-Eaton Myasthenic Syndrome (LEMS)\", \"B\": \"Anti-muscle antibody Myasthenia Gravis\", \"C\": \"Congenital Myasthenic Syndrome\", \"D\": \"Botulism\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires diagnosing a neuromuscular junction disorder (likely Myasthenia Gravis) based on classic symptoms like fluctuating weakness. Fasciculations make MG less typical, but it's listed as an option.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q198",
    "question_text": "Case of muscle weakness with deltoid sparing?",
    "options": "{\"A\": \"Myotonic dystrophy type 2\", \"B\": \"Facioscapulohumeral dystrophy\", \"C\": \"Limb-girdle muscular dystrophy\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks to identify a specific muscular dystrophy based on the pattern of muscle weakness (deltoid sparing), a key diagnostic feature in neuromuscular disorders.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q323",
    "question_text": "A scenario about a patient with CIDP is presented. What is the treatment?",
    "options": "{\"A\": \"Intravenous immunoglobulin (IVIG)\", \"B\": \"Oral antibiotics\", \"C\": \"Antiepileptic drugs\", \"D\": \"Physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the standard treatment (IVIG) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), an autoimmune peripheral nerve disorder.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q339",
    "question_text": "A patient with polymyalgia rheumatica is on steroids (5 mg) post-myocardial infarction and is also taking atorvastatin (40 mg). The patient presents with proximal muscle weakness and cannot rise from a seated position, with a creatine kinase level of 1880. What is the most likely diagnosis?",
    "options": "{\"A\": \"Steroid myopathy\", \"B\": \"Statin myopathy\", \"C\": \"Polymyalgia rheumatica flare\", \"D\": \"Inclusion body myositis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires differentiating between potential causes of myopathy (statin vs. steroid induced) in a patient presenting with proximal weakness and elevated CK.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q343",
    "question_text": "A 45-year-old female with a picture of Miller Fisher syndrome is asked about treatment. What is the most appropriate treatment?",
    "options": "{\"A\": \"IVIG\", \"B\": \"Corticosteroids\", \"C\": \"Plasmapheresis\", \"D\": \"Anticoagulation\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the appropriate treatment (IVIG or Plasmapheresis) for Miller Fisher syndrome, a variant of GBS (autoimmune neuropathy).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q354",
    "question_text": "In Myasthenia Gravis, which statement is correct regarding the association with thymoma?",
    "options": "{\"A\": \"Related to thymoma\", \"B\": \"Bad prognosis\", \"C\": \"No response to steroids\", \"D\": \"More common in males\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge about the association between Myasthenia Gravis (a neuromuscular junction disorder) and thymoma.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q384",
    "question_text": "In a case of neurofascin 51, what is the pathophysiology?",
    "options": "{\"A\": \"Paranodal dissection\", \"B\": \"Complement mediated\", \"C\": \"Antibody mediated\", \"D\": \"Demyelination\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about the underlying mechanism (paranodal dissection due to antibodies) in a specific type of autoimmune neuropathy (anti-neurofascin associated).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q100",
    "question_text": "A lady who has symptoms of peripheral neuropathy (among other symptoms) and electrophoresis showed the presence of IgM antibody. What is the treatment?",
    "options": "{\"A\": \"Prednisolone\", \"B\": \"Periodic plasma exchange\", \"C\": \"Periodic IVIG\", \"D\": \"Rituximab\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the treatment of peripheral neuropathy associated with an IgM monoclonal gammopathy (often anti-MAG positive), focusing on immunotherapy options.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q317",
    "question_text": "A patient presents with right hand pain, left leg pain, absent brachioradialis tendon reflex, and absent bilateral knee reflexes, along with a high ESR. What is the most likely diagnosis?",
    "options": "{\"A\": \"Mononeuritis multiplex\", \"B\": \"Mononeuropathy\", \"C\": \"Polyneuropathy\", \"D\": \"Radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to recognize the clinical pattern of Mononeuritis Multiplex (involvement of multiple individual peripheral nerves), often associated with vasculitis (suggested by high ESR).",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q346",
    "question_text": "Mitochondrial myopathy (MINGE) *Classification Reason: Although incomplete, the term points towards a mitochondrial muscle disease (myopathy). Reclassified as Neuromuscular.*  ----------  Q355 (Source: Neuroimmunology) Which of the following is the most characteristic feature of mitochondrial myopathy?",
    "options": "{\"A\": \"Demyelination of peripheral nerves\", \"B\": \"Ragged red fibers on muscle biopsy\", \"C\": \"Autoantibody-mediated neuromuscular junction dysfunction\", \"D\": \"Upper motor neuron signs without muscle atrophy E. Pure sensory neuropathy without weakness\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Although incomplete, the term points towards a mitochondrial muscle disease (myopathy). Reclassified as Neuromuscular.",
    "subspecialty": "Neuromuscular"
  },
  {
    "question_number": "Q355",
    "question_text": "Muscle biopsy *Classification Reason: Refers to a diagnostic procedure primarily used in neuromuscular disorders. Too incomplete for specific classification, but best fit is Neuromuscular.*  ----------  Q44 (Source: Neuroimmunology) What is the primary diagnostic use of a muscle biopsy?",
    "options": "{\"A\": \"To diagnose central nervous system tumors\", \"B\": \"To evaluate neuromuscular disorders\", \"C\": \"To assess cognitive decline in dementia\", \"D\": \"To measure intracranial pressure E. To detect peripheral vascular disease\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Refers to a diagnostic procedure primarily used in neuromuscular disorders. Too incomplete for specific classification, but best fit is Neuromuscular.",
    "subspecialty": "Neuromuscular"
  }
]